Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,platelet-derived growth factor binding (GO:0048407),-0.7755442529776395,-1.9249498692909648,0.0034129692832764505,0.1917407684089613,0.132,6/11,14.73%,COL4A1;COL3A1;PDGFRA;COL1A2;COL1A1;COL6A1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.7925015098122015,1.8457423179657813,0.0,0.038791969765705404,0.037,8/35,2.77%,SLA;PTK2B;BTK;FGR;LYN;HCK;SYK;TEC
prerank,phosphotyrosine residue binding (GO:0001784),0.7669255696485159,1.8039844417906703,0.0,0.054403372232391715,0.099,12/37,5.42%,VAV1;FGR;SH3BP2;HCK;SYK;STAP1;PLCG2;GRB2;VAV2;NCK2;LDLRAP1;SAMSN1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.8478668619910292,1.7898309397508056,0.0013227513227513227,0.05298415382632933,0.138,6/15,8.32%,PTAFR;P2RX1;P2RX7;P2RX4;P2RY12;GPR34
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.8563779553941316,1.780664293745279,0.0,0.04825342580612135,0.167,4/13,4.55%,PIK3CG;PIK3CD;PIK3CB;PIP4K2A
prerank,protein phosphorylated amino acid binding (GO:0045309),0.7431254693195413,1.773576325267431,0.0,0.04427961426914665,0.189,13/42,6.62%,VAV1;FGR;SH3BP2;HCK;SYK;STAP1;PLCG2;GRB2;VAV2;NCK2;LDLRAP1;SAMSN1;YWHAB
prerank,protein phosphatase 1 binding (GO:0008157),0.7863285187108701,1.7375555053176266,0.002506265664160401,0.0872030865058337,0.378,3/21,5.90%,LILRB1;PPP1R3E;PPP1R11
prerank,chemokine binding (GO:0019956),0.7553536209080182,1.7373452755704817,0.0012033694344163659,0.07501583003472646,0.379,6/30,5.85%,CX3CR1;CCR2;ITGA4;ITGB3;CXCR4;HMGB1
prerank,anion:anion antiporter activity (GO:0015301),-0.5771183805592653,-1.7295134683432165,0.0205761316872428,0.7588701191250773,0.657,8/17,25.59%,SLC26A2;SLC26A7;SLC25A4;SLC25A11;SLC19A1;SLC4A2;SLC25A5;SLC26A6
prerank,kinase activator activity (GO:0019209),0.7463091960817088,1.7150390050130493,0.00117096018735363,0.10324813904103906,0.53,9/30,10.57%,NCKAP1L;TREM2;GPRC5B;FGF13;RGCC;WNK1;EPO;MALT1;DUSP19
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.7334633783610286,1.7098226120757773,0.0,0.10334012541920977,0.567,8/34,6.59%,BTK;MYO1G;ARHGAP9;DAPP1;IQGAP2;ARAP1;ADAP2;GAB2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.8641096591862814,1.7072195114984963,0.001483679525222552,0.09754761177668847,0.586,3/10,2.52%,CYBB;NCF4;NCF2
prerank,chemokine receptor binding (GO:0042379),0.7244065067865417,1.689471791261315,0.004634994206257242,0.12489121973349054,0.709,12/35,18.57%,PF4;CX3CR1;CXCL5;CXCL2;CCL8;CCL14;CCL13;CCL2;ITCH;CXCL16;CCL25;CKLF
prerank,SH2 domain binding (GO:0042169),0.7317797558342525,1.6890055055532585,0.0011534025374855825,0.11495669089105381,0.709,6/31,3.76%,SLAMF1;LILRB1;BLNK;SH3PXD2B;NUP62;LAT2
prerank,C-C chemokine receptor activity (GO:0016493),0.7634977783789542,1.671723828079868,0.003865979381443299,0.14614310560888638,0.812,3/21,4.58%,CX3CR1;CCR2;CXCR4
prerank,CXCR chemokine receptor binding (GO:0045236),0.8406039444349105,1.6709741252706345,0.005673758865248227,0.13773176721691222,0.815,3/11,2.27%,PF4;CXCL5;CXCL2
prerank,MHC protein binding (GO:0042287),0.7591037541445133,1.6678714536607198,0.005069708491761723,0.1357403559931675,0.831,3/20,1.33%,TUBB;LILRB1;CD74
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.797334701417554,1.6673927006814975,0.006711409395973154,0.12838013164839393,0.833,4/15,10.68%,CX3CR1;CCR2;GPR17;CMKLR1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.8004216383292391,1.6546453537348196,0.008321775312066574,0.1473760917354202,0.885,5/14,7.82%,CYBB;NCF4;NCF2;MICAL1;KMO
prerank,C-C chemokine binding (GO:0019957),0.7446984377331999,1.6473218667513347,0.007653061224489796,0.15763837036226355,0.92,3/22,4.58%,CX3CR1;CCR2;CXCR4
prerank,amyloid-beta binding (GO:0001540),0.6461812268175511,1.63450897741043,0.002068252326783868,0.18609190117386532,0.951,19/79,9.31%,LILRB3;LILRB1;TREM2;GSAP;CALCR;ITGB2;FCGR2B;CD74;CLSTN1;TLR2;ITGA2;MSR1;APOE;LDLRAP1;APBA1;C1QA;CACNA1A;BCHE;ITGAM
prerank,chemokine receptor activity (GO:0004950),0.7223610799267307,1.6220498441288471,0.007398273736128237,0.2133558337113797,0.975,5/24,10.68%,CX3CR1;CCR2;CXCR4;GPR17;CMKLR1
prerank,chemokine activity (GO:0008009),0.7076645958818417,1.6206213260001932,0.009422850412249705,0.2084674147571648,0.977,10/31,18.57%,PF4;CXCL5;CXCL2;CCL8;CCL14;CCL13;CCL2;CXCL16;CCL25;CKLF
prerank,lipoprotein particle binding (GO:0071813),0.7471854397010609,1.6197893111081771,0.009900990099009901,0.2017440467526874,0.981,9/20,12.78%,TREM2;PCSK9;LPL;MSR1;STAB2;STAB1;LIPC;THBS1;SORL1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.7187473694317567,1.6057418329599866,0.013301088270858524,0.23423274214838447,0.989,5/25,6.59%,MYO1G;DAPP1;PLEK;ADAP2;GAB2
prerank,phospholipase binding (GO:0043274),0.803505255593749,1.604664146391431,0.013623978201634877,0.22806051330752616,0.989,3/13,0.95%,BTK;BLNK;SYK
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.7397211917492819,1.6032405012997508,0.01107011070110701,0.22272267519139147,0.989,11/22,14.61%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;ATP6V0D1;ATP2C1;ATP6V0A1;ATP2A3;ATP6V0B
prerank,lipase activity (GO:0016298),0.6739734748877944,1.6025828281107135,0.007683863885839737,0.21637622160120476,0.989,8/43,4.92%,PLBD1;LPL;DAGLB;ABHD12;DDHD1;CEL;LIPA;SMPD3
prerank,cytokine receptor activity (GO:0004896),0.6391105163110082,1.5984888590910058,0.0010224948875255625,0.2207322651799262,0.991,15/83,5.93%,IL10RA;CX3CR1;FLT3;CCR2;CSF3R;CD74;CSF2RB;IL10RB;IL21R;IL12RB2;IL6R;IFNAR1;CD44;IFNGR2;GPR17
prerank,MHC class I protein binding (GO:0042288),0.7741242201097779,1.5860752909059412,0.016973125884016973,0.2510664942153233,0.997,5/13,13.07%,TUBB;LILRB1;DERL1;TAP1;ATP5F1A
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.7333915617857139,1.5857851944566177,0.01608910891089109,0.2435183030540161,0.997,3/21,5.57%,P2RX1;P2RX7;P2RX4
prerank,phospholipase activity (GO:0004620),0.6445815404205114,1.5827959762752828,0.0031380753138075313,0.24473632957875927,0.997,20/67,17.09%,PLBD1;PLD4;PLCB2;PNPLA7;LPL;ABHD12;DDHD1;SMPD3;ASPG;PLD3;LIPC;ABHD4;PRDX6;ABHD3;GDE1;ABHD16A;GDPD3;PDIA3;PLAAT3;PNPLA3
prerank,low-density lipoprotein particle binding (GO:0030169),0.7597551028972849,1.5820594745857475,0.015604681404421327,0.2391917128669026,0.997,8/16,12.78%,TREM2;PCSK9;MSR1;STAB2;STAB1;LIPC;THBS1;SORL1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.6213081142205289,1.5775863448446945,0.0010152284263959391,0.24460820569487865,0.998,19/100,8.70%,BTK;DENND1C;MYO1G;ARHGAP9;DAPP1;NCF4;PLEKHN1;SH3PXD2B;IQGAP2;ZFYVE26;ARAP1;SNX24;ZFYVE28;ADAP2;GAB2;DENND1A;TECPR1;SNX27;DENND1B
prerank,dynactin binding (GO:0034452),0.7808007506269848,1.5665023397596582,0.0375,0.270827011387179,1.0,3/12,2.06%,HOOK3;SPTBN5;SNX5
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.8075160355668325,1.5663413794129641,0.018105849582172703,0.2633624116661663,1.0,3/11,6.71%,AQP1;HCN4;CNGB1
prerank,mannose binding (GO:0005537),0.7817530949515579,1.5625776938670959,0.0379746835443038,0.26770514048068333,1.0,2/12,1.78%,CLEC4D;LMAN1L
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7845198293820222,1.5617216416516342,0.015047879616963064,0.26292335063422545,1.0,3/12,2.72%,PIK3CG;PIK3CD;PIK3CB
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.74967995523841,1.5582520853214232,0.026582278481012658,0.2584471413145199,1.0,7/16,10.51%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V0D1;ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.74967995523841,1.5582520853214232,0.026582278481012658,0.2584471413145199,1.0,7/16,10.51%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V0D1;ATP6V0A1
prerank,GTPase activator activity (GO:0005096),0.6004058196426072,1.551253566647064,0.0,0.27198047094641853,1.0,78/313,11.84%,ARHGAP45;ARHGAP30;NCKAP1L;FGD2;DOCK2;VAV1;CYTH4;DOCK8;DENND1C;ARHGAP25;RGS10;TBC1D9;PREX1;ARHGAP9;ABR;ARHGAP15;RIN2;SIPA1L2;SMAP2;ARHGAP39;IQGAP2;ARHGAP22;TBC1D10C;RIN3;RINL;THY1;ARHGAP24;GNAQ;ELMO1;VAV2;ARHGEF18;RASA4;ARAP1;FNIP1;ASAP1;RIC8A;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;TBC1D16;TBC1D22A;TAGAP;RGL2;FGD6;USP6NL;DENND2C;RP2;DOCK11;MYO9B;DOCK10;GAPVD1;DOCK4;TBC1D10A;DENND1A;RASGRP3;FLCN;ITSN1;DENND1B;SIPA1;ARHGAP10;DENND4B;ARHGAP1;ACAP2;ARFGEF2;RAP1GAP2;EIF2B2;TBC1D2;DENND4C;ARHGEF17;TBC1D17;RAPGEF1;NRP1;DENND4A;TBC1D2B;ARHGAP27;CYTH1;ADAP1
prerank,kinesin binding (GO:0019894),0.6889040327938132,1.5501392614150211,0.016203703703703703,0.26870535154781305,1.0,9/27,9.38%,PLEKHM2;NEFH;SPTBN5;CLSTN1;KLC2;NEK6;SNCA;ACTB;ATCAY
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.8072435895317389,1.5489712818266268,0.019801980198019802,0.2657746078474891,1.0,3/10,2.72%,PIK3CG;PIK3CD;PIK3CB
prerank,diacylglycerol kinase activity (GO:0004143),0.7768190953023241,1.5479465793210767,0.034532374100719423,0.2627806778844097,1.0,7/11,12.73%,DGKZ;DGKK;DGKE;DGKG;DGKD;AGK;DGKI
prerank,protein tyrosine kinase binding (GO:1990782),0.6224785102358531,1.5395706555830542,0.004145077720207254,0.28232544756878386,1.0,15/71,7.98%,TREM2;BLNK;ITGAX;CASS4;SIRPA;CBL;ANGPT4;DUSP3;PTPN1;FIZ1;SHC2;TP53;NEDD9;DOCK4;FLT3LG
prerank,triglyceride lipase activity (GO:0004806),0.7133249128267986,1.5387917642495537,0.02763819095477387,0.2776937347862081,1.0,6/20,17.09%,LPL;DAGLB;CEL;LIPC;LIPE;PNPLA3
prerank,phosphatidylinositol kinase activity (GO:0052742),0.7398657566448141,1.538103529258944,0.03137254901960784,0.2730786467842719,1.0,4/15,4.77%,PIK3CG;PIK3CD;PIK3CB;PI4K2A
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.5914287023443553,1.5307744035371065,0.002008032128514056,0.29038442690998345,1.0,38/147,11.79%,FGD2;DOCK2;VAV1;CYTH4;DOCK8;DENND1C;PREX1;ABR;RIN2;RIN3;RINL;ELMO1;VAV2;ARHGEF18;FNIP1;RIC8A;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;RGL2;FGD6;DENND2C;DOCK11;DOCK10;GAPVD1;DOCK4;DENND1A;ITSN1;DENND1B;DENND4B;ARFGEF2;EIF2B2;DENND4C;ARHGEF17;RAPGEF1;DENND4A;CYTH1
prerank,receptor tyrosine kinase binding (GO:0030971),0.6263941866442466,1.5305182926541416,0.014861995753715499,0.2849106113617169,1.0,17/56,13.66%,BLNK;ITGAX;STAP1;CBL;ANGPT4;DUSP3;PTPN1;FIZ1;SHC2;GAB2;TP53;DOCK4;FLT3LG;SH2B3;NRG1;GAS6;TRADD
prerank,glutamate receptor activity (GO:0008066),-0.507574310046873,-1.5276271605391225,0.06030150753768844,1.0,0.993,5/19,10.77%,GRM7;GRIK4;GRIA2;GRM5;GRM1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.6100661326405167,1.52730584303226,0.0030959752321981426,0.2875888408951432,1.0,25/85,17.09%,PNPLA7;LPL;DAGLB;ABHD12;ESD;CEL;LIPA;ASPG;PON3;PLA2G7;BCHE;LIPC;PAFAH1B2;ABHD4;PGAP1;PRDX6;ABHD3;LIPE;GDE1;ABHD16A;GDPD3;TARS2;PGLS;PLAAT3;PNPLA3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.6080499310939,1.5242903302320845,0.01134020618556701,0.2903701549709695,1.0,26/78,16.22%,CTSS;CTSB;LGMN;CTSC;CTSK;CTSL;ESPL1;CAPN15;PYCARD;USP35;CASP1;CFLAR;MALT1;CTSZ;USP7;USP48;CASP7;USP18;CASP8;USP9X;CAPN2;USP8;CAPN3;USP29;USP16;PDIA3
prerank,GTPase regulator activity (GO:0030695),0.5915927375726883,1.517287365237963,0.0,0.30607810290745596,1.0,48/212,11.84%,ARHGAP45;ARHGAP30;NCKAP1L;ARHGAP25;RGS10;TBC1D9;PREX1;ARHGAP9;ABR;ARHGAP15;RIN2;SIPA1L2;SIRPA;SMAP2;ARHGAP39;IQGAP2;ARHGAP22;TBC1D10C;THY1;ARHGAP24;GNAQ;RASA4;ARAP1;ASAP1;RIC8A;VAV3;ARFGEF1;RAB3GAP2;TBC1D16;TBC1D22A;TAGAP;USP6NL;RP2;MYO9B;TBC1D10A;RASGRP3;FLCN;SIPA1;ARHGAP10;ARHGAP1;ACAP2;RAP1GAP2;TBC1D2;TBC1D17;NRP1;TBC1D2B;ARHGAP27;ADAP1
prerank,tau protein binding (GO:0048156),0.6317710652193423,1.5126135043001325,0.02765486725663717,0.31458413740653585,1.0,21/40,21.61%,BAG2;LGMN;PPP2CB;S100B;SNCA;APOE;ACTB;HDAC6;FYN;PPP2CA;STUB1;GSK3A;HSP90AA1;BIN1;PICALM;TAOK1;ROCK2;GSK3B;MARK1;BRSK1;PIN1
prerank,WW domain binding (GO:0050699),0.6649109844637213,1.5067542627320798,0.046341463414634146,0.32814876863250325,1.0,6/26,11.44%,NFE2;TCEAL3;TCEAL6;KIF20B;LITAF;TCEAL8
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.674417693734439,1.500625212570472,0.0423728813559322,0.34186204372446316,1.0,5/24,6.39%,PTK2B;MAPKAPK3;CAMK1D;MYLK3;MKNK1
prerank,aspartic-type peptidase activity (GO:0070001),0.7766523058309355,1.4974877682281114,0.039647577092511016,0.34550083640918916,1.0,4/10,9.82%,NAPSA;CTSD;DDI2;CTSE
prerank,protein tyrosine kinase activity (GO:0004713),0.590296467808795,1.4966200218199224,0.004024144869215292,0.3420402371847097,1.0,12/108,4.28%,SLA;PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TYK2;TEC;TTN
prerank,cysteine-type peptidase activity (GO:0008234),0.6008881248616103,1.4965386738366402,0.013499480789200415,0.336320971322357,1.0,29/73,17.04%,CTSS;CTSB;LGMN;CTSC;OTULINL;CTSK;CTSL;ESPL1;OTULIN;USP35;CASP1;MALT1;CTSZ;TINAGL1;USP7;USP48;CASP7;USP18;GGH;CASP8;USP9X;CAPN2;USP8;CAPN3;USP29;USP21;USP16;PDIA3;ATG4A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7059177402854229,1.495218463132769,0.04639175257731959,0.3291771059302646,1.0,6/16,15.43%,PTPRC;PTPRE;PTPRU;PTPRO;PTPRT;PTPRA
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7059177402854229,1.495218463132769,0.04639175257731959,0.3291771059302646,1.0,6/16,15.43%,PTPRC;PTPRE;PTPRU;PTPRO;PTPRT;PTPRA
prerank,CCR chemokine receptor binding (GO:0048020),0.6520159788948647,1.4926243537455337,0.036773428232502965,0.33164808876583435,1.0,5/28,11.55%,CCR2;CCL8;CCL14;CCL13;CCL2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5925935792626487,1.488844374762516,0.011282051282051283,0.3373482151210307,1.0,11/73,12.36%,CALCR;GP1BA;CX3CR1;CYSLTR2;EDNRB;GALR1;CCKBR;SORCS3;CYSLTR1;GPR37;LTB4R2
prerank,ankyrin binding (GO:0030506),0.6887207340046672,1.4881986519695622,0.05402010050251256,0.3338653135573006,1.0,3/19,3.19%,PTPRC;KCNJ11;SLC8A1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.5663305108996812,-1.485284750212844,0.07119741100323625,1.0,0.998,8/12,32.75%,CRYZL1;DHRS4;AIFM2;NQO2;CBR4;NDUFS7;CRYZ;NQO1
prerank,sterol transfer activity (GO:0120015),0.7015522486364747,1.473581170673909,0.05370843989769821,0.3742005863984509,1.0,7/17,19.11%,ABCA1;NPC2;ABCG1;OSBP;STARD4;STARD5;GRAMD1C
prerank,chemoattractant activity (GO:0042056),0.6405360983210958,1.4725218502480688,0.05402160864345738,0.37188027694092024,1.0,5/26,8.95%,GPNMB;LGALS3;HMGB1;VEGFB;NTF3
prerank,ephrin receptor binding (GO:0046875),0.6811960339746692,1.4715570178526465,0.06056860321384425,0.36917418787697986,1.0,6/21,6.35%,LYN;PIK3CG;CBL;GRB2;PTPN1;EFNA2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.7353426269986055,1.4681653280424092,0.06676136363636363,0.3750375613558723,1.0,5/12,13.66%,BLNK;STAP1;GAB2;SH2B3;TRADD
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.42149244500820926,-1.4660492506846923,0.029850746268656716,1.0,0.999,11/32,21.70%,KCNQ3;KCNQ5;KCNA1;KCNS3;KCNA2;KCNB2;KCNC1;KCNC3;KCNH1;KCNQ2;KCNQ4
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6021055975778429,-1.4607545812089906,0.06645569620253164,1.0,0.999,6/10,22.86%,GNAS;IGSF11;SHANK3;SHANK1;SHANK2;SHISA7
prerank,P-type ion transporter activity (GO:0015662),0.7259769667640845,1.4567486180190894,0.06821480406386067,0.40851986785414146,1.0,6/12,13.41%,ATP7A;ATP6V1E1;ATP2C1;ATP2B1;ATP2B3;ATP2A3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7105513629048597,1.4554102748942113,0.062087186261558784,0.40681436658552644,1.0,2/14,3.05%,AKR1A1;DHRS3
prerank,ligand-gated ion channel activity (GO:0015276),-0.41537448611844174,-1.45525894449966,0.04697986577181208,1.0,1.0,7/30,12.81%,GRIA3;GRIN3A;GRIK4;GRIA2;GABRB1;GRIN2B;GRIN1
prerank,steroid hydroxylase activity (GO:0008395),0.6976253276809464,1.4511809665600948,0.07388535031847134,0.41523269502078414,1.0,1/16,0.47%,CYP1A1
prerank,water transmembrane transporter activity (GO:0005372),0.7495188849934189,1.4510455090698466,0.06926406926406926,0.40974960782566583,1.0,2/11,8.14%,AQP1;AQP11
prerank,actin monomer binding (GO:0003785),0.6505267162613683,1.442264482033703,0.0685785536159601,0.43391589037924755,1.0,9/22,12.64%,CORO1A;MYL3;MRTFA;MTSS1;TMSB4X;PFN2;PFN1;TWF2;TMSB10
prerank,DNA replication origin binding (GO:0003688),0.6522736317763156,1.4415646310123735,0.05513784461152882,0.4303629898946946,1.0,9/23,13.79%,MCM5;ORC3;DHX9;MCM6;MCM2;ORC4;MCM9;KAT7;CDC6
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.6369054069504578,1.4411174829105404,0.0587557603686636,0.4262123127984041,1.0,3/29,1.28%,MGAM;HPSE;GUSB
prerank,3'-5' DNA helicase activity (GO:0043138),0.6927167525658005,1.4407063104116888,0.07652399481193256,0.42166987783409937,1.0,5/16,10.17%,MCM5;DHX9;NAV2;MCM6;MCM2
prerank,ligand-gated channel activity (GO:0022834),-0.417863718356505,-1.4395865016326466,0.06040268456375839,1.0,1.0,7/29,12.81%,GRIA3;GRIN3A;GRIK4;GRIA2;GABRB1;GRIN2B;GRIN1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.5727303607878149,1.4392237833541093,0.023735810113519093,0.42125215157241125,1.0,15/71,11.36%,PTPRC;PTPN7;UBASH3B;PTPRJ;DUSP3;PTPN1;PTPN18;PALD1;PTPRE;PTP4A2;MTMR3;PTP4A1;PTPRU;PTPRO;TIMM50
prerank,lipase activator activity (GO:0060229),0.7473318720928636,1.439126576152658,0.08285714285714285,0.41596345336084695,1.0,5/10,17.77%,BTK;CCL8;FYN;SRC;PDPK1
prerank,phospholipase activator activity (GO:0016004),0.7429208922636701,1.4385863454574146,0.0948905109489051,0.4121335555499606,1.0,5/10,17.77%,BTK;CCL8;FYN;SRC;PDPK1
prerank,cholesterol transfer activity (GO:0120020),0.6935069560401993,1.4383933088126317,0.07225806451612904,0.407432414789756,1.0,6/16,19.11%,ABCA1;NPC2;ABCG1;STARD4;STARD5;GRAMD1C
prerank,lysophospholipase activity (GO:0004622),0.6629702768741861,1.4353733046154127,0.07701564380264742,0.41241031271551526,1.0,7/20,15.84%,PNPLA7;ABHD12;ASPG;ABHD4;GDE1;ABHD16A;GDPD3
prerank,thyroid hormone receptor binding (GO:0046966),0.6303370813741214,1.4338795479321842,0.07885304659498207,0.4126033190485695,1.0,6/28,3.64%,BRD8;GAS2L1;MED17;GTF2H1;NSD1;TACC1
prerank,Toll-like receptor binding (GO:0035325),0.7389993100369489,1.432223217850568,0.08383233532934131,0.413098997544611,1.0,3/11,2.43%,TLR1;UNC93B1;TLR2
prerank,protein kinase activator activity (GO:0030295),0.5686913218996558,1.4146144286059625,0.03597883597883598,0.46754777892559174,1.0,23/60,19.10%,NCKAP1L;GPRC5B;FGF13;RGCC;WNK1;EPO;ABI1;DBF4;DUSP19;MAP2K2;PARP16;NRG1;GAS6;STK3;STRADA;ERCC6;ALS2;INCENP;IRGM;STK4;IQGAP1;TAOK1;RPTOR
prerank,acetylcholine receptor activity (GO:0015464),-0.44909563988381496,-1.4035369177317827,0.11602209944751381,1.0,1.0,5/22,21.96%,CHRM2;CHRFAM7A;CHRNA7;CHRM3;CHRNB1
prerank,metal ion:proton antiporter activity (GO:0051139),0.6969857127315371,1.3995087828636428,0.10618279569892473,0.5164685778354371,1.0,4/13,7.37%,SLC11A1;SLC9A4;SLC9A9;SLC9A1
prerank,retinoic acid binding (GO:0001972),-0.543657015191817,-1.3990644203092433,0.0984251968503937,1.0,1.0,1/12,0.35%,NR2F2
prerank,MAP kinase kinase activity (GO:0004708),0.6762823874124243,1.3976612154323713,0.10993377483443709,0.5171198696595533,1.0,6/15,14.53%,MAPKAPK3;MAPK14;MAP2K6;MAP2K3;MAP2K2;LRRK2
prerank,endoribonuclease activity (GO:0004521),0.5990686186331438,1.3893163032541727,0.08352668213457076,0.5420963765632606,1.0,8/32,11.72%,SLFN14;ERN1;NOB1;SND1;ZC3H12D;ENDOV;RNASEL;AGO3
prerank,cytokine activity (GO:0005125),0.5427066669694347,1.3883872118973979,0.017189079878665317,0.5390024539353666,1.0,19/131,12.63%,PF4;TGFB1;CXCL5;IL1A;CXCL2;SLURP1;OSM;CCL8;TNF;IL18;TIMP1;NDP;HMGB1;EPO;CCL14;INHBA;CCL13;CCL2;NRG1
prerank,protein kinase regulator activity (GO:0019887),0.5448841347052987,1.381978358013361,0.038461538461538464,0.5566086575032142,1.0,17/95,10.57%,NCKAP1L;GMFG;PRKAR2B;TAOK3;GPRC5B;FGF13;CCND3;SNCA;RGCC;DNAJC3;CCND2;YWHAB;WNK1;EPO;QARS1;CCNL1;DUSP19
prerank,bHLH transcription factor binding (GO:0043425),0.6434925470813272,1.3803589077704395,0.11337579617834395,0.5565293694393632,1.0,5/19,8.71%,ASCL1;BHLHE41;USF1;LMO2;SMAD3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6866862138585124,1.3789205820270651,0.13788300835654596,0.5553874695724162,1.0,6/12,9.92%,TNF;TRAF2;TRAF3;TRAP1;BABAM2;TRAF5
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.702240776139969,1.3720937589521336,0.14450867052023122,0.5752033730098717,1.0,2/10,3.38%,PRKAR2B;PKIB
prerank,hormone activity (GO:0005179),0.5500069337864563,1.3670033894174136,0.07709011943539631,0.5890807658052308,1.0,6/54,10.80%,TSHB;METRNL;PPY;VGF;INHBA;CHGB
prerank,SH3 domain binding (GO:0017124),0.5479043930120543,1.3641050699635677,0.06203995793901157,0.59312932168968,1.0,14/62,12.52%,SH3BP2;CD3E;CBL;GRB2;ELMO1;WIPF1;AKAP5;DNM2;MICAL1;WASF2;ABI1;ZNF106;ARHGAP27;SYNJ1
prerank,ligand-gated cation channel activity (GO:0099094),0.5484686949614015,1.3585923502455814,0.07533539731682147,0.6072403623504351,1.0,7/75,5.98%,PTK2B;KCNJ11;P2RX1;P2RX7;KCNK6;P2RX4;CCDC51
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6750106873902992,1.353633618006734,0.13953488372093023,0.6204171760351461,1.0,4/13,15.28%,EHHADH;SREBF2;ECI1;ECH1
prerank,G protein-coupled receptor activity (GO:0004930),0.5244667878970989,1.3514562674917536,0.005005005005005005,0.6225235459443039,1.0,26/239,11.03%,GPR141;CNR2;LPAR6;CALCR;PTAFR;CX3CR1;ADGRE1;P2RY6;CYSLTR2;ADGRG5;ADGRE5;FFAR2;MRGPRF;CXCR4;LGR6;S1PR4;GALR1;ADGRG3;GPR17;P2RY12;GPR34;GPR183;XPR1;CYSLTR1;CMKLR1;GPR37
prerank,cholesterol binding (GO:0015485),0.5638425852401814,1.3511255975797012,0.08287292817679558,0.6170064469640515,1.0,18/47,21.44%,TSPO;ABCA1;NPC2;ABCG1;NPC1;SOAT2;ERLIN1;ERLIN2;OSBPL10;STARD4;VDAC2;VDAC1;OSBPL8;STARD5;GRAMD1C;OSBPL7;STARD3;SCARB2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6892805292436793,1.3507057504911437,0.16332378223495703,0.6120280819310314,1.0,3/10,13.47%,APOBEC1;CDA;LACC1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.579516673096446,1.3505555841384518,0.09427609427609428,0.6062549883876422,1.0,9/38,8.72%,BLNK;CD3E;STAP1;LAT;NUP62;NCK2;LDLRAP1;GAB2;MMS19
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5989474142615068,1.3490164123197002,0.11811926605504587,0.6054656047577608,1.0,7/29,10.11%,MAPKAPK3;NFATC1;PTPRJ;MAPK14;GCH1;DUSP10;TPR
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6768649137184014,1.34819675208684,0.14124293785310735,0.6024558241169098,1.0,3/13,3.63%,ITGB3;PTPRJ;ERN1
prerank,carbohydrate kinase activity (GO:0019200),0.6886277115415489,1.340456731562361,0.15555555555555556,0.6253076297110901,1.0,5/11,15.88%,HK3;NAGK;POMK;HK2;XYLB
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6782998857504594,1.3403850027591706,0.14862914862914864,0.6193131884038999,1.0,1/11,1.17%,GATA1
prerank,phospholipase inhibitor activity (GO:0004859),0.6863720639747126,1.3378285694389476,0.1618320610687023,0.6231481915089248,1.0,4/10,9.80%,ANGPTL3;SNCA;ANXA1;ANXA4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3242767449019588,-1.3369549711200739,0.04918032786885246,1.0,1.0,13/60,7.11%,ROR1;CRIM1;NTRK3;AXL;EGFR;ALK;EPHA7;EFEMP1;EPHA3;EPHB4;EPHB2;PDGFRA;ROR2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4905105053582344,-1.3367139045595406,0.13008130081300814,1.0,1.0,7/14,14.48%,RECK;COL4A3;TIMP2;SPOCK2;TIMP3;NGF;BST2
prerank,serine-type endopeptidase activity (GO:0004252),0.528820292644302,1.3336726287438574,0.08,0.6323835128061702,1.0,5/80,4.68%,KLK3;PCSK9;F10;MASP1;RHBDF2
prerank,E-box binding (GO:0070888),0.5721977813994019,1.332878119082183,0.12655367231638417,0.6290321682716155,1.0,7/34,8.69%,ASCL1;SREBF2;MITF;BHLHE41;TAL1;SNAI1;CIART
prerank,protein phosphatase binding (GO:0019903),0.5236520657529297,1.328653744458688,0.04044489383215369,0.6387834463857969,1.0,29/117,17.46%,CD22;LILRB1;LGALS3;SIRPA;PPP1R3E;KCNN4;MAPK14;PPP6R1;TRAF2;AKAP5;TRAF3;PPP1R11;CTNNB1;TP53;MAP3K5;SLC9A1;MTMR3;ENSA;STRN;BOD1L1;ADCY8;CTTNBP2NL;PTPRT;PTPA;CD33;SMG7;PPP3CB;IQGAP1;ANK1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.5324768008193859,1.327404251507605,0.08367768595041322,0.6373986564585878,1.0,18/74,14.28%,HK3;PIK3CG;DGKZ;PIK3CD;PIK3CB;CHKB;DGKK;DGKE;NADK;DGKG;DGKD;AGK;FAM20C;PAPSS1;POMK;DGKI;SHPK;HK2
prerank,copper ion binding (GO:0005507),0.5560580667657792,1.3265336864866735,0.1365149833518313,0.6347487480422604,1.0,7/42,6.70%,IL1A;SNCA;ATP7A;ATOX1;RNF7;P2RX4;TP53
prerank,cation:chloride symporter activity (GO:0015377),-0.5371522443547382,-1.3244782744412726,0.14576271186440679,1.0,1.0,2/10,1.03%,SLC12A2;SLC12A7
prerank,transforming growth factor beta receptor binding (GO:0005160),0.6312734218988928,1.3229532793931564,0.15414012738853503,0.6427219651899225,1.0,6/18,12.94%,TGFB1;TGFBR1;TGFBR2;TGFBRAP1;SMAD3;BAMBI
prerank,hexosaminidase activity (GO:0015929),0.6577432054562771,1.320056324259081,0.1671388101983003,0.648604512157762,1.0,3/12,6.91%,HEXB;HEXA;OGA
prerank,sodium channel regulator activity (GO:0017080),0.5581046725083683,1.3165545878325133,0.12979683972911965,0.6555326810983826,1.0,12/37,20.21%,PCSK9;SCN4B;FGF13;PKP2;PRSS8;NEDD4L;FXYD5;SGK3;YWHAH;FXYD6;PTPN3;FXYD1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.5888030567900953,1.3164648508390475,0.14201183431952663,0.6500276014793879,1.0,6/26,11.22%,LGALS3;MGAT5;SAG;PPP1R11;ENSA;BOD1L1
prerank,GABA receptor binding (GO:0050811),0.6687069551267768,1.3116185361861463,0.18394160583941604,0.6629101592888575,1.0,3/11,9.62%,PLCL2;AKAP5;ARFGEF2
prerank,single-stranded DNA helicase activity (GO:0017116),0.6078149333350223,1.307964638542728,0.18444165621079048,0.6709930656343835,1.0,5/19,13.34%,MCM5;DHX9;MCM6;MCM2;DNA2
prerank,glutamate receptor binding (GO:0035254),-0.44808877190957763,-1.307914049775118,0.15418502202643172,1.0,1.0,9/17,15.99%,GNAS;SYNDIG1;IGSF11;HOMER3;SHANK3;SHANK1;SHANK2;CAMK2A;HOMER2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.5075213481962858,1.305607536510018,0.021,0.6733983848694991,1.0,46/188,14.60%,RUNX1;AHRR;CIITA;GATA1;NFE2L2;POU2F2;BASP1;DHX9;TNF;SNCA;ATF3;CEBPA;FOXO3;DDIT3;SPI1;MAFK;HDAC5;HMGB1;XRCC5;FLI1;TFEB;TP53;TBL1XR1;NKX2-1;TAL1;YY1;CREB3L1;CEBPB;MEF2C;SMAD3;HSF1;HNRNPL;ARID4A;HDAC4;RNF10;TBL1X;CREB3L2;RBBP5;ATF6B;NFKB1;FOXK1;SOX6;IRF1;SOX2;BRD7;SOX4
prerank,CoA-ligase activity (GO:0016405),-0.46409277887593875,-1.2892519608687392,0.1759656652360515,1.0,1.0,6/14,29.46%,ACSL1;ACSS2;ACSS1;ACSBG1;SLC27A2;AACS
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.5390631267114443,-1.2884403662342263,0.1461794019933555,1.0,1.0,6/10,14.50%,ATF2;USP22;HAT1;BRCA2;NAA60;MSL3
prerank,calcium channel inhibitor activity (GO:0019855),-0.5016104485966443,-1.287025600668432,0.1694915254237288,1.0,1.0,4/11,26.19%,FKBP1A;SLC30A1;PACSIN3;CALM2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5674679056638786,1.2831779441221949,0.1773049645390071,0.7524983946300557,1.0,8/28,18.46%,MAPKAPK3;MAPK14;MAP2K6;MAP2K3;MAP2K2;LRRK2;RPS6KA2;MAP2K5
prerank,1-phosphatidylinositol binding (GO:0005545),0.6122759928529742,1.2813052139447896,0.20052083333333334,0.7533765936457412,1.0,8/15,18.20%,SNX9;ZFYVE9;WDFY1;EPB41;FRMPD2;WDFY3;SNX10;PICALM
prerank,insulin-like growth factor I binding (GO:0031994),0.6228134958985516,1.2808401680268056,0.21508379888268156,0.7488216819542536,1.0,2/13,3.96%,ITGB3;ITGA6
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.41269415995259,-1.2804395445959027,0.15228426395939088,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.41269415995259,-1.2804395445959027,0.15228426395939088,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,serotonin receptor activity (GO:0099589),-0.41269415995259,-1.2804395445959027,0.15228426395939088,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,MAP kinase phosphatase activity (GO:0033549),0.6403905065995055,1.2792230689499626,0.21904761904761905,0.7483209909660508,1.0,3/12,8.91%,DUSP3;DUSP29;DUSP10
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6340875766479714,1.2772111047578552,0.2188365650969529,0.7498084649978712,1.0,5/12,14.82%,NAPSA;DDI2;SPPL3;CTSE;SPPL2A
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.4962479743575082,-1.2771546241536615,0.16911764705882354,1.0,1.0,5/11,35.22%,KCND3;KCNJ3;KCNJ8;KCNE4;KCNH2
prerank,receptor antagonist activity (GO:0048019),0.603516109239977,1.275070621554965,0.20052770448548812,0.7521699861196675,1.0,3/17,13.45%,DKK2;IL18BP;PXDN
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3459649201706785,-1.2729641688824187,0.09009009009009009,1.0,1.0,5/38,4.45%,APP;SERPINH1;SERPINE2;SERPING1;TFPI
prerank,sterol binding (GO:0032934),0.5239890644922208,1.2714766283923304,0.15075921908893708,0.7597001843492992,1.0,16/56,15.24%,TSPO;ABCA1;NPC2;ABCG1;NPC1;OSBPL11;SOAT2;ERLIN1;ERLIN2;OSBPL10;GPR183;OSBP;STARD4;VDAC2;VDAC1;OSBPL8
prerank,protein kinase C binding (GO:0005080),0.5267917515183055,1.2690144596990032,0.17993456924754633,0.7630664296595464,1.0,11/43,12.18%,PLEK;PKP2;PRKD2;ADCY6;HDAC5;PRKCB;HINT1;PKN1;NELL1;HDAC9;TWF2
prerank,lipoprotein particle receptor binding (GO:0070325),0.5590781749851641,1.2685115120925274,0.18478260869565216,0.7587933899599928,1.0,9/27,19.92%,PCSK9;APOE;LDLRAP1;CLTC;LRP1;AP2M1;MESD;PICALM;RELN
prerank,phosphatase inhibitor activity (GO:0019212),0.5978023755740997,1.2672028719833122,0.17572692793931732,0.7574124466547495,1.0,5/20,11.22%,LGALS3;MGAT5;SAG;ENSA;BOD1L1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.605790053491516,1.2663337004674142,0.22402159244264508,0.7546078879594145,1.0,4/14,10.15%,BLVRB;CRYM;QDPR;PYCR2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4602532782221735,-1.2643433060453981,0.17916666666666667,1.0,1.0,6/15,30.79%,SLC26A2;SLC26A7;SLC39A8;SLC26A6;CFTR;SLC26A8
prerank,chemorepellent activity (GO:0045499),-0.39173633241800376,-1.261911657703599,0.11267605633802817,1.0,1.0,8/25,8.55%,SEMA6A;SEMA5A;EPHA7;SEMA3A;SEMA6D;NRG3;SEMA3C;SEMA3D
prerank,alanine transmembrane transporter activity (GO:0022858),0.6361769828254347,1.2608865236005697,0.23374827109266944,0.7694716852170661,1.0,6/12,23.02%,SLC7A8;SLC36A1;SLC36A4;SLC1A4;SLC38A7;SLC6A6
prerank,insulin-like growth factor binding (GO:0005520),0.6057357976934952,1.2597368758895013,0.2169811320754717,0.7677487329047444,1.0,2/15,3.96%,ITGB3;ITGA6
prerank,Hsp70 protein binding (GO:0030544),0.5514068402380726,1.2596785685987588,0.1930635838150289,0.7619650570423417,1.0,7/31,13.60%,CYP1A1;ERN1;SNCA;DNAJC8;GPR37;NOD2;STUB1
prerank,phosphatase binding (GO:0019902),0.5008970329300889,1.2575848431316237,0.10670731707317073,0.763906225563909,1.0,16/105,8.71%,CD22;LGALS3;SIRPA;CTSC;KCNN4;MAPK14;PPP6R1;TRAF2;TRAF3;CTNNB1;CEP192;TP53;MAP3K5;WNK1;MTMR3;SMAD3
prerank,Hsp90 protein binding (GO:0051879),0.5470575095471454,1.2569129052833823,0.17734553775743708,0.7605991730459303,1.0,12/33,17.78%,CYP1A1;PTGES3;ERN1;CSNK2A1;HSF1;AHSA1;HDAC6;NOD2;STUB1;CHORDC1;HIF1A;NPAS2
prerank,semaphorin receptor activity (GO:0017154),0.6341670557930537,1.2542301019111064,0.22946175637393768,0.7650490019367175,1.0,3/11,11.24%,PLXNC1;PLXNB2;NRP1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5624137807354959,1.2525798636222323,0.21508034610630408,0.7654532969788332,1.0,2/23,2.02%,PLCB2;PLCG2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5640173986484195,1.247960852080688,0.21820448877805487,0.776621921753541,1.0,7/22,18.20%,PCSK9;APOE;LDLRAP1;CLTC;AP2M1;MESD;PICALM
prerank,transcription cis-regulatory region binding (GO:0000976),0.4800999934369445,1.2469263577141825,0.015,0.7748720673457968,1.0,83/406,14.65%,RUNX1;NFE2;NPAS4;MMP12;AHRR;ASCL1;CIITA;GATA1;NFE2L2;POU2F2;BASP1;RREB1;CREB3;BARX2;RXRB;NR1H4;TNF;SNCA;MLXIP;NFXL1;ATF3;CEBPA;FOXO3;DDIT3;SPI1;MAFK;HOXC8;HDAC5;HMGB1;XRCC5;FLI1;TEAD1;TRPS1;TFEB;ZFP69;ZNF177;TP53;MEF2A;ACTN4;TBL1XR1;NKX2-1;TAL1;LONP1;YY1;CREB3L1;ZFP90;CEBPB;FOXN2;SNAI1;MEF2C;CDC5L;TFAP2B;RB1;SMAD3;IRF2;HSF1;CREBRF;HNRNPL;ARID4A;HDAC4;NFX1;RNF10;TBL1X;CREB3L2;RBBP5;SOX9;NR2C2;ETV6;E2F6;ATF6B;SNAPC3;MAX;TIPARP;FOXN3;NFKB1;FOXK1;SOX6;CUX1;IRF1;SOX2;BRD7;SOX4;SREBF1
prerank,ephrin receptor activity (GO:0005003),-0.42584698800970655,-1.2457170467475913,0.16908212560386474,1.0,1.0,4/17,4.78%,EPHA7;EPHA3;EPHB4;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.42584698800970655,-1.2457170467475913,0.16908212560386474,1.0,1.0,4/17,4.78%,EPHA7;EPHA3;EPHB4;EPHB2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6160907216774439,1.2424442846507469,0.229901269393512,0.7865834042844471,1.0,5/12,12.40%,ARSB;GNS;IDS;SULF2;ARSA
prerank,cytokine receptor binding (GO:0005126),0.4974106529693736,1.2422709225135455,0.14754098360655737,0.7814606133145904,1.0,17/83,13.68%,SYK;TYK2;OSM;IL6R;PYCARD;IL18;CD300LF;VEGFB;EPO;TGFBRAP1;SMAD3;SH2B3;TIMM50;SDCBP;PRLR;PXDN;ERAP1
prerank,endonuclease activity (GO:0004519),0.5084305279948721,1.2406699419443672,0.19679144385026737,0.7818684837252635,1.0,13/49,17.89%,SLFN14;ERN1;NOB1;SND1;ZC3H12D;RNASEL;AGO3;ERCC5;REXO4;OGG1;ZC3H12C;N4BP2;AGO2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.5458262942453286,1.239097962647841,0.2211764705882353,0.782064759143599,1.0,12/28,21.10%,EXO1;ELAC2;ENDOV;RPP38;ELAC1;AGO3;RNASEH1;RPP14;PRORP;AGO2;RNASEH2A;DICER1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.39292025815893833,-1.2378235883166648,0.1712707182320442,1.0,1.0,4/21,10.77%,CHRFAM7A;CHRNA7;GRM5;GRM1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.5029022678863702,1.2348739585289652,0.1976241900647948,0.79223017671362,1.0,11/54,13.99%,KLK3;ASPG;PIGL;HDAC5;HINT1;ACER3;HDAC4;HDAC6;HDAC9;DARS1;HDAC11
prerank,protein kinase binding (GO:0019901),0.4769213439981202,1.233274001008961,0.012,0.7922415051784577,1.0,89/480,12.82%,PTPRC;CD226;TREM2;IRF5;BLNK;FGR;PLEK;CD3E;ITGB2;CASS4;HCLS1;STAP1;LYST;NEFH;MAPKAPK3;LAT;SIRPA;PRKAR2B;PLCG2;GPRC5B;PRKCD;PTPRJ;THY1;MAD2L2;DUSP3;GRB2;PTPN1;RFFL;MAP2K6;TRIM5;NEK6;PKP2;CCND3;GCH1;RGCC;PRKD2;TUBA4A;CIR1;TTN;SKI;TRAF2;DNAJC3;FOXO3;ADCY6;NBEAL2;CCND2;HDAC5;SHC2;PRKCB;MAP2K3;BCL2L1;CEP192;ACTB;MAPRE1;TP53;USF1;NEDD9;WNK1;TICAM1;HINT1;TRAP1;CHEK2;KIF14;AP1B1;TRIM27;MAP3K1;SMAD3;DUSP10;HSF1;QARS1;IBTK;BCAR1;TPR;DUSP19;PKN1;SH2B3;LIMS1;CLTC;SOX9;NELL1;BECN1;ADIPOR1;PRDX3;HDAC9;TWF2;NOD2;MAP3K12;TBL2;EXOC2
prerank,ribosomal large subunit binding (GO:0043023),-0.4933442293152789,-1.232992354146599,0.22875816993464052,1.0,1.0,6/11,25.32%,CPSF6;NEMF;DHX33;NPM1;NMD3;MRRF
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.5241582878367449,1.2325552090636953,0.19457013574660634,0.789320292608573,1.0,7/38,8.38%,NCF4;SH3PXD2B;ZFYVE26;ZFYVE28;DENND1A;TECPR1;SNX27
prerank,peptide hormone receptor binding (GO:0051428),-0.4848758956049165,-1.2323788010028007,0.21846153846153846,1.0,1.0,5/11,34.94%,PSMC5;PTHLH;ADCYAP1;GNRH1;CCK
prerank,fatty acid synthase activity (GO:0004312),-0.500075323230046,-1.2289189169466856,0.1919191919191919,1.0,1.0,7/10,42.93%,ELOVL5;CBR4;ELOVL1;OXSM;MCAT;ELOVL4;ELOVL2
prerank,actin binding (GO:0003779),0.477530621073415,1.2218675812135238,0.0914572864321608,0.8240128651536907,1.0,46/170,14.92%,MYO1F;LCP1;SPTBN5;IQGAP2;CORO1A;MYL3;SNCA;GAS2L3;CXCR4;MYH9;SYNE1;FLII;MRTFA;MACF1;MYO9B;CAPZB;MTSS1;ACTN4;KCNMA1;LDB3;TMSB4X;MICAL1;P4HB;CAPZA1;CAP1;TNNT3;MYO19;TLNRD1;VCL;PFN2;MAP1B;PARVB;MAEA;PFN1;TWF2;NOD2;COTL1;TMSB10;SMTN;SSH2;ADCY8;SYNPO;MYH10;LRRK2;PDLIM1;FXYD5
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5307402205876964,1.2215915811194775,0.22939068100358423,0.8193025454745921,1.0,11/30,22.07%,TNFAIP8;PTTG1;CST7;SNCA;PRDX3;GAS6;PRDX5;UBE2Z;BIRC2;BIRC3;MT3
prerank,glycerophospholipid flippase activity (GO:0140333),0.631580659856815,1.2211648663891765,0.254985754985755,0.815071585603916,1.0,5/11,15.26%,ATP8A1;ATP8A2;ABCB4;ABCA4;ABCA3
prerank,nuclear receptor coactivator activity (GO:0030374),0.502374353141561,1.2210576245278202,0.20064377682403434,0.8098092850702497,1.0,20/52,22.17%,BRD8;MED17;TACC1;ZMIZ2;PRKCB;CCAR1;ACTN4;PPARGC1A;RNF4;ACTN1;PKN1;SRA1;BUD31;THRAP3;TMF1;MED4;MED13;SFR1;FGF2;MED30
prerank,acid-thiol ligase activity (GO:0016878),-0.46059717657490046,-1.2204459851345635,0.23076923076923078,1.0,1.0,6/13,30.53%,ACSL1;ACSS2;ACSS1;SLC27A2;AACS;AASDH
prerank,protein kinase C activity (GO:0004697),0.5928988026590879,1.2200164487762244,0.252361673414305,0.8079176195607236,1.0,6/14,10.83%,PRKCD;PRKCB;PRKCQ;SMG1;PRKCH;PKN1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5751204911681078,1.2170191751565544,0.25551232166018156,0.8133312194198379,1.0,8/18,22.07%,TNFAIP8;SNCA;PRDX3;GAS6;PRDX5;BIRC2;BIRC3;MT3
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.39214301924773576,-1.214758972892841,0.1881720430107527,1.0,1.0,8/20,26.16%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;SLC39A10;SLC39A12
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4707571452057344,1.2140499556263071,0.10130391173520562,0.8189785205578423,1.0,37/173,13.82%,BATF3;ASCL1;IRF8;BCL11A;ZEB2;SREBF2;MITF;SKI;ATF3;FOXO3;LRRFIP1;MYT1L;ZBTB12;ZBTB39;MAFK;BHLHE41;BACH1;TRPS1;ZFP69;ZNF177;YY1;CREB3L1;ZFP90;CEBPB;SNAI1;GTF2IRD1;HSF1;NFX1;TGIF1;JDP2;ETV6;E2F6;GZF1;MAX;NFKB1;FOXK1;ZFHX3
prerank,leucine zipper domain binding (GO:0043522),0.6287203829767896,1.2128840663011304,0.27913669064748203,0.8177809504462874,1.0,4/10,12.41%,DDIT3;MRTFA;NRL;PMF1
prerank,serine-type peptidase activity (GO:0008236),0.4778217051875084,1.2126024413258485,0.15967246673490276,0.8133950681571991,1.0,5/96,4.68%,KLK3;PCSK9;F10;MASP1;RHBDF2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.390529824849401,-1.211522857812231,0.1935483870967742,0.994848599253737,1.0,7/21,16.99%,PDE10A;PDE7A;PDE1C;PDE8A;PDE9A;PDE2A;PDE8B
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5655913406098385,1.210759635154236,0.25647668393782386,0.8143368694282243,1.0,4/18,12.33%,PIK3R5;WDR91;CCKBR;WDR81
prerank,kinase inhibitor activity (GO:0019210),0.5292401860047957,1.210589579697857,0.25232558139534883,0.8095209338895625,1.0,7/33,10.57%,GMFG;TAOK3;SNCA;DNAJC3;YWHAB;QARS1;DUSP19
prerank,Notch binding (GO:0005112),-0.3930077646398458,-1.210243768949074,0.22043010752688172,0.9703855275151003,1.0,13/22,35.84%,CCN3;SNED1;SNW1;AAK1;JAG1;JAG2;NOTCH4;HIF1AN;TCIM;KCTD10;GALNT11;DLL4;DLL1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5183503035640189,1.210187119893542,0.24769585253456222,0.8057697529844434,1.0,9/35,16.22%,PLD4;PLCB2;SMPD3;PLD3;PLCXD3;PDE11A;GDE1;GDPD3;PDIA3
prerank,ADP binding (GO:0043531),0.5380200601520504,1.2095362194394965,0.24689826302729528,0.8028721268581536,1.0,9/25,14.20%,ERN1;ABCG1;MYH9;MYO9B;LONP1;ABCD1;TAP1;ATP5F1A;MYH10
prerank,ribonuclease activity (GO:0004540),0.49480662676286163,1.209106732329803,0.21938232161874335,0.7992427646424659,1.0,20/56,22.63%,SLFN14;ERN1;NOB1;EXOSC1;SAMHD1;SND1;ELAC2;ZC3H12D;RNASEL;AGO3;RNASEH1;ZC3H12C;AGO2;RNASEH2A;EXOSC3;DIS3L2;DICER1;RNASE6;CNOT7;EXOSC2
prerank,solute:anion antiporter activity (GO:0140323),-0.4361970673297626,-1.2060835124332767,0.21755725190839695,0.9575299189729148,1.0,5/14,30.79%,SLC26A2;SLC26A7;SLC4A2;SLC26A6;SLC26A8
prerank,DNA polymerase activity (GO:0034061),-0.3940468417247354,-1.2052115048438679,0.1774193548387097,0.9339061993771972,1.0,12/22,22.73%,REV3L;REV1;PRIMPOL;POLN;POLA1;POLE4;TERT;POLG;POLE2;POLQ;POLK;POLI
prerank,death domain binding (GO:0070513),0.6008356875948585,1.2037641099610583,0.269774011299435,0.8135032683980714,1.0,5/11,16.29%,BCL2L1;CRADD;DAP;TRADD;IRGM
prerank,RNA stem-loop binding (GO:0035613),0.5955939716804829,1.2033578557064926,0.27884615384615385,0.8097198449059669,1.0,6/12,14.20%,DHX9;RC3H2;RC3H1;EPRS1;CPEB3;MYH10
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5733173638242132,1.2007240084607895,0.28940568475452194,0.8137750434255225,1.0,2/16,4.46%,ALOX12;HAAO
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6107774828920813,1.2006126479371726,0.2948148148148148,0.8090616022786629,1.0,5/11,12.90%,PYCARD;CASP1;CFLAR;CASP7;CASP8
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.40713354145131697,-1.1985959583524155,0.21973094170403587,0.9329611800874783,1.0,7/18,20.96%,STXBP6;CNN3;BAIAP2L1;BAIAP2;S100A11;ANXA2;PPP1CA
prerank,retinoid X receptor binding (GO:0046965),0.6128551405654765,1.1959840949710185,0.26874115983026875,0.820308238704063,1.0,3/11,11.82%,NSD1;TACC1;NRIP1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5522570793144355,1.1932228800566964,0.2536407766990291,0.825197637105073,1.0,5/22,10.57%,DUSP3;DUSP29;MTMR3;DUSP10;DUSP19
prerank,DNA-binding transcription factor binding (GO:0140297),0.4616582161149414,1.1924157114694003,0.11711711711711711,0.8230882714665556,1.0,29/189,8.71%,ASCL1;CIITA;HCLS1;GATA1;NFE2L2;NFATC1;MAD2L2;DHX9;TLE3;NEK6;SKI;DDIT3;SPI1;FIZ1;BHLHE41;HDAC5;HMGB1;TAF1;CTNNB1;MTA3;TP53;MEF2A;TAL1;USF1;MYOCD;LMO2;MEF2C;RB1;SMAD3
prerank,endopeptidase activity (GO:0004175),0.46135003748525916,1.1920238013921147,0.078,0.8195014028822115,1.0,47/257,16.22%,CTSS;KLK3;MMP12;CTSB;PCSK9;NAPSA;F10;LGMN;CTSC;CTSK;CTSL;ADAMTS8;MASP1;ECE2;EEF1AKMT4-ECE2;ESPL1;RHBDF2;USP35;CASP1;DDI2;PSMB10;MALT1;ZMPSTE24;CTSZ;NLN;CTSE;MMP19;USP7;PSMA2;USP48;CASP7;USP18;PARL;CASP8;PCSK7;PSMB5;USP9X;KLK2;ECEL1;USP8;USP29;PSMB9;PMPCB;USP16;IDE;PDIA3;RHBDF1
prerank,acylglycerol lipase activity (GO:0047372),0.6074716172704341,1.1914341158372708,0.2793053545586107,0.8165467330099464,1.0,4/11,15.34%,ABHD12;ABHD3;LIPE;ABHD16A
prerank,inward rectifier potassium channel activity (GO:0005242),0.5406597364751449,1.1907621052517472,0.265717674970344,0.8138973854597085,1.0,2/24,3.18%,KCNJ11;KCNK6
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.30212046828424255,-1.1871457291297642,0.12962962962962962,0.9496934675894981,1.0,14/60,8.94%,ROR1;NTRK3;AXL;EGFR;ALK;EPHA7;EPHA3;EPHB4;ACVR1;EPHB2;ACVRL1;PDGFRA;ROR2;ACVR1B
prerank,CARD domain binding (GO:0050700),0.5825822638906885,1.1870479479121865,0.30526315789473685,0.8219554440026655,1.0,4/14,16.29%,CARD11;CASP1;NOD2;IRGM
prerank,amino acid binding (GO:0016597),-0.33443811695858594,-1.1861953316842848,0.1736111111111111,0.9285667648922825,1.0,9/31,20.08%,GRIN3A;GRM7;CASTOR2;GRIN2B;NOS3;GRIN1;GLRB;NOS1;ASS1
prerank,voltage-gated ion channel activity (GO:0005244),0.5690338074818675,1.1822296410443678,0.300944669365722,0.8337808988622121,1.0,6/14,20.98%,PKD2;VDAC3;VDAC2;VDAC1;HVCN1;HCN1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4544439948860572,1.1817665454105606,0.022,0.8306820494340903,1.0,103/597,14.65%,RUNX1;BATF3;NFE2;IRF5;AHRR;ASCL1;CIITA;MEOX1;IRF4;IRF8;MCM5;GATA1;NFE2L2;ORC3;POU2F2;BASP1;NFATC1;HES7;ELF4;DHX9;CREB3L4;CREB3;BARX2;RXRB;FOXD2;TNF;SNCA;SREBF2;RFX1;ATF3;CEBPA;FOXO3;DDIT3;SPI1;ZBTB12;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;HMGB1;XRCC5;FLI1;TEAD1;TFEB;ZNF177;TP53;KLF6;TBL1XR1;NKX2-1;NRL;TAL1;USF1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;SMAD3;IRF2;HSF1;ZNF32;HNRNPL;ARID4A;GMEB1;MCM6;HDAC4;MCM2;TGIF1;HOXA6;RNF10;NFIC;TBL1X;KLF13;CREB3L2;RBBP5;ELF2;SOX9;ORC4;JDP2;NR2C2;ZNF740;HSF5;ATF6B;CREB1;MCM9;KAT7;NR4A1;MAX;NFKB1;FOXK1;RFX7;SOX6;CUX1;CDC6;IRF1;SOX2;BRD7;SOX4;SREBF1
prerank,kinase binding (GO:0019900),0.45489018693430017,1.1789019690324485,0.049,0.8354969548210147,1.0,91/435,15.47%,PTPRC;CD226;IRF5;BLNK;FGR;CD3E;ITGB2;HCLS1;STAP1;LYST;NEFH;LAT;PLCG2;GPRC5B;PRKCD;PTPRJ;THY1;DUSP3;GRB2;PTPN1;RFFL;PFKL;MAP2K6;TRIM5;NEK6;CCND3;RGCC;TUBA4A;CIR1;TTN;SKI;TRAF2;DNAJC3;CEBPA;FOXO3;ADCY6;NBEAL2;CASP1;WWC2;CCND2;SHC2;MAP2K3;CTNNB1;BCL2L1;CEP192;ACTB;MAPRE1;TP53;USF1;WNK1;TAX1BP1;TICAM1;TRAP1;CHEK2;SNAI1;KIF14;DGKD;AP1B1;RB1;TRIM27;MAP3K1;SMAD3;HSF1;QARS1;IBTK;BCAR1;LIMS1;CLTC;BECN1;ADIPOR1;PARP16;PRDX3;NOD2;MAP3K12;TBL2;EXOC2;STUB1;MOB1B;CEP152;TRADD;CDC6;NISCH;KCNA5;LRBA;PPP1CC;VDAC1;PIH1D1;TBC1D14;SRC;BCAR3;STRADA
prerank,hydro-lyase activity (GO:0016836),0.49492902985541987,1.177458006316596,0.26004464285714285,0.8355578796162627,1.0,13/41,20.10%,TBXAS1;EHHADH;ENO3;IREB2;HACD4;ECHS1;ECI1;ACO1;CDYL;NAXD;CBS;ECHDC1;ENO1
prerank,glutathione transferase activity (GO:0004364),0.528819465790782,1.1770227698697875,0.28536585365853656,0.8322374195363067,1.0,2/23,3.21%,GSTT4;HPGDS
prerank,gated channel activity (GO:0022836),0.5740617576317936,1.1754476516965615,0.30987821380243574,0.8326961451011657,1.0,3/14,10.20%,TMC6;PACC1;TMEM63A
prerank,syntaxin binding (GO:0019905),0.47652095140351974,1.172158589928435,0.25583864118895966,0.8394006913266595,1.0,15/61,14.53%,SYT17;ABCA1;VAMP3;VPS18;SYT2;STXBP3;CACNA1A;VPS11;SYT10;SNAP29;VPS54;RAB11A;SNAP23;STX8;LRRK2
prerank,receptor ligand activity (GO:0048018),0.4522514769352552,1.1719665415140381,0.119,0.8353758793293461,1.0,30/245,13.41%,TSHB;GPNMB;LGALS3;SHH;TGFB1;IL1A;METRNL;SLURP1;MDK;ANGPTL3;OSM;SEMA4D;TNF;IL18;TIMP1;NDP;HMGB1;VEGFB;EPO;PPY;NTF3;VGF;INHBA;SEMA4A;CHGB;ARTN;GRN;NRG1;TAFA1;GAS6
prerank,acetylation-dependent protein binding (GO:0140033),-0.3727714146351483,-1.1702714009375519,0.235,0.9372036101737984,1.0,6/20,7.33%,SMARCA4;MLLT3;PSME4;BRD9;ATAD2B;BRD4
prerank,lysine-acetylated histone binding (GO:0070577),-0.3727714146351483,-1.1702714009375519,0.235,0.9372036101737984,1.0,6/20,7.33%,SMARCA4;MLLT3;PSME4;BRD9;ATAD2B;BRD4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4565156324611465,-1.1695360313684624,0.2673611111111111,0.9169050660001812,1.0,7/11,27.37%,TRPC1;ITPR3;RPH3A;TRPC4;TRPC7;TRPC3;CYTH2
prerank,GABA receptor activity (GO:0016917),-0.39646154402940403,-1.1686911219022833,0.2753623188405797,0.8985351140541962,1.0,6/21,10.55%,GABRB2;GABRB1;GABRA2;GPR156;GABBR2;GABRB3
prerank,phospholipase C activity (GO:0004629),0.5214991989240487,1.1682617114417484,0.3027744270205066,0.8432157754144871,1.0,2/25,2.02%,PLCB2;PLCG2
prerank,endopeptidase inhibitor activity (GO:0004866),-0.265720652630046,-1.1660105988005498,0.11538461538461539,0.8885554706035704,1.0,19/82,14.48%,APP;SERPINH1;SERPINE2;CAST;SERPING1;RECK;TFPI;COL4A3;TIMP2;SPOCK2;USP14;TIMP3;BIRC6;NGF;ROCK1;SERPINB9;SERPINF1;UBE2O;BST2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5204491034729305,1.1655595922571322,0.3056872037914692,0.8473271466922053,1.0,12/27,21.67%,SLC11A1;AQP1;ATP2B1;ZDHHC13;ITPR2;ATP2B3;ATP2A3;TMEM165;MMGT1;TUSC3;MAGT1;SLC12A3
prerank,kinase activity (GO:0016301),0.45425255605443293,1.1631813727289133,0.22188449848024316,0.8506009343995643,1.0,21/109,13.18%,LYN;PIK3CG;DGKZ;PIK3CD;MTOR;PIK3CB;CHKB;CKB;DGKK;DGKE;TAF1;NADK;CERK;DGKG;DGKD;CSNK2A1;AGK;PAPSS1;POMK;DGKI;SHPK
prerank,sodium:proton antiporter activity (GO:0015385),0.5992949136206802,1.1631607930718542,0.33661971830985915,0.8458860625616368,1.0,4/11,14.66%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,metalloaminopeptidase activity (GO:0070006),-0.41545075848072816,-1.1615927276571778,0.2558139534883721,0.8817308524757256,1.0,7/16,20.31%,LTA4H;MMP14;MMP16;RNPEPL1;NPEPPS;ENPEP;MMP15
prerank,double-stranded RNA binding (GO:0003725),0.46390555935152844,1.1596262731723297,0.25630252100840334,0.8537563358123044,1.0,20/70,17.89%,RFTN1;DHX9;TLR8;TLR7;LRRFIP1;RC3H2;EIF4A1;ADAR;RC3H1;AGO4;EIF4H;ACTN1;APTX;CLTC;AGO3;ADARB1;PRKRA;MTDH;TARBP2;AGO2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.45288115505370136,1.1592615055225937,0.1636546184738956,0.85026951616538,1.0,45/181,17.26%,HCLS1;GATA1;NFE2L2;NFATC1;MAD2L2;DHX9;MAPK14;TACC1;NR1H4;SPI1;FIZ1;BHLHE41;HDAC5;TAF1;CTNNB1;MTA3;ACTB;TP53;SETD6;MEF2A;ACTN4;TAL1;MYOCD;LMO2;RB1;SMAD3;ARID1A;MDFIC;PPARGC1A;ANXA4;HDAC4;NRIP1;CREB1;SMARCD3;SMARCB1;RERE;PTPRT;BUD31;PIAS1;MTDH;RBPJ;HIF1A;FAF1;TRIP4;PPARD
prerank,potassium:proton antiporter activity (GO:0015386),0.6068676689868461,1.1578875662924313,0.33815028901734107,0.850318304520653,1.0,4/10,14.66%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,vinculin binding (GO:0017166),-0.45267507395371503,-1.1525724288119188,0.26158940397350994,0.8909016646218184,1.0,4/11,9.70%,UTRN;DMD;SORBS3;SYNM
prerank,protein heterodimerization activity (GO:0046982),0.44736998205259926,1.1518928675849174,0.1927710843373494,0.8664666278155209,1.0,40/178,16.30%,NPAS4;CYBB;CD3E;IRAK2;MLXIPL;ABCG1;ATF3;HEXA;DDIT3;BHLHE41;FZD9;TAF1;BCL2L1;TP53;MEF2A;USF1;P4HB;MEF2C;DGKD;TFAP2B;PAFAH1B2;BAK1;ALG2;HSF1;TPM4;VAPB;METTL3;SDCBP;PPP2CA;IKBKG;KATNA1;NR4A1;ADCY8;ATP1B2;UBA2;MIGA1;SNX2;YWHAH;TOP2A;HIF1A
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.4082851295925538,-1.1477700539923295,0.2616822429906542,0.8879732739801578,1.0,3/16,1.33%,MTM1;SACM1L;MTMR7
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.43913163191454746,1.1451543578523566,0.16416416416416416,0.8850339043707116,1.0,47/254,14.68%,RUNX1;IRF5;NPAS4;IRF4;GATA1;NFATC1;RREB1;ELF4;SP7;CREB3;BARX2;RXRB;FOXD2;NR1H4;MLXIP;MITF;ATF3;CEBPA;FOXO3;DDIT3;TP53;KLF6;MEF2A;NRL;YY1;CREB3L1;MEF2C;NKRF;CDC5L;TFAP2B;SMAD3;IRF2;CREBRF;GMEB1;LITAF;NFIC;SOX9;NR2C2;ATF6B;CREB1;SMARCD3;NR4A1;ZNF445;NFKB1;IRF1;SOX4;MEIS1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3793579761659882,-1.144969593583017,0.23711340206185566,0.8781374423318419,1.0,11/21,22.73%,REV3L;REV1;PRIMPOL;POLN;POLA1;POLE4;POLG;POLE2;POLQ;POLK;POLI
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5794540192905666,1.1446757936471748,0.3333333333333333,0.8819105448802494,1.0,6/10,16.60%,CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;CACNA1D
prerank,fibroblast growth factor binding (GO:0017134),0.5267934580030801,1.1422294491455096,0.3161764705882353,0.8854899993716852,1.0,6/21,17.43%,ITGB3;RPS2;FGFBP3;THBS1;FIBP;SCN5A
prerank,secondary active transmembrane transporter activity (GO:0015291),0.47306232798961556,1.139807780684026,0.30010718113612006,0.8891683088218645,1.0,10/51,15.59%,SLC16A10;SLCO2B1;SLC25A16;SLC7A8;SLC16A2;TMEM241;SLC20A2;SLC25A30;SLCO1B1;CLCN4
prerank,G protein-coupled receptor binding (GO:0001664),0.4449682296266713,1.1396890299551836,0.23742454728370221,0.8848080470480323,1.0,11/132,8.28%,GNA15;ARRB2;GPRC5B;GNAQ;GRK3;GNAZ;SAG;NDP;GNA13;GNA12;PPY
prerank,protein kinase inhibitor activity (GO:0004860),0.4844643825319921,1.1388503258531126,0.3108407079646018,0.8827790120177242,1.0,8/42,10.57%,GMFG;TAOK3;SNCA;DNAJC3;YWHAB;QARS1;IBTK;DUSP19
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5447891996035069,1.1383587794336443,0.33509234828496043,0.8796951450572136,1.0,2/15,6.98%,PIK3R5;CCKBR
prerank,thioesterase binding (GO:0031996),0.5776038621239995,1.138129820655238,0.32954545454545453,0.8758818436572429,1.0,5/11,17.93%,TRAF2;TRAF3;TRAF5;ARF6;CDC42
prerank,chloride transmembrane transporter activity (GO:0015108),-0.4021112520023331,-1.137527231176384,0.29707112970711297,0.8836947314771874,1.0,3/16,5.23%,SLC26A2;CLCN6;SLC26A7
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5742439142754158,1.137362224604199,0.3654891304347826,0.8739462732619812,1.0,6/12,22.80%,SLC9A4;SLC9A9;SLC9A1;SLC9A8;SLC9A7;LETM1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5767371584179414,1.1365170646252096,0.3452722063037249,0.8722131952007823,1.0,3/10,10.14%,NSD1;ASH1L;SETD2
prerank,ATPase regulator activity (GO:0060590),0.4846130573050417,1.1364480440931155,0.32036613272311215,0.8678900482005796,1.0,10/38,14.38%,BAG2;FNIP2;FNIP1;ATP5IF1;AHSA1;PFN1;ATP1B3;TOR1AIP2;ATP1B2;BAG1
prerank,hormone receptor binding (GO:0051427),0.5550669872543575,1.1357879109549578,0.33608815426997246,0.8655720394829808,1.0,1/14,2.15%,TYK2
prerank,glycine binding (GO:0016594),-0.44280282829562906,-1.1356994629853692,0.31756756756756754,0.8716734543059338,1.0,4/11,17.41%,GRIN3A;GRIN2B;GRIN1;GLRB
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4851518594574538,1.1346549226606737,0.3097949886104784,0.8648547145538367,1.0,16/37,22.57%,VARS1;FARSB;GARS1;RARS1;EPRS1;QARS1;LARS2;CARS2;DARS1;DARS2;TARS2;FARS2;TARS1;YARS1;SARS2;SARS1
prerank,phosphatidylinositol binding (GO:0035091),0.44734995516706555,1.1342456097415496,0.2796352583586626,0.8618083088976629,1.0,23/91,18.20%,DENND1C;PLEKHN1;MYO1E;SNX5;THY1;SNX9;SNX24;PLEKHF2;DENND1A;ZFYVE9;SNX27;ITPR2;DENND1B;WDFY1;EPB41;EXOC8;FRMPD2;SNX2;SNX13;APPL2;WDFY3;SNX10;PICALM
prerank,cardiolipin binding (GO:1901612),0.5883565891603003,1.131389956425375,0.3548387096774194,0.8666597677629738,1.0,1/10,1.51%,PLEKHN1
prerank,calcium ion binding (GO:0005509),0.4366068523094128,1.131303100976309,0.159,0.8626745363072588,1.0,51/323,13.37%,MMP12;SHH;SYT17;LCP1;PCDHB6;SMOC2;LPL;TPD52;CABP4;ADAM8;S100B;SDF4;SLC8A1;IDS;HPGDS;MASP1;MAN1C1;SNCA;PKD2;TTN;KCNIP2;MCTP1;RASGRP2;PGS1;ASPH;S100A2;ANXA1;AIF1;AGRN;SYT2;CETN3;RASGRP3;TPT1;ITSN1;ITPR2;PDCD6;SYT10;TPM4;CDH8;ANXA4;ACER3;NAALADL1;DYSF;CDH9;THBS1;CDH12;ARSA;CAMKK2;BRAF;CDH23;NDUFAB1
prerank,phosphatidic acid binding (GO:0070300),0.532453366444883,1.1302827775164501,0.33122629582806573,0.8618388007709138,1.0,3/19,6.76%,PLEKHN1;SMPD3;MICALL1
prerank,phosphatidate phosphatase activity (GO:0008195),0.5494134832507465,1.1297707068468372,0.35195530726256985,0.8591096699258087,1.0,2/13,8.67%,LPIN2;PLPPR1
prerank,retinoic acid receptor binding (GO:0042974),0.5391162700621988,1.1282946563671086,0.3472750316856781,0.8599051383120128,1.0,4/17,11.82%,NSD1;TACC1;ACTN4;NRIP1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5502795536147512,1.127597519865561,0.38140161725067384,0.8579011328527651,1.0,4/14,19.37%,CAPN15;CAPN2;CAPN3;CAPNS1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.40249688319627963,-1.1258534962296896,0.2975206611570248,0.8854156084359827,1.0,3/14,6.22%,SLC25A12;SLC17A6;SLC25A13
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.5663120260294511,1.1245724140635354,0.35382513661202186,0.863663147121772,1.0,1/11,1.72%,NEIL2
prerank,ATP hydrolysis activity (GO:0140603),0.4726103326915724,1.1201506607668044,0.34743875278396436,0.8739880878274818,1.0,14/41,17.99%,MYO1E;DHX9;ABCD1;KIF14;KIF20B;MYO19;ATP2B1;TOR3A;ABCA4;DNA2;TOR1A;ABCA3;HSP90AA1;ABCD2
prerank,voltage-gated sodium channel activity (GO:0005248),0.5066415577929463,1.117782334723202,0.3558282208588957,0.8777600459192326,1.0,3/22,4.10%,SCN4B;HCN4;PKD2
prerank,NADPH binding (GO:0070402),-0.4078684822898101,-1.1168269812845555,0.3191489361702128,0.8967376696369153,1.0,10/13,34.82%,HMGCR;DUS2;MTRR;CBR4;DHFR;LBR;NDOR1;CRYZ;CBR3;GRHPR
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4070172660424798,-1.1158875898171057,0.3151750972762646,0.8829190198336685,1.0,4/14,16.37%,SLC26A2;SLC26A7;SLC25A14;SLC25A11
prerank,histone demethylase activity (GO:0032452),-0.33169144777317744,-1.109602687449108,0.2896551724137931,0.8857980808965218,1.0,10/27,18.26%,PHF2;KDM5C;JMJD1C;KDM3A;KDM4B;KDM4A;KDM2A;KDM4D;KDM6A;KDM8
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5631431879791294,1.1064598076902235,0.3624823695345557,0.9106100286121299,1.0,2/11,13.95%,SLC25A20;SLC25A45
prerank,alkali metal ion binding (GO:0031420),0.5524956525203758,1.1054961226397364,0.3748251748251748,0.9095613073519868,1.0,3/13,14.80%,KCNJ11;HDAC4;CAPN3
prerank,ubiquitin protein ligase binding (GO:0031625),0.4282807368833939,1.1052434659544843,0.259,0.9060708791781026,1.0,57/254,17.04%,ARRB2;TUBB;PRKAR2B;RPL23;LAPTM5;RFFL;SNX9;NEK6;MAP1LC3B;SKI;TANK;TRAF2;CXCR4;TRAF3;CKB;HLTF;XRCC5;ATXN3;ERLIN2;TP53;CASC3;CHEK2;RB1;SMAD3;PPARGC1A;DERL1;ACTG1;VCL;TRAF5;USP7;GPR37;HDAC6;BECN1;RNF40;GPI;NLK;PRKACB;TNFRSF1B;SPOP;DET1;PRDX6;IKBKG;CASP8;STUB1;WFS1;BAG1;UBE2J2;SLF2;RTN4;HIF1A;RPL11;FAF1;FZD8;HSP90AA1;FANCL;CBS;UBE2N
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.36907917915936916,-1.1051384502948949,0.3056768558951965,0.8835468938608925,1.0,6/18,9.87%,FAR1;AKR1B1;ALDH2;ALDH1A1;ALDH3A2;ALDH1A2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4832765543193981,1.1047495820572133,0.357981220657277,0.9033562822741255,1.0,3/30,4.91%,SLC11A1;ATP7A;SLC25A37
prerank,alpha-tubulin binding (GO:0043014),0.4784417358842119,1.103652949491004,0.351288056206089,0.9023075243876678,1.0,16/31,24.43%,TBCEL;SNCA;DIP2B;ARL8A;SETD2;HDAC6;FYN;INO80;ARL8B;EML4;TAOK1;CDK5R1;TTLL7;DNAL1;ARL4C;FNTA
prerank,vitamin D receptor binding (GO:0042809),0.5417141641904489,1.103072205500399,0.37329700272479566,0.8999279607199993,1.0,7/14,22.17%,MED17;THRAP3;RXRA;TAF11;MED4;MED13;MED30
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.33062418675109384,-1.1007264391462668,0.2962962962962963,0.8807758047913963,1.0,8/26,14.69%,ABCG2;SLC16A12;SLC16A9;SLC16A11;SLC5A6;SLC16A4;SLC6A11;SLC27A1
prerank,semaphorin receptor binding (GO:0030215),-0.3396188072087065,-1.0979131228461672,0.3197278911564626,0.8736677505187087,1.0,6/23,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.48315191852672507,1.0963521227091013,0.3956170703575548,0.9175157736174119,1.0,11/32,23.02%,SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC25A38;SLC36A4;SLC1A4;SLC43A1;SFXN2;SLC38A7;SLC6A6
prerank,amino acid transmembrane transporter activity (GO:0015171),0.45283442702990906,1.087823856949814,0.3726775956284153,0.9416414179265802,1.0,10/47,13.28%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC43A2;SLC36A4;SLC66A1;SLC38A10
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.369003646128171,-1.087770997265784,0.3113207547169811,0.8900103289560608,1.0,6/18,8.94%,BMPR1A;LTBP4;ACVR1;TGFBR3;ACVRL1;ACVR1B
prerank,carboxylic acid binding (GO:0031406),-0.29784555074742175,-1.0872928496648575,0.27927927927927926,0.8765503298924748,1.0,11/38,19.71%,GRIN3A;GRM7;UBR2;SESN3;CASTOR2;GRIN2B;NOS3;GRIN1;GLRB;HIF1AN;NOS1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.39138587579838724,-1.0851573249911743,0.36,0.8680212491933822,1.0,4/15,9.48%,SLC25A12;SLC17A6;SLC25A13;SLC1A5
prerank,potassium channel activity (GO:0005267),0.42762492174329175,1.0840819670127473,0.36187563710499493,0.9504076805009226,1.0,10/89,7.52%,KCNJ11;AQP1;HCN4;KCNN4;KCNK6;PKD2;CCDC51;TMEM38A;KCNMA1;KCNK13
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5108581945428525,1.083322212553187,0.4010416666666667,0.9485131683903131,1.0,1/17,0.31%,PTK2B
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4274952919020716,-1.0790717729952048,0.3811188811188811,0.8726715513439579,1.0,9/11,57.27%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,nuclear receptor binding (GO:0016922),0.42810510704041627,1.0789814576059757,0.3765182186234818,0.958668892383979,1.0,34/111,19.48%,BRD8;GAS2L1;MED17;GTF2H1;NSD1;TACC1;NR1H4;TAF1;PRKCB;CTNNB1;ACTN4;SMAD3;MMS19;ARID1A;PPARGC1A;STRN;STAT5B;PKN1;NRIP1;SMARCD3;NR4A1;BUD31;YWHAH;THRAP3;HIF1A;TMF1;GTF2B;TRIP4;KDM4C;RXRA;TAF11;MED4;DCAF1;MED13
prerank,microtubule minus-end binding (GO:0051011),0.5226214688742816,1.075853524511118,0.39448275862068966,0.9645889031434198,1.0,4/13,15.94%,MACF1;TUBGCP6;TUBGCP4;CAMSAP2
prerank,nuclear localization sequence binding (GO:0008139),-0.3571620886673763,-1.0754560510380864,0.32608695652173914,0.8702034685238289,1.0,9/18,31.83%,IPO5;NUP153;RANBP6;NFKBIA;CABP1;TNPO2;KPNA2;POM121;KPNA6
prerank,ribosomal small subunit binding (GO:0043024),0.510588436979134,1.0745550552008034,0.41448189762796506,0.9643567368606709,1.0,7/17,18.92%,PIM1;ERAL1;EIF1;LARP1;EIF4H;CPEB2;MTIF3
prerank,ATPase binding (GO:0051117),0.4342002629658952,1.0742246080827487,0.38929695697796435,0.961219129212833,1.0,24/71,18.68%,ABCA1;TCIRG1;PKD2;ALDOB;ATP6V1E1;FBL;ATP6V0A2;ATXN3;SVIP;ATP5IF1;DERL1;TMTC4;ATP6V0A1;ATP1B3;TOR1AIP2;ATP1B2;WFS1;PIH1D1;SRC;NUFIP1;ZNHIT6;ANK1;SNX10;PTPN3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.4152688699275357,1.0709250477379466,0.325,0.9673435662339633,1.0,60/269,17.43%,ARRB2;TUBB;PRKAR2B;RPL23;LAPTM5;RFFL;SNX9;NEK6;MAP1LC3B;SKI;TANK;TRAF2;CXCR4;TRAF3;CKB;HLTF;XRCC5;ATXN3;ERLIN2;TP53;CASC3;CHEK2;RB1;SMAD3;PPARGC1A;DERL1;ACTG1;VCL;TRAF5;USP7;GPR37;HDAC6;BECN1;RNF40;GPI;NLK;PRKACB;TNFRSF1B;SPOP;DET1;PRDX6;IKBKG;CASP8;ITCH;STUB1;WFS1;BAG1;UBE2J2;SLF2;RTN4;HIF1A;RPL11;FAF1;FZD8;HSP90AA1;FANCL;CBS;UBE2N;TRIP4;SCN5A
prerank,ion channel inhibitor activity (GO:0008200),0.4603294287977215,1.070324421310115,0.39661016949152544,0.9648587372328431,1.0,7/35,15.93%,PCSK9;WNK1;ENSA;NEDD4L;STX8;WNK4;RASA1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4113711099217665,1.0697301359587161,0.213,0.9623621987414972,1.0,118/730,13.88%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;BHLHE41;HDAC5;BACH1;TEAD1;TFEB;CCAR1;TP53;KLF6;MEF2A;NKX2-1;NRL;TAL1;USF1;YY1;CREB3L1;STAT4;CEBPB;ST18;SNAI1;MEF2C;NKRF;TFAP2B;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;GMEB1;STAT5B;HDAC4;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;CREB3L2;TRIM24;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;MAX;ZNF445;NFKB1;FOXK1;RFX7;SOX6;ZFHX3;IRF1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.32416218928555,-1.068566525880324,0.36551724137931035,0.8776161928197016,1.0,6/29,10.55%,GABRB2;GRIK4;GRIA2;GABRB1;GABRA2;GABRB3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4106128551392188,1.0673617309038201,0.221,0.9658491923158963,1.0,117/731,13.88%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;BHLHE41;HDAC5;BACH1;TEAD1;TFEB;CCAR1;TP53;KLF6;MEF2A;NKX2-1;NRL;TAL1;USF1;YY1;STAT4;CEBPB;FOXN2;ST18;SNAI1;MEF2C;NKRF;TFAP2B;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;GMEB1;STAT5B;HDAC4;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;ZNF445;TIPARP;FOXN3;NFKB1;FOXK1;RFX7;SOX6;ZFHX3;IRF1
prerank,ATP binding (GO:0005524),0.41411473123634396,1.0656021575215355,0.332,0.9673662983036709,1.0,57/266,17.64%,MYO1F;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;TGFBR1;P2RX7;MTHFS;DHX9;PFKL;ERN1;NEK6;ATP7A;ABCG1;PI4K2A;MYH9;P2RX4;TLK1;MYO9B;MKNK1;CDK11B;MAP3K5;PIM1;LONP1;ABCD1;WNK1;KIF14;TRIP13;MCM6;STK17B;EIF2B2;TAP1;CARS2;RPS6KA4;NLK;PRKACB;TWF2;CDK6;ATP5F1A;STK3;UBA2;MYH10;DARS2;NIM1K;WNK4;PTPA;ERCC6;IDE;TAP2;HSP90AA1;STK4;GCK;RPS6KA5;KSR1;SIK2;N4BP2
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4049218406679641,-1.064527593362142,0.4013605442176871,0.8749339811713296,1.0,12/12,59.54%,OPN3;GPR88;ELOVL4;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5645953879415873,1.0644583072538627,0.4342857142857143,0.966830449491731,1.0,2/10,3.69%,SIRPA;PKP2
prerank,ribosome binding (GO:0043022),0.44194357123474887,1.0619739682425466,0.4176533907427341,0.9706658465321775,1.0,19/46,25.36%,SLFN14;YTHDF3;TMEM147;CPEB3;NOMO1;SRP19;CPEB4;CCDC47;CPEB2;MTIF3;SERBP1;PYM1;NAA15;EIF3C;EFL1;RACK1;EIF2A;EIF2S1;C1QBP
prerank,calcium activated cation channel activity (GO:0005227),0.5084475819669334,1.0615825007553026,0.4139715394566624,0.9675568373806335,1.0,3/17,10.20%,KCNN4;KCNMA1;TMEM63A
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.4191780811785354,-1.0593671124937045,0.397212543554007,0.8768548606850171,1.0,6/11,43.03%,SLC5A3;SLC5A11;SLC2A9;SLC23A1;SLC23A2;SLC2A10
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5159467103178011,1.0568624047069861,0.4336870026525199,0.978663134538393,1.0,5/14,14.17%,MINDY4;ATXN3;USP7;MINDY1;USP9X
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5472409005296904,1.0566638605046152,0.43617021276595747,0.974992715864383,1.0,4/10,12.90%,CASP1;CFLAR;CASP7;CASP8
prerank,phosphate ion binding (GO:0042301),-0.41846864494505204,-1.056162922772877,0.3656957928802589,0.8731335817631213,1.0,5/10,20.60%,ADSS2;RELA;RPH3A;PDE2A;MTHFD2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4125709665398301,-1.055107049111314,0.3623693379790941,0.8630936217051955,1.0,5/12,5.20%,BMPR1A;LTBP4;ACVR1;TGFBR3;ACVRL1
prerank,calcium channel regulator activity (GO:0005246),-0.2912502843523442,-1.0526239357364013,0.3302752293577982,0.8575968402157113,1.0,10/37,27.18%,SRI;FKBP1A;PRKG1;SLC30A1;CACNG8;REM1;PACSIN3;CALM2;CACNB3;NRXN2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4293267991542962,1.0512940885211155,0.4309623430962343,0.9881256731252668,1.0,15/70,19.87%,HEXB;LFNG;GCNT1;HEXA;B4GALT1;CHSY3;POGLUT2;POGLUT1;B3GALNT1;CHSY1;LARGE1;MGAT4B;B4GALNT1;CHPF;GXYLT1
prerank,monocarboxylic acid binding (GO:0033293),0.49842934166709285,1.0505507744881653,0.44106463878326996,0.9863219773318289,1.0,2/18,3.77%,PSAP;NR1H4
prerank,hexosyltransferase activity (GO:0016758),0.4178172250707766,1.0477351473541607,0.4348717948717949,0.9911446152269183,1.0,17/101,12.61%,HEXB;PIGM;LFNG;GCNT1;HEXA;GYG1;B4GALT1;CHSY3;PIGV;POGLUT2;GBE1;POGLUT1;FUT9;B3GALNT1;TMTC4;CHSY1;B4GALT7
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4015214825259049,1.0462575377640513,0.289,0.9915484109033508,1.0,130/830,13.88%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;BARX2;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;NFXL1;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;TAF1;BACH1;TEAD1;TRPS1;TFEB;ZFP69;CCAR1;ZNF177;TP53;KLF6;MEF2A;ACTN4;NKX2-1;NRL;TAL1;USF1;YY1;STAT4;ZFP90;CEBPB;ST18;SNAI1;MEF2C;NKRF;CDC5L;TFAP2B;RB1;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;CREBRF;GMEB1;STAT5B;HDAC4;NFX1;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ETV6;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;MAX;ZNF445;NFKB1;FOXK1;RFX7;SOX6;CUX1;ZFHX3;IRF1
prerank,protein serine/threonine kinase activity (GO:0004674),0.40598049629088173,1.0457868829146015,0.365,0.9890254080196341,1.0,71/335,16.10%,PTK2B;SYK;MAPKAPK3;IRAK2;MAP4K1;TAOK3;TGFBR1;PRKCD;CAMK1D;MTOR;BMP2K;MAPK14;GRK3;ERN1;NEK6;CDK14;PRKD2;TTN;MYLK3;CDK8;RPS6KC1;MAP3K14;TLK1;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;MAP3K5;PIM1;PLK4;WNK1;PIM2;SRPK3;TNIK;PLK2;ATP23;CSNK1G2;CHEK2;PRKCQ;CSNK2A2;CSNK2A1;MAP3K1;CASK;SMG1;PRKCH;CDK7;STK17B;STK32C;FAM20C;PKN1;RPS6KA4;NLK;CSNK1A1;ALPK1;MAP3K12;CDK6;BRAF;STK3;STK24;LRRK2;NIM1K;WNK4;GAK;TESK2;SGK3;GSK3A;RPS6KA2;CDK15;MAP3K11
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3202022982204327,-1.0457204873757222,0.33098591549295775,0.8639341718317569,1.0,7/27,16.37%,SLC26A2;SLC26A7;SLC25A14;SLC39A8;SLC22A6;SLC39A14;SLC25A11
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5349402349744307,1.0449841131445894,0.4418604651162791,0.9873492385597299,1.0,3/10,6.99%,TNFAIP3;ATXN3;STAMBPL1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.39000633755293723,-1.0442558227641776,0.37890625,0.855967786541081,1.0,3/13,6.30%,CDH5;BMP4;BMP5
prerank,endopeptidase activator activity (GO:0061133),0.5392654654427802,1.0422147980366367,0.44807121661721067,0.9916808657818682,1.0,2/10,12.47%,VSIR;PSME3
prerank,GTPase binding (GO:0051020),0.40508174239292094,1.0420404796809095,0.40543259557344064,0.9880874003118947,1.0,67/195,23.62%,FGD2;LCP1;UNC13D;IQGAP2;ABCA1;CYRIB;RIN3;RAB34;MYO5A;PPP6R1;RAB3GAP2;FGD6;USP6NL;MYO9B;MICALL1;DOCK4;ARHGAP1;CHML;EPRS1;ARHGDIB;PKN1;ATP6AP1;CYFIP1;BECN1;BICD2;EXOC8;RANBP9;SORL1;EXOC2;EXOC5;BRAF;FNBP1L;GGA2;LRRK2;TMEM127;RNF152;RASA1;ALS2;RABGEF1;NOX1;HSP90AA1;ARFIP2;ARHGEF2;IQGAP1;LAMTOR1;MYO1C;PICALM;ATG14;RAB29;DNM1L;OPTN;ENO1;KIF3A;FMNL1;LZTR1;AIMP1;RIMS1;RRAGB;FLNA;RAPGEF6;TNFAIP1;CCDC186;MYO5B;GOLGA4;OCRL;MYCBP2;FGD3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.5175026965726064,1.040136756418178,0.44992947813822287,0.9900777682023668,1.0,4/13,14.03%,EXO1;ENDOV;DNA2;SLX4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.43017027343596054,1.0378666781303212,0.4408839779005525,0.9932311932234811,1.0,16/44,23.08%,SMYD5;NSD1;CXXC1;ASH1L;DOT1L;SETD2;RBBP5;TTLL12;SMYD3;SUV39H1;SETD1B;WDR82;EED;SETD5;NSD3;SETDB1
prerank,cAMP binding (GO:0030552),-0.404753231710569,-1.036670314905512,0.40939597315436244,0.8650956271401937,1.0,4/11,16.49%,PDE10A;RAPGEF4;RAPGEF2;PDE2A
prerank,small GTPase binding (GO:0031267),0.40290081728996147,1.036593134973776,0.44511581067472306,0.9930074073551052,1.0,56/170,23.62%,FGD2;UNC13D;IQGAP2;ABCA1;CYRIB;RIN3;RAB34;MYO5A;PPP6R1;RAB3GAP2;FGD6;USP6NL;MYO9B;MICALL1;DOCK4;ARHGAP1;CHML;ARHGDIB;PKN1;ATP6AP1;CYFIP1;BICD2;EXOC8;RANBP9;SORL1;EXOC2;EXOC5;BRAF;GGA2;LRRK2;TMEM127;RNF152;ALS2;RABGEF1;NOX1;ARFIP2;ARHGEF2;IQGAP1;MYO1C;PICALM;RAB29;DNM1L;OPTN;KIF3A;FMNL1;LZTR1;RIMS1;FLNA;RAPGEF6;TNFAIP1;CCDC186;MYO5B;GOLGA4;OCRL;MYCBP2;FGD3
prerank,heme binding (GO:0020037),0.4245026240503644,1.0357264489246643,0.46290491118077326,0.99164696317372,1.0,13/65,20.70%,TBXAS1;CYBB;BACH1;CYB5A;CYB561D2;PXDN;SRC;CBS;SDHD;PTGES2;PGRMC1;THAP4;HMOX2
prerank,protein phosphatase regulator activity (GO:0019888),0.42802615126144505,1.0355867942519013,0.4524838012958963,0.9879558564780447,1.0,15/53,22.18%,LGALS3;MGAT5;PPP6R1;SAG;ENSA;BOD1L1;RCAN1;PPP4R4;PTPA;PPP2R5C;PPP4R2;ANKLE2;PPP2R3A;PPP4R1;RCAN3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.32918094038234486,-1.030562848188526,0.4187192118226601,0.8711166313673724,1.0,7/23,16.99%,PDE10A;PDE7A;PDE1C;PDE8A;PDE9A;PDE2A;PDE8B
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4270830201088437,1.030243325120204,0.46557377049180326,1.0,1.0,5/46,4.73%,HEXB;MGAT5;LFNG;GCNT1;HEXA
prerank,calcium-activated potassium channel activity (GO:0015269),0.5215722175940387,1.027380836664763,0.45874125874125876,1.0,1.0,2/11,7.14%,KCNN4;KCNMA1
prerank,GTPase inhibitor activity (GO:0005095),0.5009726311203517,1.0268924557265222,0.46153846153846156,1.0,1.0,4/13,17.31%,IQGAP2;GPS2;CPEB2;IQGAP1
prerank,protein homodimerization activity (GO:0042803),0.39448682831459764,1.026050686431783,0.406,1.0,1.0,125/590,17.18%,LILRB1;SLC11A1;PLEK;IRAK2;LPL;TPD52;CORO1A;PEX11A;CSF1R;RPE;DUSP29;RABEP1;MLXIPL;S100B;HPGDS;MASP1;SNX9;CST7;PSAP;ERN1;TRIM5;ATG7;GCH1;PKD2;ABCG1;APOE;CRYM;IL6R;ATF3;PIP4K2A;CEBPA;ATIC;PYCARD;LRRFIP1;DDIT3;GYG1;COQ9;MUC13;NDP;MYH9;XDH;BHLHE41;TBC1D22A;SYNE1;FZD9;MYO9B;CDA;BCL2L1;TYROBP;STK10;ACTN4;USF1;MAP3K5;TMEM192;KLHL7;ABCD1;PON3;DPY30;CEBPB;KYNU;CHEK2;DGKD;TFAP2B;KIF20B;TRIM27;ATP5IF1;SMAD3;PAFAH1B2;BAK1;PDCD6;SPPL3;TPM4;EPRS1;VAPB;F11R;TPR;ACTN1;NAALADL1;TRIM8;TAP1;SLC8B1;ZDHHC3;PAPSS1;MID2;PTPRO;RNF40;GBP3;PEX7;TPST1;DEFA6;MAP3K12;IKBKG;B2M;MMUT;ADCY8;STUB1;SOX6;CUBN;PTPRT;MIGA1;CADM1;LRRK2;SNX2;DARS2;PRKRA;SPPL2A;ERCC5;PTPA;PSMD7;PDCD6IP;TOP2A;IDE;MAP3K11;ALS2;ZBTB7B;DCK;TARS2;APPL2;HSP90AA1;STK4;CBS;TARBP2;GALM;CPOX;PECAM1
prerank,death receptor activity (GO:0005035),0.515796011466497,1.0257104117819371,0.4642857142857143,0.9979346265786087,1.0,3/11,19.33%,TNFRSF11A;TNFRSF1B;EDA2R
prerank,double-stranded DNA binding (GO:0003690),0.39467285503511995,1.023672167422407,0.421,1.0,1.0,69/531,13.64%,BATF3;NFE2;IRF5;ASCL1;MEOX1;IRF4;IRF8;GATA1;PCID2;AIM2;POU2F2;NFATC1;HES7;ELF4;DHX9;CREB3L4;CREB3;BARX2;RXRB;FOXD2;SREBF2;RFX1;ATF3;FOXO3;ZBTB12;MAFG;HOXC8;BHLHE41;HMGB1;XRCC5;FLI1;TEAD1;TFEB;ZNF177;KLF6;NRL;USF1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;IRF2;HSF1;ZNF32;GMEB1;TGIF1;HOXA6;NFIC;KLF13;APTX;ELF2;SOX9;JDP2;NR2C2;ZNF740;HSF5;ATF6B;MBD1;CREB1;NR4A1;MAX;ZNF445;FOXK1;RFX7;CUX1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3971061872729987,1.0235407119439983,0.42,0.9964775103513741,1.0,91/431,17.99%,MYO1F;TUBB;TUBB1;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;RAB39A;TGFBR1;P2RX7;RAB32;MTHFS;DHX9;PFKL;RAP2A;ERN1;NEK6;TUBB3;GCH1;ATP7A;ABCG1;TUBA4A;PI4K2A;RAB14;MYH9;RAP1B;RAB7A;P2RX4;TLK1;ARL8A;MYO9B;MKNK1;CDK11B;DNM2;MAP3K5;PIM1;LONP1;ABCD1;WNK1;RAP2B;KIF14;RAB28;TRIP13;RAB31;ARL5B;ARL4A;MCM6;STK17B;RAB1B;EIF2B2;TAP1;CARS2;RPS6KA4;NLK;ATL1;GBP3;PRKACB;TWF2;CDK6;ATP5F1A;RRAS2;STK3;ARF6;UBA2;TSR1;MYH10;LRRK2;RAP1A;DARS2;NIM1K;WNK4;TUBB6;PTPA;ERCC6;IDE;ARL8B;TAP2;RAB27B;HSP90AA1;STK4;GCK;ARFIP2;RPS6KA5;KSR1;SIK2;N4BP2;RHOA;MTG2;CDC42;ABCD2
prerank,adenyl nucleotide binding (GO:0030554),0.5139292763816796,1.0209862766125077,0.4658119658119658,0.9960086082259068,1.0,3/11,14.38%,BAG2;PFN1;BAG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5139292763816796,1.0209862766125077,0.4658119658119658,0.9960086082259068,1.0,3/11,14.38%,BAG2;PFN1;BAG1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.49718715609090436,1.019791584595796,0.48257372654155495,0.9955929754909117,1.0,1/15,1.63%,SH3PXD2B
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4505520083884992,1.0189470612395366,0.47769953051643194,0.9941110724899647,1.0,6/27,14.66%,SLC9A4;SLC8A1;SLC9A9;SLC9A1;SLC8B1;SLC9A8
prerank,poly-pyrimidine tract binding (GO:0008187),-0.30506540610187965,-1.018831568756982,0.48427672955974843,0.8935679236536107,1.0,6/23,12.34%,DAZAP1;SSB;U2AF2;FMR1;RBMS3;HNRNPU
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.4118651140590154,-1.0170994902135202,0.42857142857142855,0.8863551842562374,1.0,3/11,4.60%,RYR2;RYR3;ITPR3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3914628106596308,-1.0167724041302655,0.44029850746268656,0.87535056081698,1.0,6/12,16.80%,PHF2;JMJD1C;KDM3A;KDM4B;KDM4A;KDM4D
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.46600409475952814,1.0166823276251002,0.47515151515151516,0.9932079994990994,1.0,6/21,15.87%,CDK14;CDK8;CDK11B;CDK7;CDK6;CDK15
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.46600409475952814,1.0166823276251002,0.47515151515151516,0.9932079994990994,1.0,6/21,15.87%,CDK14;CDK8;CDK11B;CDK7;CDK6;CDK15
prerank,sequence-specific DNA binding (GO:0043565),0.3909542645691097,1.0165315295841166,0.439,0.9897422194528243,1.0,81/590,13.64%,BATF3;NFE2;IRF5;MMP12;ASCL1;MEOX1;IRF4;IRF8;GATA1;NFE2L2;POU2F2;NFATC1;HES7;ELF4;ZEB2;CREB3L4;CREB3;BARX2;RXRB;FOXD2;NR1H4;SREBF2;TET3;RFX1;BPTF;ATF3;FOXO3;CXXC1;ZBTB12;MAFG;MAFK;HOXC8;BHLHE41;XRCC5;TAF1;FLI1;TEAD1;TFEB;ZNF177;KLF6;MEF2A;NRL;USF1;LONP1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;SMAD3;IRF2;HSF1;PPARGC1A;ZNF32;SMG1;GMEB1;HDAC4;TGIF1;HOXA6;NFIC;KLF13;ELF2;SOX9;JDP2;NR2C2;STN1;ZNF740;GZF1;HSF5;ATF6B;MBD1;CREB1;NR4A1;MAX;FOXK1;SAFB2;RFX7;CUX1
prerank,exonuclease activity (GO:0004527),-0.2737356493871757,-1.0160874885007514,0.4383561643835616,0.8656840126680052,1.0,20/46,24.02%,REV3L;FAN1;MRE11;ENPP3;ERI1;EXOSC7;APLF;WRN;ISG20L2;EXD2;EXOSC8;APEX2;ZC3H12A;EXOG;EXOSC9;POLG;ENPP2;DCLRE1B;EXD1;EXOSC5
prerank,mechanosensitive ion channel activity (GO:0008381),0.5099521950513748,1.015750969669169,0.47191011235955055,0.9881662496623372,1.0,2/12,10.20%,TMC6;TMEM63A
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4510858761802349,1.0152680042839295,0.46926713947990545,0.9857443646324522,1.0,6/28,9.92%,TNF;TRAF2;TRAF3;TRAP1;BABAM2;TRAF5
prerank,ubiquitin protein ligase activity (GO:0061630),0.39313558068030646,1.0148354625192002,0.47347347347347346,0.9831548747541257,1.0,55/228,18.32%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;UBE2D3;FBXL22;MSL2;VPS18;MGRN1;RNF7;HLTF;PPP1R11;RNF111;HECTD1;RNF150;RC3H2;VPS11;TRIM27;RNF114;RC3H1;RING1;UBE4B;NFX1;NEDD4L;RNF10;TRIM56;TRIM24;TRIM35;RNF216;RNF135;ITCH;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;DTX4;ZNRF1;RNF152;SMURF1;FANCL;TRIM62;ZNRF3;ANAPC11;UBE2K;CDC42;BIRC2;FBXO44
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.3920023922488518,-1.0148069900354169,0.4354243542435424,0.8585484769305287,1.0,4/13,8.95%,GDI2;GDI1;GPSM2;GPSM1
prerank,metalloexopeptidase activity (GO:0008235),-0.26891399390946835,-1.012708837852812,0.42105263157894735,0.8526973116582005,1.0,16/51,21.21%,AGBL4;LTA4H;MMP14;FOLH1;CPM;CPQ;ACE;MMP16;RNPEPL1;NPEPPS;CPXM2;CPD;CPXM1;ENPEP;MMP15;AGBL1
prerank,BMP receptor binding (GO:0070700),-0.3900102789504729,-1.0120002617296244,0.45588235294117646,0.8437318787418826,1.0,3/12,6.30%,CDH5;BMP4;BMP5
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3022248264124044,-1.0108401517252559,0.4491525423728814,0.8362667783213245,1.0,6/29,9.48%,SLC25A12;SLC26A2;SLC26A7;SLC25A13;SLC25A14;SLC1A5
prerank,outward rectifier potassium channel activity (GO:0015271),0.51727131151843,1.010219007315252,0.47191011235955055,0.9926049922215914,1.0,4/11,14.28%,PKD2;KCNIP2;KCNT1;KCNA5
prerank,GTPase activity (GO:0003924),0.39880416762061516,1.0080614503355372,0.485,0.9951929221361652,1.0,51/192,19.75%,GNA15;RAB8B;RAB32;GNAQ;GNGT2;GFM1;RAP2A;GCH1;GNAZ;RAB14;RAP1B;RAB7A;ARL8A;DNM2;GNA13;GTPBP1;GNA12;GSPT1;TBCC;RAP2B;RAB28;GPN1;RAB31;RAB11A;ARHGDIB;RAB1B;ATL1;GBP3;ABCA4;SAR1A;RRAS2;MMUT;RAB33B;GNAI3;TSR1;LRRK2;RAP1A;GNB5;IRGM;ARL8B;RAB27B;RHOA;MTG2;CDC42;GNAI2;ATL2;RAB29;DNM1L;RHOD;ATL3;MFN1
prerank,LRR domain binding (GO:0030275),0.4946754721018819,1.007120344666351,0.4743243243243243,0.9940487392996552,1.0,5/14,18.09%,DDIT3;MRTFA;NRL;PMF1;LRRFIP2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5080513859519775,1.005303155459542,0.4791386271870794,0.9956077938133361,1.0,4/12,13.41%,PYCARD;CASP1;APAF1;ATP2A3
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4794315013768762,1.0044986593094583,0.4960835509138381,0.9941839967558889,1.0,3/17,6.00%,ABCA1;ABCG1;ABCB4
prerank,estrogen receptor binding (GO:0030331),0.4420228564259051,1.0038516832788795,0.48847926267281105,0.9922353912211156,1.0,10/32,22.43%,NSD1;TACC1;CTNNB1;MMS19;STRN;NRIP1;TRIP4;DCAF1;PADI2;CNOT1
prerank,ubiquitin binding (GO:0043130),0.40491004909652156,1.003819688467273,0.502079002079002,0.9885834356273856,1.0,21/73,20.78%,OTULINL;NUP62;RNF19B;CXCR4;TNFAIP3;DDI2;SMAD3;IKBKG;MVB12B;TOP2A;USP16;FAF1;VPS28;UBE2N;BIRC2;UBXN2A;PLAA;HSPB1;RAD23B;NSFL1C;PRKN
prerank,single-stranded RNA binding (GO:0003727),0.4176404076189776,1.0024308509305822,0.49562363238512036,0.988736330689445,1.0,19/43,25.80%,DHX9;TLR8;TLR7;LONP1;ENDOV;AGO4;EIF4H;SRA1;AGO3;AGO2;CNBP;HNRNPF;PTBP1;DDX60;ILF3;ZFR;DDX11;AGO1;JMJD6
prerank,potassium ion antiporter activity (GO:0022821),0.4918749270915704,1.0016982242782766,0.4918918918918919,0.9870134455057201,1.0,3/15,7.37%,SLC9A4;SLC9A9;SLC9A1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3871585885915825,1.0005506589795228,0.5105105105105106,0.9864922071046476,1.0,63/232,21.33%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;UBE2D3;FBXL22;MSL2;VPS18;MGRN1;RNF7;HLTF;PPP1R11;RNF111;HECTD1;RNF150;RC3H2;VPS11;TRIM27;RNF114;RC3H1;RING1;NFX1;NEDD4L;RNF10;TRIM56;TRIM24;TRIM35;RNF216;RNF135;ITCH;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;DTX4;ZNRF1;RNF152;PIAS1;SMURF1;FANCL;TRIM62;ZNRF3;ANAPC11;CDC42;BIRC2;FBXO44;NEURL4;WWP1;KCMF1;CUL3;PRKN;BIRC3;HERC2;RNF125;NSMCE2
prerank,nucleotide diphosphatase activity (GO:0004551),0.48864876720618955,0.9986308597053912,0.507323568575233,0.9882280579635786,1.0,2/14,6.79%,NUDT17;NUDT4
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.49615799987628123,0.9984715483000496,0.4880952380952381,0.9849864521779891,1.0,4/14,13.41%,PYCARD;CASP1;APAF1;ATP2A3
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3048571182935834,-0.9977213150214848,0.43529411764705883,0.8633868222513185,1.0,10/26,26.59%,AGBL4;FOLH1;CPM;CPXM2;CPD;CPXM1;AGBL1;CPA6;ACE2;CPE
prerank,nucleotidase activity (GO:0008252),0.4772326074560792,0.9925394265293138,0.49022346368715086,0.9978948987155907,1.0,3/15,10.21%,NT5C3B;BPNT1;NT5DC3
prerank,palmitoyltransferase activity (GO:0016409),0.43870347874711635,0.9924188508778455,0.5005973715651135,0.9945965767320767,1.0,8/28,14.36%,ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;YKT6;ZDHHC1;ZDHHC24
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.3761828032403688,-0.9923561262018844,0.4444444444444444,0.8670697323403337,1.0,5/12,22.66%,IRS1;GNAS;SHC1;SOCS2;IGF2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4845331904264981,0.9919067823826317,0.5013736263736264,0.9923133658154496,1.0,6/13,20.54%,PRKAR2B;SOX9;GSK3A;CSK;GSK3B;PRKAR1A
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4014194893517973,-0.991381501147205,0.4742268041237113,0.8592482564907918,1.0,4/11,16.42%,DAB2IP;TRAF6;ROR2;PPEF2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.38913836469576624,0.9898777858315255,0.555,0.9940446553123846,1.0,67/248,20.02%,GNA15;RAB8B;MYO1E;RAB32;GNAQ;DHX9;GNGT2;GFM1;RAP2A;GCH1;GNAZ;RAB14;MYH9;RAP1B;RAB7A;ARL8A;DNM2;GNA13;GTPBP1;GNA12;GSPT1;TBCC;ABCD1;RAP2B;KIF14;RAB28;GPN1;KIF20B;MYO19;ATP2B1;RAB31;TOR3A;RAB11A;ARHGDIB;RAB1B;ATL1;GBP3;ABCA4;SAR1A;RRAS2;MMUT;DNA2;TOR1A;RAB33B;GNAI3;TSR1;KIF2A;LRRK2;RAP1A;ABCA3;GNB5;IRGM;ARL8B;RAB27B;HSP90AA1;RHOA;MTG2;CDC42;ABCD2;GNAI2;ATL2;RAB29;DNM1L;RHOD;ATL3;MFN1;MYL6
prerank,death receptor binding (GO:0005123),-0.3575780746469862,-0.988982174832039,0.4675324675324675,0.8553185715088985,1.0,4/15,9.81%,EDA;DAB2IP;NGF;TMBIM1
prerank,RNA polymerase II complex binding (GO:0000993),0.4185050601689731,0.9861245868029067,0.5231481481481481,1.0,1.0,11/32,17.89%,DHX9;ZNF326;UVSSA;SCAF1;PCIF1;RTRAF;ELOF1;ERCC5;GTF2B;PCF11;AGO2
prerank,growth factor receptor binding (GO:0070851),0.389932181402996,0.9842500156508038,0.5295315682281059,1.0,1.0,14/95,15.27%,ITGB3;PTPRJ;GRB2;ERN1;IL6R;PYCARD;CD300LF;VEGFB;TIMM50;SDCBP;FYN;ERAP1;SNX2;SRC
prerank,sodium channel activity (GO:0005272),0.41520285518780564,0.9782602664842044,0.5240761478163494,1.0,1.0,3/37,4.10%,SCN4B;HCN4;PKD2
prerank,symporter activity (GO:0015293),-0.3970785032672719,-0.9760812776529443,0.5,0.8799421833943111,1.0,9/10,57.31%,SLC5A6;MFSD2A;SLC4A4;SLC46A2;SLC28A2;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,adenyl ribonucleotide binding (GO:0032559),0.3785585891740827,0.9756210394193499,0.586,1.0,1.0,58/291,17.64%,MYO1F;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;TGFBR1;P2RX7;MTHFS;DHX9;PFKL;ERN1;NEK6;ATP7A;ABCG1;PI4K2A;MYH9;P2RX4;TLK1;MYO9B;MKNK1;CDK11B;MAP3K5;PIM1;LONP1;ABCD1;WNK1;KIF14;TRIP13;MCM6;STK17B;EIF2B2;TAP1;CARS2;RPS6KA4;PDE4A;NLK;PRKACB;TWF2;CDK6;ATP5F1A;STK3;UBA2;MYH10;DARS2;NIM1K;WNK4;PTPA;ERCC6;IDE;TAP2;HSP90AA1;STK4;GCK;RPS6KA5;KSR1;SIK2;N4BP2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.4735970139678808,0.9743662936764208,0.5246113989637305,1.0,1.0,2/16,5.45%,NEIL2;OARD1
prerank,gamma-tubulin binding (GO:0043015),-0.3069339152798885,-0.9710055548731057,0.4696969696969697,0.8822478621318101,1.0,8/22,14.98%,DIXDC1;PAK1;TUBGCP2;CDK5RAP2;BRCA2;NDRG1;MARK4;BLOC1S2
prerank,rRNA binding (GO:0019843),0.4099549021123401,0.9689211281856697,0.5531914893617021,1.0,1.0,9/42,16.37%,RPL23;EMG1;CIRBP;GTF3A;ERAL1;RPS14;RRS1;RCC1L;RPL11
prerank,transforming growth factor beta binding (GO:0050431),0.4439978025746352,0.9689089238669798,0.5442260442260443,1.0,1.0,7/23,18.76%,NRROS;TGFBR1;TGFBR2;THBS1;VASN;CD36;LTBP3
prerank,mRNA methyltransferase activity (GO:0008174),-0.35866801826219125,-0.9670932263755133,0.4707692307692308,0.8825971540019003,1.0,5/12,14.68%,METTL14;NSUN2;METTL16;RNMT;CMTR1
prerank,MHC class II protein complex binding (GO:0023026),0.4926707612368485,0.9663636742635072,0.5372714486638537,1.0,1.0,1/11,1.33%,CD74
prerank,beta-tubulin binding (GO:0048487),0.4197786724137054,0.9663261015833549,0.5433526011560693,1.0,1.0,11/31,21.22%,UXT;FGF13;ARL8A;GJB6;VAPB;CCT5;ARL8B;EML4;TAOK1;CDK5R1;TTLL7
prerank,neuropeptide receptor activity (GO:0008188),0.42130539357803853,0.9654822763135174,0.5327868852459017,1.0,1.0,4/29,11.58%,GALR1;SORCS3;GPR37;TACR1
prerank,endodeoxyribonuclease activity (GO:0004520),0.4441107192527857,0.9635036809837574,0.5164556962025316,1.0,1.0,9/20,25.94%,EXO1;ENDOV;DNA2;ERCC5;ERCC1;DCLRE1C;ERCC4;ZRANB3;MBD4
prerank,hyaluronic acid binding (GO:0005540),0.494931561346838,0.9617412332058228,0.540785498489426,1.0,1.0,2/10,5.80%,CD44;STAB2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.35276481014812733,-0.9613794412475095,0.4732824427480916,0.8875367770287884,1.0,7/13,17.11%,ALDH2;ALDH1A1;ALDH3A2;ALDH1A2;ADH5;ALDH1L1;ALDH1L2
prerank,metal ion binding (GO:0046872),0.3710094937253511,0.9609902714017887,0.651,1.0,1.0,73/477,15.36%,MMP12;SHH;SYT17;LCP1;PCDHB6;SMOC2;LPL;TPD52;CABP4;ADAM8;RPE;S100B;SDF4;SLC8A1;IDS;HPGDS;MASP1;RAP2A;ERN1;NEK6;MAN1C1;SNCA;PKD2;APOE;TTN;KCNIP2;MCTP1;PI4K2A;RASGRP2;PGS1;ASPH;RP2;S100A2;ANXA1;AIF1;MAP3K5;AGRN;SYT2;CERK;CETN3;RASGRP3;ENDOV;TPT1;TRIM27;ITSN1;ITPR2;PPA2;PDCD6;SYT10;TPM4;CDH8;ANXA4;ACER3;NAALADL1;DYSF;CDH9;THBS1;NLK;PRKACB;CDH12;ARSA;CAMKK2;BRAF;CDH23;NDUFAB1;STK3;UBA2;LRRK2;NIM1K;CAPN3;LRP1;EFHD2;CCDC47
prerank,adenylyltransferase activity (GO:0070566),-0.3091501200598578,-0.960875973157397,0.4838709677419355,0.8790613355110097,1.0,8/21,17.43%,ABL1;PAPOLA;SELENOO;PAPOLG;NMNAT1;GPHN;TUT1;KARS1
prerank,single-stranded DNA binding (GO:0003697),0.38083968860756057,0.9603233648642263,0.5769622833843018,1.0,1.0,23/93,20.39%,MCM5;FAM111A;DHX9;NABP1;HMGB1;SAMHD1;LONP1;MCM6;MCM2;APTX;STN1;MCM9;PCBP1;ERCC5;TWNK;REXO4;RAD51B;ERCC1;TOP1;FUBP3;RAD51D;CDC45;RAD23B
prerank,chloride channel regulator activity (GO:0017081),0.47065772647561427,0.9593329920463229,0.5389784946236559,1.0,1.0,7/14,23.15%,WNK1;STX8;WNK4;SGK3;VAMP8;SGK1;STX7
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.45536588991820137,0.959240813119069,0.5290237467018469,1.0,1.0,1/17,1.52%,BLVRB
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4487574011377673,0.9581942629887138,0.5169270833333334,1.0,1.0,2/16,8.66%,SLC7A8;SLC44A2
prerank,phosphatidylglycerol binding (GO:1901611),0.4724218038914533,0.958001138291358,0.5393700787401575,1.0,1.0,1/13,1.51%,PLEKHN1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3943614824246248,0.9557006698361799,0.5639097744360902,1.0,1.0,7/49,10.73%,SYT17;MCTP1;ANXA1;SYT2;SYT10;ANXA4;DYSF
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4836415897951787,0.9550685843234391,0.5489051094890511,1.0,1.0,3/10,11.35%,EHHADH;ECHS1;ECI1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4900939645274174,0.9530694010801775,0.539454806312769,1.0,1.0,2/10,4.82%,RPE;RENBP
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3878375672499222,0.9493976056548311,0.580441640378549,1.0,1.0,15/60,17.79%,PPM1H;PPP2CB;MTMR3;RPAP2;TIMM50;PPP2CA;ILKAP;LRRC39;LRRK2;PPP1CC;PHLPP1;PTEN;PPP3CB;PPM1M;PPP4C
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.36317742997777464,-0.9486913950817739,0.5323741007194245,0.9012922844043166,1.0,6/12,29.48%,PDE7A;PDE8A;PDE2A;PDE8B;PDE4D;PDE4C
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.49120099187795085,0.948142497572129,0.5450704225352113,1.0,1.0,1/11,2.81%,AKR1A1
prerank,protease binding (GO:0002020),0.3717832866325871,0.9472879675030015,0.59375,1.0,1.0,26/99,20.78%,ITGB3;RFFL;PSAP;TNF;TTN;PYCARD;TNFAIP3;TIMP1;CFLAR;TP53;CRADD;DERL1;CLTC;CCBE1;TWNK;A2M;PTEN;FURIN;TRIP4;BIN1;FLOT1;ITGB1;RIOK3;DPP4;GSK3B;PRKN
prerank,phospholipase A2 activity (GO:0004623),0.4217997571879318,0.9470214454729058,0.5639187574671446,1.0,1.0,8/26,23.51%,PLA2G7;PRDX6;ABHD3;PLAAT3;PNPLA3;PLA2G5;PLA2G6;PLA2G4E
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4354387297045902,0.9465243156683324,0.5609167671893848,1.0,1.0,9/22,19.53%,TNFAIP3;PRPF8;WDR81;TAB2;IKBKG;RNF169;TAB3;PARP10;OPTN
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.42664070331016063,0.9465230844753605,0.5543071161048689,1.0,1.0,3/20,9.18%,CARD11;MPP1;CASK
prerank,RNA polymerase core enzyme binding (GO:0043175),0.39757133964639046,0.945117295020781,0.5704545454545454,1.0,1.0,10/33,17.89%,DHX9;ZNF326;UVSSA;RTRAF;ELOF1;ERCC5;SPTY2D1;GTF2B;PCF11;AGO2
prerank,voltage-gated cation channel activity (GO:0022843),0.37110974219738224,0.9429027215849004,0.601842374616172,1.0,1.0,12/97,14.35%,PTK2B;KCNJ11;HCN4;PKD2;KCNMA1;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;KCNA5;KCNA6
prerank,regulatory RNA binding (GO:0061980),0.40110125878710684,0.9424861712401356,0.5845303867403315,1.0,1.0,12/38,21.10%,DHX9;TLR7;RC3H1;PUM2;AGO4;AGO3;SOX2;TUT7;TARBP2;AGO2;ZC3H7A;DICER1
prerank,hexose transmembrane transporter activity (GO:0015149),0.47611250207185096,0.9420743808501122,0.5514809590973202,1.0,1.0,1/12,4.15%,SLC2A3
prerank,retinoid binding (GO:0005501),-0.2983860795355484,-0.9395553479885931,0.5418994413407822,0.9153726722466633,1.0,2/22,9.87%,NR2F2;ALDH1A2
prerank,zinc ion binding (GO:0008270),0.36382402206477565,0.9392285922914768,0.6926926926926927,1.0,1.0,86/293,22.72%,MMP12;SHH;ADAM8;PTPN1;NSD1;S100B;SNCA;TET3;GCH1;SKI;RBSN;TIMP1;SORD;P2RX4;SAMHD1;CDA;TP53;KDM7A;CRIP2;SMAD3;RC3H1;WDFY1;EPRS1;ACER3;HDAC4;LITAF;HPF1;NAALADL1;TRIM8;POLR2L;TRIM24;LIMS1;RASSF1;SEC24D;ZCCHC4;MBD1;TAB2;ERAP1;CHORDC1;ATAD3A;CSRP1;TAB3;USP16;IDE;GTF2B;PITRM1;ARHGEF2;RPS27;KDM4C;BIRC2;RXRA;SLU7;TNFSF10;MSRB2;KLF7;CHD4;RNPEP;TET2;KDM5A;SMPD1;KDM5B;ATP13A2;ZMYND11;TES;PRKN;SIRT5;RNF125;CDADC1;TARS1;KDM2B;CXXC5;MT3;ZFP37;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;MDM4;ADAMTS3;LNPEP;GRIN2A;NUDT12
prerank,chloride channel inhibitor activity (GO:0019869),0.4934511367304028,0.9392005209024713,0.555886736214605,1.0,1.0,5/10,23.15%,WNK1;STX8;WNK4;VAMP8;STX7
prerank,RNA methyltransferase activity (GO:0008173),0.43282609612391343,0.9365069644753993,0.5517241379310345,1.0,1.0,4/19,14.11%,FBL;METTL4;METTL3;BCDIN3D
prerank,aminopeptidase activity (GO:0004177),-0.2815194374891037,-0.9351491141428314,0.5351351351351351,0.9171293332537048,1.0,9/26,20.31%,LTA4H;MMP14;MMP16;RNPEPL1;NPEPPS;BLMH;KDM8;ENPEP;MMP15
prerank,clathrin adaptor activity (GO:0035615),0.44303952288250203,0.9349718419693185,0.5654520917678812,1.0,1.0,5/15,15.42%,LDLRAP1;AP2S1;STON2;STON1;AP2M1
prerank,transferrin receptor binding (GO:1990459),-0.38126244555322786,-0.9331511482773399,0.5379537953795379,0.9123551100079524,1.0,4/10,13.29%,SNX4;RGMA;CHUK;CD81
prerank,myosin binding (GO:0017022),0.384455808557131,0.9331280044156435,0.5769230769230769,1.0,1.0,9/55,9.82%,CORO1A;NCKIPSD;CXCR4;PYCARD;RAB14;ARFGEF1;SPATA6;RAB39B;RAB11A
prerank,endopeptidase regulator activity (GO:0061135),0.3910957641983638,0.9326418597644757,0.5892857142857143,1.0,1.0,6/40,15.74%,VSIR;CST7;RENBP;SPINT2;PSME3;A2M
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.384601778330571,0.9324886359546819,0.582534611288605,1.0,1.0,12/53,16.72%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC25A38;SLC36A4;SLC66A1;SLC25A18;CTNS;SLC1A4;SLC43A1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4166322358943787,0.9303094355582496,0.5691747572815534,1.0,1.0,8/24,21.35%,ZDHHC14;ZDHHC7;ZDHHC3;YKT6;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,ferrous iron binding (GO:0008198),0.4276933499454566,0.9286377999691346,0.59125,1.0,1.0,6/21,19.67%,SNCA;HAAO;FTL;FTH1;TET2;FTO
prerank,I-SMAD binding (GO:0070411),0.4551191349684217,0.9280844216878866,0.5617367706919946,1.0,1.0,3/13,8.71%,TGFBR1;CTNNB1;SMAD3
prerank,muscle alpha-actinin binding (GO:0051371),0.44979673830786104,0.9278363952650506,0.5778961384820239,1.0,1.0,3/15,7.20%,PKD2;TTN;LDB3
prerank,GTP binding (GO:0005525),0.36420334880767724,0.9275077920667346,0.675025075225677,1.0,1.0,38/172,19.74%,TUBB;TUBB1;RAB39A;RAB32;RAP2A;TUBB3;GCH1;TUBA4A;RAB14;RAP1B;RAB7A;ARL8A;DNM2;RAP2B;RAB28;RAB31;ARL5B;ARL4A;RAB1B;EIF2B2;ATL1;GBP3;RRAS2;ARF6;TSR1;LRRK2;RAP1A;TUBB6;ARL8B;RAB27B;ARFIP2;RHOA;MTG2;CDC42;ATL2;RAB29;RHOD;ATL3
prerank,transition metal ion binding (GO:0046914),0.3568811006152134,0.9264861973122019,0.755,1.0,1.0,120/397,24.02%,MMP12;SHH;IL1A;ADAM8;MGAT5;PTPN1;NSD1;S100B;SNCA;TET3;GCH1;ATP7A;SKI;RBSN;ATOX1;GYG1;RNF7;TIMP1;SORD;P2RX4;SAMHD1;B4GALT1;CDA;TP53;PIM1;KDM7A;CRIP2;SMAD3;RC3H1;FTL;WDFY1;EPRS1;ACER3;HDAC4;LITAF;HPF1;NAALADL1;ADPRM;TRIM8;FAM20C;POLR2L;TRIM24;LIMS1;RASSF1;SEC24D;ZCCHC4;MBD1;TAB2;B4GALT7;AGMO;LACC1;ERAP1;GALNT2;CHORDC1;ATAD3A;FTH1;CSRP1;TAB3;LARGE1;MGAT5B;USP16;IDE;GTF2B;PITRM1;ARHGEF2;PPM1M;RPS27;GALNT1;KDM4C;FDX1;BIRC2;LOXL3;RXRA;SLU7;TNFSF10;MSRB2;KLF7;CHD4;RNPEP;TET2;KDM5A;MGAT1;SMPD1;KDM5B;ATP13A2;ZMYND11;TES;PRKN;SIRT5;NEK4;RNF125;CDADC1;TARS1;KDM2B;CXXC5;XXYLT1;MT3;ZFP37;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;MDM4;ADAMTS3;LNPEP;GRIN2A;NUDT12;HMGCL;SCD;EEA1;MYCBP2;TIMM8B;POMGNT1;UBA5;GALNT3;RNF2
prerank,methylated histone binding (GO:0035064),0.3755752397991911,0.9248270364560971,0.6116303219106958,1.0,1.0,18/62,20.16%,BPTF;NCAPG2;CXXC1;MORC3;TAF1;KDM7A;ATRX;CHD1;TRIM24;RBBP5;TTLL12;MTF2;CDYL;MORC4;LRWD1;PHF1;KDM5A;ZMYND11
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.40207863000084865,0.9243072548437252,0.5782857142857143,1.0,1.0,11/31,17.82%,UBE2D3;TAF1;UBE2S;UBE2E3;UBE2H;CDC34;UBE2G2;UBE2J2;UBE2N;UBE2Z;UBE2K
prerank,GABA-A receptor activity (GO:0004890),-0.3270965904022918,-0.9226968938033221,0.5732758620689655,0.9286897096038901,1.0,4/18,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,anion channel activity (GO:0005253),0.3764012215130921,0.9222412342718297,0.6213080168776371,1.0,1.0,13/61,15.59%,LRRC8D;CLCC1;VDAC3;CLIC1;GABRA5;CLCN7;GLRA2;GABRA4;VDAC2;VDAC1;SLC1A4;LRRC8C;CLCN4
prerank,DNA polymerase binding (GO:0070182),0.4292442615281952,0.9207076728405438,0.5710627400768246,1.0,1.0,3/18,6.95%,PTGES3;HMGB1;LONP1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4714688755038272,0.9187328808758717,0.5738880918220947,1.0,1.0,3/10,12.61%,B4GALT1;A3GALT2;B4GALT7
prerank,transcription coregulator binding (GO:0001221),0.3769655666966317,0.9185742974717167,0.6223404255319149,1.0,1.0,19/50,24.34%,RPL23;NEK6;CTNNB1;LMO2;FAM89B;SMAD3;HDAC6;MTF2;PPARD;PHF1;CTBP2;PER1;EED;CTBP1;WIZ;UBE2I;TEAD2;CHD6;CNOT2
prerank,titin binding (GO:0031432),-0.34942746017161197,-0.9162329864327383,0.5430711610486891,0.9351261494701159,1.0,7/13,36.78%,ACTN2;CALM3;TRIM63;MYBPC1;CALM2;CAMK2D;ANKRD23
prerank,guanyl ribonucleotide binding (GO:0032561),0.35867674125689586,0.915694012368213,0.6936936936936937,1.0,1.0,38/196,17.93%,TUBB;TUBB1;RAB8B;RAB39A;RAB32;RAP2A;TUBB3;GCH1;TUBA4A;RAB14;RAP1B;RAB7A;ARL8A;DNM2;CNGB1;RAP2B;RAB28;RAB31;ARL5B;ARL4A;RAB1B;EIF2B2;PDE11A;ATL1;GBP3;RRAS2;ARF6;GNAI3;TSR1;LRRK2;RAP1A;TUBB6;ARL8B;RAB27B;ARFIP2;RHOA;MTG2;CDC42
prerank,histone deacetylase activity (GO:0004407),0.4205242400323518,0.9150489395308807,0.5637319316688568,1.0,1.0,5/19,13.99%,HDAC5;HDAC4;HDAC6;HDAC9;HDAC11
prerank,DNA binding (GO:0003677),0.349156235824705,0.9110005878351657,0.85,1.0,1.0,143/694,20.43%,NFE2;IRF5;MMP12;CIITA;MEOX1;IRF4;MCM5;IKZF1;GATA1;PCID2;FAM111A;AIM2;NFE2L2;POU2F2;HES7;MLXIPL;DHX9;TLR8;ZEB2;SP7;BARX2;YAF2;NABP1;FOXD2;NR1H4;DNMT3A;BPTF;CEBPA;FOXO3;LRRFIP1;DDIT3;EXO1;MAFK;HMGB1;XRCC5;TAF1;SAMHD1;BRIP1;FLI1;GTF3C4;TEAD1;TP53;MEF2A;NKX2-1;NRL;USF1;LONP1;YY1;RC3H2;CEBPB;CDC5L;ENDOV;TFAP2B;SMAD3;ARID1A;IRF2;HSF1;PPARGC1A;ARID3B;SURF6;RPL6;RNF4;ARID4A;MCM6;HDAC4;MCM2;APTX;SOX9;DENND4A;NR2C2;STN1;GZF1;MTF2;MBD1;SNAPC3;MCM9;PMS1;NR4A1;MAX;SMARCB1;DNA2;SAFB2;SOX6;CUX1;PCBP1;IRF1;INO80;HUWE1;MBD5;SOX2;ZDHHC1;SREBF1;MEIS1;POU6F1;C1D;ERCC5;SPTY2D1;TWNK;NR2C1;REXO4;ERCC6;THRAP3;TOP2A;NUFIP1;OGG1;RBPJ;SMARCAD1;HIF1A;RAD51B;APLP2;SNAPC4;PPARD;ZGPAT;TIGD2;NFYA;RPS27;NPAS2;CNBP;ZNF638;ZNF35;RXRA;JUNB;PHF1;CUX2;POU2F3;CHD4;ERCC1;MAFB;TOP1;FUBP3;ZIC4;TINF2;RAD51D;QRICH1;KDM5A;MAU2;KDM5B;HHEX;ZMYND11;CRLF3;CDC45;RAD23B;POU2F1
prerank,antiporter activity (GO:0015297),0.4179320470088601,0.9108151539295125,0.5894206549118388,1.0,1.0,9/20,28.62%,SLC25A16;TMEM241;SLC25A30;CLCN4;SLC35C2;SLC35E1;SLC35A1;SLC35E2A;SLC35E2B
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.37557273862781654,0.9105203807820822,0.6422413793103449,1.0,1.0,12/55,17.42%,SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC36A4;SLC16A1;ABCC1;SLC38A10;SLC16A6;SLC13A3;SLC16A13
prerank,ubiquitin-protein transferase activity (GO:0004842),0.35136550206692624,0.9095190122450469,0.766,1.0,1.0,76/346,18.32%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2D3;TRAF2;SEL1L;FBXL22;MSL2;VPS18;MGRN1;RNF7;TNFAIP3;TRAF3;HLTF;PPP1R11;TAF1;RNF111;HECTD1;KLHL21;UBE2S;RNF150;RC3H2;MALT1;VPS11;TRIM27;RNF114;UBE2E3;RC3H1;RNF4;RING1;TRAF5;NFX1;NEDD4L;UBE2H;RNF10;TRIM56;TRIM24;MAEA;RNF40;TRIM35;CDC34;RNF216;FBXL3;RMND5B;RNF135;ITCH;UBE2G2;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;UBE2J2;DTX4;ZNRF1;RNF152;SMURF1;FANCL;UBE2N;TRIM62;ZNRF3;ANAPC11;UBE2Z;UBE2K;CDC42;BIRC2;FBXO44
prerank,cell adhesion mediator activity (GO:0098631),0.4138832139190173,0.9087192524287636,0.5987577639751552,1.0,1.0,8/24,20.03%,SIRPA;EMB;NINJ1;NPTN;CD47;VSTM2L;PALLD;CNTN4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.36272278167565436,0.9080494805338181,0.6491228070175439,1.0,1.0,11/72,12.29%,MYO1G;LDLRAP1;ADAP2;FLII;SLC9A1;AMER1;PFN2;PFN1;TWF2;EXOC1;SDCBP
prerank,RNA polymerase binding (GO:0070063),-0.31342723101411074,-0.9072831246626735,0.5779816513761468,0.9477576022898576,1.0,5/18,7.97%,SCAF8;PPIB;ANP32B;PHRF1;CCNT1
prerank,adrenergic receptor binding (GO:0031690),-0.31447536205877735,-0.9072135568513635,0.5665236051502146,0.9381152630832337,1.0,6/16,18.12%,ARRDC3;GNAS;RAPGEF2;SAV1;MAGI2;UCHL1
prerank,GDP binding (GO:0019003),0.3755116605000632,0.9063097788615454,0.6390346274921301,1.0,1.0,14/63,16.64%,RAB8B;RAP2A;RAB14;RAP1B;RAB7A;RAP2B;RAB28;RAB31;RRAS2;ARF6;GNAI3;RAP1A;ARL8B;RAB27B
prerank,manganese ion binding (GO:0030145),0.3740730236970644,0.906302204050306,0.6318622174381054,0.9985112328312524,1.0,20/48,24.58%,MGAT5;GYG1;B4GALT1;PIM1;ADPRM;FAM20C;B4GALT7;GALNT2;LARGE1;MGAT5B;PPM1M;GALNT1;MGAT1;ATP13A2;NEK4;XXYLT1;HMGCL;POMGNT1;GALNT3;ABL2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.3602080953559581,-0.9054646178932194,0.563573883161512,0.9330401558411158,1.0,4/12,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,tropomyosin binding (GO:0005523),0.42626863964568196,0.9038710253107469,0.5893089960886571,1.0,1.0,2/16,8.17%,PYCARD;TNNT3
prerank,PDZ domain binding (GO:0030165),0.3710464306785313,0.903399511101454,0.638004246284501,0.9984222543301842,1.0,23/61,24.40%,GNG12;FZD3;DOCK4;TBC1D10A;KIF14;ATP2B1;F11R;MAP2K2;SNTG2;ATP2B3;CADM1;PLEKHA1;GRIA1;FZD8;PTEN;KIDINS220;PLEKHA2;FZD2;PRKN;GNG5;NSF;ATP2B4;ATP2B2
prerank,Wnt-activated receptor activity (GO:0042813),0.4427539659496546,0.9023756804318233,0.6101036269430051,0.9975145921474157,1.0,4/15,9.91%,FZD10;FZD9;FZD3;LRP5
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3720234885268032,-0.9011631331461483,0.5601173020527859,0.9336641024473881,1.0,6/10,39.28%,INCA1;KAT2B;CDKN1A;CDKN2C;CDKN2D;CDKN2B
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.362825777798889,0.8994665812468408,0.6493236212278877,1.0,1.0,19/69,23.51%,CERS6;ASPG;SOAT2;ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;PLAAT3;GTF2B;DGAT2;MOGAT1;NMT1;ZDHHC21;NAA15;ZDHHC2;CERS4;PLA2G4E
prerank,cadherin binding (GO:0045296),0.34775238664625446,0.8992750936998241,0.788,0.9981056943906087,1.0,98/315,20.59%,CBL;SNX5;TRIM25;PTPRJ;PTPN1;KLC2;SNX9;PKP2;ASAP1;ITGA6;RPS2;ATIC;LRRFIP1;MYH9;P2RX4;MACF1;CTNNB1;ANXA1;CAPZB;MAPRE1;YWHAB;MICALL1;ARGLU1;SND1;GAPVD1;CLIC1;WASF2;TBC1D10A;CLINT1;CAPZA1;PLIN3;LARP1;CCT8;ARHGAP1;ABI1;RARS1;RPL6;CDH8;EIF4H;VCL;VAPB;F11R;PRDX1;AHSA1;TBC1D2;SCYL1;PFN1;CDH9;PTPRO;YKT6;CDH12;TLN1;TWF2;PRDX6;NUMB;STX5;VASN;FNBP1L;CDH23;STK24;HCFC1;PCBP1;ARHGAP18;PTPRT;EXOC3;SNX2;PDLIM1;USP8;FXYD5;EPS15;ATXN2L;FASN;GOLGA3;SRC;EFHD2;RTN4;DCHS1;CDH19;LDHA;ARFIP2;GCN1;IQGAP1;GIPC1;ADD1;PICALM;ITGB1;SCRIB;SERBP1;RPL7A;LASP1;RPL15;MB21D2;ENO1;RPL29;CDK5R1;USO1;PKM;TES
prerank,BMP binding (GO:0036122),-0.35074283386640154,-0.8989328580005045,0.5894736842105263,0.9299302760842151,1.0,1/11,2.45%,NBL1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.4386385226611499,0.8985871904805837,0.6116373477672531,0.9966353740027238,1.0,4/13,19.03%,GABRA5;GLRA2;GABRA4;GABRG1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.3734480369255475,-0.8973010742720419,0.5771812080536913,0.9245322199521203,1.0,8/10,54.46%,SLC6A11;SLC6A1;SLC10A1;SLC10A3;SLC10A6;SLC6A13;SLC10A4;SLC10A5
prerank,growth factor activity (GO:0008083),0.3534733322555874,0.8972204790591176,0.6745867768595041,0.9964766770659481,1.0,9/74,12.63%,MDK;ANGPTL3;OSM;VEGFB;NTF3;INHBA;ARTN;GRN;NRG1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.35820639869329285,-0.8971204191353885,0.5700325732899023,0.9157489296415001,1.0,4/11,9.06%,SH3RF1;AKAP13;SPAG9;MAPK8IP3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.37230794634494035,0.895532922963454,0.6423200859291085,0.9968650769906119,1.0,7/53,10.09%,CYBB;CYB5R1;XDH;ACADL;MICAL1;KMO;ILVBL
prerank,O-acyltransferase activity (GO:0008374),0.38569923113244264,0.8947668271064708,0.6262975778546713,0.9954826966151363,1.0,4/30,12.19%,LPCAT1;SOAT2;LPCAT2;PRDX6
prerank,histone methyltransferase binding (GO:1990226),0.4591738575019697,0.8945872694726548,0.6162464985994398,0.9929839251181933,1.0,6/11,25.14%,PRDM12;CTNNB1;PHF1;LCORL;WIZ;HSP90AB1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3932449551044427,0.8937509829561764,0.6195402298850575,0.9918750633953164,1.0,2/29,3.38%,PRKAR2B;PKIB
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.36329881639022654,0.8931910014770643,0.6646026831785345,0.9901127448634128,1.0,14/75,17.68%,EHHADH;AKR1A1;DHRS3;HPGD;SORD;DHRS11;HSD17B11;SPR;SDR42E1;ME3;LDHA;IMPDH2;PHGDH;PGD
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3265138617344898,-0.8925337752694296,0.591304347826087,0.9175681822985137,1.0,2/14,1.33%,MTM1;MTMR7
prerank,translation elongation factor activity (GO:0003746),0.43312055635734675,0.8920248793083856,0.6020942408376964,0.9895541118408138,1.0,2/14,6.89%,GFM1;GTPBP1
prerank,frizzled binding (GO:0005109),-0.24834896494530456,-0.8917617426878103,0.6328125,0.910469354287582,1.0,11/34,25.99%,WNT4;RNF43;WNT5A;WNT6;WNT5B;FZD1;MYOC;CCDC88C;WNT16;DVL2;WNT11
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3678844931568267,-0.8905609816374862,0.5672131147540984,0.9043476464735833,1.0,2/10,10.19%,CLCN6;CLCN2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.45681104833647207,0.8899937855293716,0.6270949720670391,0.990725599207383,1.0,11/11,54.35%,DDAH1;PADI2;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;DDAH2;ARG2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.44900094373817356,0.8886436825240731,0.6055172413793104,0.9904576575885945,1.0,2/12,8.98%,TENT4B;TENT5C
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.38129576483801486,0.8875522999985161,0.622876557191393,0.989765342402282,1.0,11/34,17.82%,UBE2D3;TAF1;UBE2S;UBE2E3;UBE2H;CDC34;UBE2G2;UBE2J2;UBE2N;UBE2Z;UBE2K
prerank,tau-protein kinase activity (GO:0050321),-0.28743112570342,-0.8874710323041644,0.6363636363636364,0.9028401386294046,1.0,7/20,16.86%,TAOK2;DYRK1A;ROCK1;PHKG2;MARK4;SIK3;TTBK1
prerank,phospholipid transfer activity (GO:0120014),-0.2813175436340233,-0.8853386616184756,0.6547619047619048,0.8993361153533075,1.0,9/21,23.14%,PITPNM2;PITPNC1;TNFAIP8L3;GLTP;PITPNB;MTTP;PRELID2;PRELID3A;PLTP
prerank,glucuronosyltransferase activity (GO:0015020),0.40375777515642125,0.884602586065595,0.610126582278481,0.9927244596451087,1.0,5/19,25.68%,CHSY1;LARGE1;CHPF;B3GAT2;EXT2
prerank,solute:proton symporter activity (GO:0015295),-0.32044732015773836,-0.8842745573436351,0.5687203791469194,0.8931071024917165,1.0,2/16,1.66%,SLC2A13;SLC33A1
prerank,microtubule binding (GO:0008017),0.34179588996158755,0.8842212421398985,0.7817817817817818,0.9906439307223275,1.0,40/222,15.94%,HOOK3;UXT;NEFH;GAS2L1;FGF13;MAP1LC3B;GAS2L3;CCDC88B;MDM1;TPGS1;CCDC69;MACF1;MAPRE1;DNM2;CLIP2;IRAG2;GJB6;STARD9;CETN3;KIF14;KIF20B;KIF23;VAPB;RAB11A;TUBGCP6;TUBGCP4;MAP1B;CCDC181;MID2;HDAC6;CEP57L1;KATNA1;HAUS8;KIF2A;HOOK2;LRRK2;FMN1;DST;SVBP;CAMSAP2
prerank,voltage-gated potassium channel activity (GO:0005249),0.35346592489896667,0.8836239690748159,0.6835051546391753,0.989048229002261,1.0,6/80,7.14%,KCNJ11;HCN4;KCNK6;PKD2;KCNIP2;KCNMA1
prerank,calcium-release channel activity (GO:0015278),0.41275402116686,0.8823142111792663,0.6174582798459564,0.9888607465654673,1.0,3/17,8.68%,RASA3;PKD2;ITPR2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4639202354177312,0.8804678351045995,0.6212765957446809,0.9895433893460759,1.0,3/10,16.08%,LAPTM5;ANKRD13A;IDE
prerank,methylation-dependent protein binding (GO:0140034),0.3574827518738747,0.8775935077593299,0.6848739495798319,0.9919952369545352,1.0,16/57,20.16%,BPTF;NCAPG2;CXXC1;MORC3;KDM7A;ATRX;CHD1;TRIM24;RBBP5;MTF2;CDYL;MORC4;LRWD1;PHF1;KDM5A;ZMYND11
prerank,NADP binding (GO:0050661),-0.24154040832338738,-0.8771094027732176,0.6722689075630253,0.9014192028472048,1.0,18/32,31.80%,ME1;CRYZL1;HMGCR;GMDS;DUS2;NOS3;MTRR;CBR4;NOS1;NNT;DHFR;LBR;NDOR1;DHCR7;CRYZ;CBR3;TM7SF2;HSD11B1
prerank,mannosyltransferase activity (GO:0000030),0.4015288829837161,0.8731996502055975,0.6359102244389028,0.9972691810376303,1.0,4/21,10.14%,PIGM;PIGV;ALG2;TMTC4
prerank,androgen receptor binding (GO:0050681),-0.26576720622548294,-0.8731855005331387,0.6566265060240963,0.9023361309068709,1.0,11/25,24.55%,FOXP1;SMARCA4;KDM3A;CALR;SNW1;RNF14;PARK7;TGFB1I1;ARID5A;PRPF6;TRIM68
prerank,histone deacetylase binding (GO:0042826),0.34708198429042725,0.8727227952824409,0.7082906857727738,0.9952450263348956,1.0,24/88,20.95%,CIR1;SPI1;BHLHE41;HDAC5;MTA3;YWHAB;TP53;MEF2A;TAL1;USF1;MEF2C;HDAC4;PKN1;ZMYND15;HDAC6;HDAC9;AKAP8L;TOP2A;HSP90AA1;DACT1;CHD4;RBBP4;PRKN;TFAP4
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.40269856914884766,0.8702054831665944,0.6397919375812744,0.9972006721085729,1.0,5/20,19.24%,OTULINL;USP7;USP9X;USP21;DESI2
prerank,channel activity (GO:0015267),0.36199652623856604,0.8693579591545438,0.6622662266226622,0.9959610874100676,1.0,4/41,13.91%,AQP1;AQP11;TMEM120A;TRPV3
prerank,N-acetyltransferase activity (GO:0008080),-0.27534030949864097,-0.8691013100220023,0.6764705882352942,0.9032701882787431,1.0,3/19,9.68%,ESCO1;SAT1;NAT10
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4119290807241182,0.8684089764547377,0.6248331108144193,0.9950890365865754,1.0,5/14,20.71%,ELAC2;RPP38;RPP14;PRORP;TSEN2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3419757776394997,-0.8659358538370852,0.6044776119402985,0.9022977277760756,1.0,4/12,13.91%,NUDT5;ENTPD5;SLC25A42;CANT1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.2568264422537638,-0.8639308843781314,0.7077922077922078,0.8985328078946319,1.0,14/27,29.01%,MED21;PRIMPOL;MED20;PRIM1;POLR3B;POLR2C;POLR3F;POLR1F;POLR1H;POLR2J;POLR2D;POLRMT;POLR1D;POLR1C
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.39357015349708735,0.8629318452286268,0.6410891089108911,1.0,1.0,6/21,17.70%,AKAP5;ARFGEF1;WASF2;ARFGEF2;AKAP8L;AKAP9
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.34185255204214676,0.8604794836878502,0.7418367346938776,1.0,1.0,22/91,21.18%,MYO1G;SH3PXD2B;LDLRAP1;ADAP2;FLII;SLC9A1;AMER1;PFN2;PFN1;TWF2;EXOC1;SDCBP;SNX14;SNX18;PLEKHA5;PICALM;TULP3;LAPTM4B;FCHO2;ATP13A2;KCNJ2;MARK1
prerank,tRNA binding (GO:0000049),0.3588316383030852,0.8601028767445714,0.6948408342480791,1.0,1.0,12/43,22.57%,SEPSECS;ELP1;TRMT10A;CTU1;DARS2;YRDC;FARS2;AIMP1;RPUSD4;ELP5;SARS2;SARS1
prerank,ribonuclease P activity (GO:0004526),0.4333081760336289,0.8588168333925608,0.645021645021645,1.0,1.0,3/11,15.01%,RPP38;RPP14;PRORP
prerank,peptidase inhibitor activity (GO:0030414),0.3683373051514694,0.856936354709001,0.6746575342465754,1.0,1.0,4/33,8.85%,CST7;RENBP;TIMP1;SPINT2
prerank,nuclear import signal receptor activity (GO:0061608),-0.30065979305383117,-0.8546945629703389,0.6954732510288066,0.9103536266343216,1.0,7/15,31.83%,TNPO3;IPO5;RANBP6;HIKESHI;TNPO2;KPNA2;KPNA6
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.44315830781892573,0.8471336886935497,0.672883787661406,1.0,1.0,1/10,2.23%,SLCO2B1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.3612274734470457,0.8462851572556546,0.6852272727272727,1.0,1.0,12/35,23.10%,MMP12;TAF1;TP53;SNAPC3;SMARCB1;PIH1D1;GTF2B;AGO2;POU2F1;TAF1C;H3-3A;GTF2A1
prerank,cation transmembrane transporter activity (GO:0008324),0.35316627757999386,0.8459624276808229,0.6857772877618522,1.0,1.0,7/48,11.13%,SLC7A8;SLC38A6;SLC36A1;SLC25A38;SLC36A4;SLC8B1;SLC66A1
prerank,nuclease activity (GO:0004518),0.3462042843693082,0.845876917877756,0.7085590465872156,1.0,1.0,20/52,26.04%,EXO1;SAMHD1;SND1;RNASEL;RNASEH1;DNA2;DDX1;ERCC5;REXO4;OGG1;N4BP2;RNASEH2A;DIS3L2;RNASE6;REXO1;DNASE1L1;XRN2;RNASE12;DFFB;RNASE3
prerank,5'-nucleotidase activity (GO:0008253),0.4134795754965346,0.8450354356524616,0.6610407876230661,1.0,1.0,2/13,10.21%,NT5C3B;NT5DC3
prerank,RNA binding (GO:0003723),0.32312730666175293,0.8440381469431986,0.996,1.0,1.0,331/1321,21.58%,SEPSECS;LGALS3;APOBEC1;RBM47;RFTN1;PCSK9;PCID2;CORO1A;RPL23;RPL17;RBM38;MYO5A;TRIM25;EMG1;GRB2;PTPN1;DHX9;TLR8;TLR7;RPL10A;GFM1;KCTD12;UTP20;PCDH20;ACIN1;NPM3;SF3B2;SF3B1;MKRN1;FBL;ZNF326;BCCIP;ELP1;PPIE;RBM39;RPS2;DHX38;EXOSC1;TENT4B;LRRFIP1;EIF5B;RRBP1;NXF1;MYH9;SCAF11;LAS1L;SAMSN1;IREB2;THOC2;SYNE1;HLTF;HMGB1;ANP32A;XRCC5;SAMHD1;RPL18A;BTF3;CHCHD1;CIRBP;MACF1;CDK11B;MRPL41;MAPRE1;CCAR1;FASTKD3;ACTN4;NUDT4;SND1;GTPBP1;RPS15A;LONP1;TNRC6A;GSPT1;YY1;TCF20;YTHDF3;RC3H2;CSTF1;TMSB4X;P4HB;CASC3;SNRPD2;TRAP1;ELAC2;ZC3H12D;GRSF1;EIF4A1;NKRF;CDC5L;ERAL1;ENDOV;TPT1;LARP4B;MOV10;RBM15B;EIF1;PRPF38B;ADAR;LARP1;CMSS1;RC3H1;KRR1;PPARGC1A;ZCCHC7;TDRD7;SMG1;PCBP3;RPP38;EPRS1;PUM2;SURF6;AGO4;RPL6;DDX27;FASTKD1;HNRNPL;EIF4H;CPEB3;MCRS1;NFX1;PRDX1;RBMX2;TPR;ACTN1;NAP1L1;DDX39B;RBM27;ZC3H18;RPL26;SON;TRMT1;TRIM56;RPS20;SNIP1;RNASEL;LGALS1;LUC7L3;DIAPH1;EIF4G3;APTX;FAU;PFN1;RPS16;CLTC;TRMT10A;CHERP;ACO1;CTU1;ZNF106;PTBP2;GRN;SECISBP2;AGO3;RNASEH1;METTL3;DDX18;PRPF8;PIN4;TRA2B;TWF2;DYNC1H1;UTP11;NOP9;HEATR1;RPS14;TBL2;PPIL4;RRS1;ADARB1;ATP5F1A;RPP14;RPGR;DNA2;FAM50A;SAFB2;DARS1;MSI2;RPL19;POLDIP3;PCBP1;ZYX;UPF3B;RCC1L;HUWE1;RTRAF;MRPL15;DDX1;TSR1;MYH10;HNRNPD;RO60;ALKBH5;SRP19;CSRP1;DARS2;YRDC;NOC2L;PPP1CC;PUM3;PRKRA;IGF2BP3;IMP3;PPIG;RPL9;MRPS9;ATXN2L;PES1;C1D;LRP1;CPEB4;FASN;RBM42;NOC3L;FAM120C;AKAP8L;CCDC47;METAP2;MTDH;REXO4;NOL7;HEATR6;THRAP3;TOP2A;NUFIP1;EWSR1;RPS11;RTN4;PDIA3;PUS7;LSM8;RPL11;SMG7;ZC3H12C;MEX3D;CPEB2;TEP1;TUT7;TASOR;RPS23;HSP90AA1;FARS2;TARBP2;GCN1;UBE2N;RPS4X;MRPS21;LRRC47;NGDN;MRPL39;MANF;CRNKL1;RPS27;RBPMS2;PCF11;AGO2;SEC63;CNBP;DDX41;ZNF638;RPL4;MRPS14;ADD1;DDX31;RBM34;PABPC4;GOLGB1;FYTTD1;MRPL3;FCF1;RBMS2;TOP1;FUBP3;DUSP14;SNRNP200;HNRNPF;SRSF6;ERH;SNRNP35;PNN;SERBP1;WDR75;SRSF2;CLNS1A;PYM1;ROCK2;PABPN1;MRPS26;RPL7A;RPL15;HSPB1;ENO1;EXOSC3;SART1;MRPL10;RPL29;ZC3H7A;USO1;SLBP;DDX51;RRP7A;UTP3;SRSF10;SRSF3;VIRMA;ARCN1;PKM;MRPL54;TES;NCOA5;NAA15;HEXIM1;AIMP1;SRFBP1;STRAP;R3HDM2;RPL22;BAG4;IMP4;RPS7;RIMS1;DICER1;PTBP1;TOE1;HNRNPA0;ZFP36L1;EIF2S2;LSM14A;DCP1B;RPUSD4;LIN28B;YARS1
prerank,nuclear export signal receptor activity (GO:0005049),0.42196361429652085,0.8438521910091846,0.6517482517482518,1.0,1.0,3/11,12.04%,XPO1;CSE1L;XPO6
prerank,solute:sodium symporter activity (GO:0015370),-0.2509142086490749,-0.8430377361929067,0.7215189873417721,0.9259963964568069,1.0,6/27,27.58%,SLC4A10;SLC5A6;SLC5A7;SLC5A3;SLC5A11;SLC20A1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.2954597228166608,-0.842684763378884,0.6571428571428571,0.9187435374777126,1.0,6/15,17.11%,ALDH2;ALDH1A1;ALDH3A2;ALDH1A2;ALDH1L1;ALDH1L2
prerank,galactosyltransferase activity (GO:0008378),0.431258070847911,0.8421916044522587,0.6648199445983379,1.0,1.0,5/11,21.71%,B4GALT1;A3GALT2;B4GALT7;B4GALT6;B4GALT2
prerank,potassium ion leak channel activity (GO:0022841),0.403251032718689,0.8400326803677512,0.6715425531914894,1.0,1.0,2/15,7.52%,KCNK6;KCNK13
prerank,mRNA 5'-UTR binding (GO:0048027),0.3795823909574167,0.8399888167915497,0.6736453201970444,1.0,1.0,10/24,25.61%,LARP1;RPL26;RPS14;CCT5;MYH10;IGF2BP3;RPS7;RPS13;RPL41;RPL5
prerank,calcium:sodium antiporter activity (GO:0005432),0.43110391488830235,0.8387992299722363,0.664756446991404,1.0,1.0,2/10,10.60%,SLC8A1;SLC8B1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.34811297695676524,0.8377364418638774,0.724400871459695,1.0,1.0,3/48,4.10%,P2RX1;AQP1;PKD2
prerank,R-SMAD binding (GO:0070412),0.3965792943102655,0.835663938039106,0.6882276843467011,1.0,1.0,4/18,17.38%,RGCC;SMAD3;SMURF1;LDLRAD4
prerank,glucose transmembrane transporter activity (GO:0005355),0.40071135146036696,0.8344838497047287,0.684,1.0,1.0,1/17,4.15%,SLC2A3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.43078587435344096,0.8341335344357843,0.6666666666666666,0.9998926187214449,1.0,3/10,19.03%,GABRA5;GABRA4;GABRG1
prerank,intracellular chloride channel activity (GO:0061778),-0.29496105983011983,-0.8321869243583626,0.6666666666666666,0.924295596073993,1.0,9/16,37.91%,TTYH3;ANO4;TTYH1;ANO5;ANO8;ANO2;ANO6;ANO1;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.29496105983011983,-0.8321869243583626,0.6666666666666666,0.924295596073993,1.0,9/16,37.91%,TTYH3;ANO4;TTYH1;ANO5;ANO8;ANO2;ANO6;ANO1;NMUR2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4005264572086961,0.8313041744077913,0.6732542819499341,1.0,1.0,5/15,18.20%,LPCAT1;LPCAT2;ABHD4;PNPLA3;LCLAT1
prerank,neurexin family protein binding (GO:0042043),0.42756783939755294,0.829534100319239,0.6886930983847284,1.0,1.0,2/10,8.73%,CEL;SYTL4
prerank,adenylate cyclase binding (GO:0008179),0.42615268204136536,0.8289064153942398,0.7011834319526628,1.0,1.0,2/10,8.17%,AKAP5;CAP1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.41655666269023617,0.8261071473991833,0.6732117812061711,1.0,1.0,1/11,5.90%,PPP1R11
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4107519344359944,0.8251918318620767,0.6845730027548209,1.0,1.0,3/12,12.44%,CDK8;CDK7;CDK6
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3412392051201258,0.8228960333020764,0.7481081081081081,1.0,1.0,10/49,15.84%,PTPRJ;DUSP3;SAMHD1;PLCXD3;DUSP10;FRA10AC1;PTPRO;PXYLP1;PPP1CC;GDPD3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.43654624333565645,0.8228841526110341,0.6791907514450867,0.9995505372753773,1.0,3/10,16.08%,LAPTM5;ANKRD13A;IDE
prerank,"DNA binding, bending (GO:0008301)",-0.29586356920266643,-0.8216247419714306,0.6809338521400778,0.937569041641767,1.0,2/14,1.44%,FOXC1;FOXD1
prerank,transcription corepressor binding (GO:0001222),0.3622468162568961,0.8179744422031576,0.6990740740740741,1.0,1.0,10/27,21.99%,NEK6;FAM89B;HDAC6;MTF2;PHF1;CTBP2;PER1;EED;CTBP1;WIZ
prerank,3'-5' exonuclease activity (GO:0008408),-0.21385864977018917,-0.8174740442899816,0.8631578947368421,0.9377555405611652,1.0,16/45,25.24%,REV3L;PAN2;MRE11;DIS3;ERI1;EXOSC7;APLF;WRN;EXD2;TATDN1;EXOSC9;POLG;PARN;EXD1;EXOSC5;CNOT6L
prerank,anion transmembrane transporter activity (GO:0008509),0.4024753566149609,0.8149925026375466,0.7044476327116213,1.0,1.0,1/12,2.23%,SLCO2B1
prerank,sialyltransferase activity (GO:0008373),0.3731933919820512,0.8125065992163993,0.7036569987389659,1.0,1.0,4/20,10.45%,ST8SIA4;ST6GALNAC4;ST3GAL1;ST8SIA1
prerank,neuropeptide binding (GO:0042923),0.37670749209562,0.8123793328405116,0.7022900763358778,1.0,1.0,3/18,19.97%,GPR37;SORL1;GPR149
prerank,sequence-specific mRNA binding (GO:1990825),0.4211403060158349,0.8117962349277824,0.6980854197349042,1.0,1.0,1/10,2.82%,DHX9
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.32013433413623305,-0.8115905950107212,0.7108843537414966,0.9410464867485857,1.0,4/11,13.74%,HNRNPA2B1;HNRNPA1;NABP2;CTC1
prerank,voltage-gated anion channel activity (GO:0008308),0.3936484459786238,0.8094736905032544,0.7159841479524438,1.0,1.0,4/15,15.59%,VDAC3;VDAC2;VDAC1;CLCN4
prerank,poly(U) RNA binding (GO:0008266),-0.25977381751953366,-0.8082194703744087,0.7910447761194029,0.939976765717872,1.0,4/20,10.45%,DAZAP1;SSB;FMR1;RBMS3
prerank,microtubule motor activity (GO:0003777),-0.2033081795268788,-0.8081105096614124,0.8472222222222222,0.932537128585976,1.0,17/51,23.03%,KIF5B;KIF3C;DYNC1I1;SMC3;KIF16B;KIF26B;KIF3B;KIF5A;KIF24;KIF13A;KIF18A;DNAH2;KIF26A;KIF9;KIFC2;KIF7;KIF1A
prerank,deubiquitinase activity (GO:0101005),0.3205378968283141,0.8078645596896533,0.8161389172625128,1.0,1.0,19/88,16.00%,MINDY4;OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;MINDY1;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3400775479206228,0.8072275596377042,0.7183908045977011,1.0,1.0,9/33,17.89%,DHX9;ZNF326;UVSSA;RTRAF;ELOF1;ERCC5;GTF2B;PCF11;AGO2
prerank,general transcription initiation factor binding (GO:0140296),-0.2559241010388846,-0.8062840046024851,0.7804878048780488,0.9284707328240596,1.0,8/25,16.36%,AR;TBP;DR1;PSMC1;RELA;TAF13;PSMC5;RUVBL1
prerank,protein phosphatase 2A binding (GO:0051721),0.3737492553056335,0.8059648812502902,0.7252090800477897,1.0,1.0,8/23,16.39%,TP53;ENSA;STRN;BOD1L1;ADCY8;CTTNBP2NL;PTPA;SMG7
prerank,deoxyribonuclease activity (GO:0004536),-0.2958915390321925,-0.8048393517186947,0.7218045112781954,0.9237522391176873,1.0,3/14,11.75%,MRE11;MAP1S;APLF
prerank,tubulin binding (GO:0015631),0.3099631569603618,0.8018650753292004,0.919,1.0,1.0,62/296,19.49%,HOOK3;UXT;NEFH;GAS2L1;TBCEL;FGF13;SNCA;MAP1LC3B;GAS2L3;CCDC88B;DIP2B;MDM1;TPGS1;CCDC69;ARL8A;DNM2;CLIP2;IRAG2;GJB6;STARD9;CETN3;KIF14;KIF20B;KIF23;VAPB;RAB11A;TUBGCP6;TUBGCP4;TPR;SETD2;MAP1B;CCDC181;TTLL12;MID2;HDAC6;CEP57L1;FYN;RAB11FIP5;KATNA1;AGBL5;INO80;CCT5;HAUS8;KIF2A;HOOK2;LRRK2;AGTPBP1;FMN1;DST;SVBP;TTLL1;ARL8B;EML4;ARHGEF2;KIF21A;NCALD;KIF1B;MAPRE2;TAOK1;CCDC66;RAD51D;DNM1L
prerank,translation initiation factor activity (GO:0003743),0.3399847652987803,0.8012159793954491,0.7418630751964085,1.0,1.0,18/36,28.71%,EIF3K;EIF5B;EIF4A1;EIF1;EIF2B2;EIF4G3;AGO2;MTIF3;EIF2S2;EIF3E;EIF3M;EIF3C;EIF2A;EIF2S1;EIF1B;EIF4E;EIF3A;EIF4A2
prerank,metallopeptidase activity (GO:0008237),0.312398389588439,0.8007437531398331,0.8232323232323232,1.0,1.0,17/113,17.05%,MMP12;COPS6;ADAM8;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ZMPSTE24;NLN;MMP19;PRPF8;ERAP1;ECEL1;METAP2;PSMD7;PMPCB;IDE;PITRM1
prerank,peptidase activator activity (GO:0016504),0.36065249841581243,0.8006301548600643,0.7233250620347395,0.9997534608158624,1.0,2/22,4.42%,VSIR;TANK
prerank,epidermal growth factor receptor binding (GO:0005154),-0.24705599366433006,-0.8003663715336541,0.8121212121212121,0.924731219812792,1.0,11/25,28.66%,SNX4;EFEMP1;ATXN2;SHC1;LINGO1;HBEGF;CCDC88A;HIP1;EGF;CNOT9;FER
prerank,phosphatase activity (GO:0016791),0.31842300703449766,0.7998392135494697,0.7899073120494335,0.9984512564297903,1.0,10/73,14.70%,LPIN2;PTPRJ;DUSP3;PLPPR1;DUSP10;FRA10AC1;APTX;PTPRO;PXYLP1;PPP1CC
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.39752514975662806,0.7997840158290315,0.7224606580829757,0.9960454168765314,1.0,2/12,7.43%,ITGB3;VEGFB
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.39952725097519026,0.7991274325502086,0.708502024291498,0.9945228464329368,1.0,6/12,24.34%,CNOT8;TOE1;PNLDC1;CNOT7;CNOT1;CNOT2
prerank,mRNA binding (GO:0003729),0.3084582903017652,0.7982540801142191,0.915,0.993229165086069,1.0,66/249,21.49%,RBM47;DHX9;SF3B1;PPIE;RPS2;IREB2;THOC2;CIRBP;TP53;YTHDF3;RC3H2;ZC3H12D;GRSF1;EIF4A1;LARP4B;LARP1;RC3H1;TDRD7;PCBP3;PUM2;ANGEL2;HNRNPL;CPEB3;TPR;RPL26;SNIP1;LUC7L3;EIF4G3;RNF40;ACO1;PTBP2;SECISBP2;METTL3;TRA2B;RPS14;ADARB1;PCBP1;UPF3B;CCT5;MYH10;PUM3;IGF2BP3;CPEB4;ZC3H12C;CPEB2;MARF1;RBPMS2;PCF11;AGO2;CNBP;PABPC4;FYTTD1;RBMS2;FUBP3;SRSF6;SNRNP35;SERBP1;SLBP;PKM;RPS7;PTBP1;HNRNPA0;ZFP36L1;EIF2S2;LSM14A;DCP1B
prerank,peptidoglycan binding (GO:0042834),0.4203776519285557,0.7972417652072945,0.7247838616714697,0.9922626470218829,1.0,2/10,12.25%,TLR2;NOD2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4103864137157074,0.7910314247658745,0.6946107784431138,0.9986033484264601,1.0,2/10,10.80%,EXO1;MGME1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.37710347830004165,0.7902801025837269,0.7199434229137199,0.997124114252511,1.0,4/14,23.58%,NME6;AK8;AK5;AK1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.39734434780581396,0.7901035872097136,0.7076271186440678,0.9949090254050168,1.0,5/11,21.07%,NAA40;NAA50;NAA25;NAA15;NAA80
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3390838599448434,0.7870890669621877,0.7578215527230591,0.9967609407716744,1.0,12/34,20.23%,DBF4;MAP2K2;PARP16;STK3;STRADA;ALS2;INCENP;IRGM;STK4;IQGAP1;TAOK1;CDK5R1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.3621880073290816,0.7860007500952048,0.7243107769423559,0.9958779564715096,1.0,1/18,5.97%,DHRS11
prerank,SUMO binding (GO:0032183),0.3916090998412136,0.7837326009760192,0.7293640054127198,0.9965089574538236,1.0,5/13,21.17%,RNF111;RNF4;UBA2;SERBP1;HERC2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3637511754218138,0.7818244184004335,0.7409713574097135,0.9966181298030895,1.0,6/19,18.40%,ANGPT4;ABI1;NRG1;GAS6;ERCC6;GREM1
prerank,metalloendopeptidase activity (GO:0004222),0.31025962276382857,0.7808163885629958,0.8055842812823164,0.9955412441793426,1.0,7/76,10.54%,MMP12;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ZMPSTE24;NLN;MMP19
prerank,N-acyltransferase activity (GO:0016410),0.33850060065942167,0.7748358607562302,0.7462165308498254,1.0,1.0,11/32,26.38%,CERS6;NAA50;PLAAT3;NMT1;NAA80;GNPNAT1;TGM2;CERS4;PLA2G4E;SIRT7;NAA10
prerank,N-methyltransferase activity (GO:0008170),-0.24572359925684362,-0.7725847447842988,0.8221153846153846,0.9646840991636053,1.0,14/20,42.35%,SETD3;METTL5;RNMT;NNMT;PRMT1;TRMT11;N6AMT1;FDXACB1;DIMT1;PEMT;METTL15;METTL18;TFB2M;GNMT
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.2733406085850576,-0.7723213386377227,0.7955555555555556,0.9576630414045995,1.0,4/16,9.48%,SLC25A12;SLC25A13;SLC25A14;SLC1A5
prerank,CoA hydrolase activity (GO:0016289),-0.27097758449033366,-0.7715406764216519,0.7717842323651453,0.9514071531835775,1.0,4/16,10.61%,HIBCH;ACOT11;ACOT13;ACAA2
prerank,FMN binding (GO:0010181),-0.300133787181038,-0.76815889039852,0.7259786476868327,0.9494807471408189,1.0,5/11,25.07%,DUS2;NOS3;MTRR;NOS1;NDOR1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.30368449795424945,-0.7663760242807394,0.7872340425531915,0.9451791511830064,1.0,4/11,17.53%,SAMD8;SGMS2;AASDHPPT;PIGF
prerank,chloride channel activity (GO:0005254),0.3129429282862316,0.763273456537579,0.8447537473233405,1.0,1.0,10/59,15.59%,PACC1;CLCC1;CLIC1;GABRA5;CLCN7;GLRA2;TTYH2;GABRA4;SLC1A4;CLCN4
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3168741452456921,0.7623683331338721,0.8058568329718004,1.0,1.0,14/49,20.39%,TNFAIP3;BABAM2;HDAC6;PRPF8;WDR81;TAB2;IKBKG;MINDY1;RNF169;TAB3;EPS15;PARP10;OPTN;RAD23B
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.22507179549210438,-0.7619270293696181,0.8205128205128205,0.9450929640039696,1.0,13/27,29.01%,MED21;MED20;TERT;POLR3B;POLR2C;POLR3F;POLR1F;POLR1H;POLR2J;POLR2D;POLRMT;POLR1D;POLR1C
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.30354852715394515,-0.7610265860175245,0.7594501718213058,0.9323715422933528,1.0,5/10,25.30%,DUSP16;DUSP1;DUSP7;DUSP8;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.30354852715394515,-0.7610265860175245,0.7594501718213058,0.9323715422933528,1.0,5/10,25.30%,DUSP16;DUSP1;DUSP7;DUSP8;DUSP6
prerank,myosin V binding (GO:0031489),0.36510449184932436,0.760955187338258,0.758800521512386,1.0,1.0,4/15,16.64%,RAB14;RAB39B;RAB11A;RAB27B
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.37244057887665033,0.7605127028543043,0.7591836734693878,1.0,1.0,2/13,6.35%,LPCAT1;LPCAT2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3355252158022211,0.759218387362358,0.8013698630136986,1.0,1.0,9/32,21.86%,TET3;HSPBAP1;KDM7A;ALKBH5;RIOX2;KDM4C;TET2;FTO;KDM2B
prerank,leak channel activity (GO:0022840),0.35481243594125783,0.7580872682220297,0.7653194263363755,1.0,1.0,2/18,7.52%,KCNK6;KCNK13
prerank,Tat protein binding (GO:0030957),0.39583211929279155,0.7570616045649928,0.7517337031900139,1.0,1.0,3/10,13.09%,ACTB;MDFIC;SMARCB1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3704409659404702,0.7560197156601861,0.7527027027027027,1.0,1.0,2/13,11.13%,SLC7A7;SLC66A1
prerank,cAMP response element binding (GO:0035497),0.38528448130086657,0.7528955100861918,0.7485549132947977,1.0,1.0,3/10,12.49%,CREB3L1;CREB3L2;CREB1
prerank,pentosyltransferase activity (GO:0016763),0.31449702292754245,0.7472181688665135,0.8172531214528944,1.0,1.0,11/36,21.54%,ART4;PARP8;PNP;PARP16;TNKS2;TIPARP;LACC1;LARGE1;PARP10;SIRT5;PARP3
prerank,ligand-gated anion channel activity (GO:0099095),-0.25793656748181026,-0.7465775341982203,0.8240343347639485,0.9461332471750895,1.0,4/17,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.2911089918338994,-0.7462646865104586,0.7687296416938111,0.9396066665816144,1.0,3/11,8.34%,UBR5;UBOX5;RBX1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.2973903459219157,-0.7459615886766537,0.7799352750809061,0.93319354074023,1.0,5/10,29.99%,OPLAH;CRMP1;DPYSL2;CAD;DPYSL3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.32513402570027805,0.7414982560933493,0.8045023696682464,1.0,1.0,10/25,25.10%,ART4;PARP8;PARP16;TNKS2;TIPARP;PARP10;SIRT5;PARP3;PARP1;PARP9
prerank,ribonuclease P RNA binding (GO:0033204),0.37546754079256517,0.7401674105741428,0.7741935483870968,1.0,1.0,2/10,13.15%,RPP38;RPP14
prerank,MAP kinase activity (GO:0004707),0.3528825536465629,0.7293271995394837,0.7821522309711286,1.0,1.0,2/14,11.40%,MAPK14;NLK
prerank,pseudouridine synthase activity (GO:0009982),-0.2716604880961554,-0.726279870212992,0.8409090909090909,0.9529115602210461,1.0,9/13,41.35%,PUS10;TRUB2;PUS1;PUS7L;RPUSD1;TRUB1;PUSL1;RPUSD2;RPUSD3
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.3172716722437759,0.7260767984245449,0.8186046511627907,1.0,1.0,3/31,6.46%,AQP1;PKD2;TMEM38A
prerank,telomeric DNA binding (GO:0042162),0.3170104491782473,0.7258001210932066,0.82063305978898,1.0,1.0,12/32,24.85%,XRCC5;SMG1;STN1;HNRNPD;SMG7;UPF2;TINF2;TERF2;TELO2;TERF2IP;TEN1;RPA1
prerank,histone acetyltransferase binding (GO:0035035),0.32822460850012714,0.722871459454482,0.7953144266337855,1.0,1.0,5/21,17.13%,TP53;MEF2A;EID1;HIF1A;TRIP4
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2784562637457371,-0.7207067997746324,0.8152173913043478,0.9528547005998353,1.0,3/12,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,transcription coactivator binding (GO:0001223),0.33024046750896113,0.7169318656944497,0.8184110970996217,1.0,1.0,2/20,8.71%,RPL23;SMAD3
prerank,pre-mRNA binding (GO:0036002),0.31722253246970616,0.7149341415291421,0.8307873090481787,1.0,1.0,9/28,21.15%,HNRNPL;PRPF8;TRA2B;RBM41;TARBP2;SLU7;SRSF6;SLBP;PTBP1
prerank,voltage-gated calcium channel activity (GO:0005245),0.2988613780697041,0.7128631964149568,0.8378378378378378,1.0,1.0,7/37,16.60%,PKD2;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;CACNA1D
prerank,disordered domain specific binding (GO:0097718),0.31629663356659476,0.7124172116443477,0.7978075517661388,1.0,1.0,9/23,25.85%,TP53;RB1;CLTC;FYN;HSP90AA1;TEAD2;NCOA3;HSP90AB1;DFFB
prerank,telomerase RNA binding (GO:0070034),-0.21909622756353023,-0.7116977780189855,0.8716814159292036,0.9571297179256791,1.0,9/22,23.23%,SNRPD3;PINX1;HNRNPU;WRAP53;DHX36;TERT;SMG6;PARN;GAR1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.29743882213057876,0.709933272169039,0.8306010928961749,1.0,1.0,8/42,20.77%,CCND3;CCND2;CCNL1;CCNE2;CCNYL1;CNPPD1;CDK5R1;HEXIM1
prerank,myosin II binding (GO:0045159),0.3666560234188341,0.7093770724053521,0.8100719424460432,1.0,1.0,1/10,2.68%,MYL3
prerank,O-methyltransferase activity (GO:0008171),0.3676160203763121,0.7090916152363328,0.7831669044222539,1.0,1.0,3/10,19.85%,COMT;BCDIN3D;COQ3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.2220417564987104,-0.706966657981639,0.9037433155080213,0.9559841148333318,1.0,10/24,28.83%,PPIP5K2;IP6K1;IP6K2;AK3;ITPKC;PMVK;AK4;CMPK2;NME2;CMPK1
prerank,carboxypeptidase activity (GO:0004180),0.294619385677618,0.7036446364457496,0.8455467869222097,1.0,1.0,7/35,17.36%,CTSA;CTSZ;NAALADL1;AGBL5;MINDY1;AGTPBP1;PEPD
prerank,thiol-dependent deubiquitinase (GO:0004843),0.28050033671366137,0.7024610101576358,0.9023638232271326,1.0,1.0,17/83,16.00%,OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,omega peptidase activity (GO:0008242),0.2782735680886513,0.7019118121183946,0.90992835209826,1.0,1.0,18/89,16.00%,OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;GGH;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2710110512690229,-0.7009832831877497,0.8715277777777778,0.9559243549593097,1.0,6/13,23.22%,THUMPD3;TARBP1;TRMT10B;TRMT5;WDR4;TRMT11
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2952384417810779,0.7007891557792105,0.8639910813823858,1.0,1.0,11/40,22.08%,DNMT3A;FBL;METTL4;COMT;PCMTD2;METTL9;SUV39H1;AS3MT;METTL2B;METTL2A;TPMT
prerank,mRNA 3'-UTR binding (GO:0003730),0.2778737562515492,0.7006541760536599,0.8926728586171311,1.0,1.0,21/79,21.24%,CIRBP;TP53;LARP4B;LARP1;RC3H1;PUM2;ANGEL2;CPEB3;RNF40;SECISBP2;CCT5;IGF2BP3;CPEB4;MEX3D;CPEB2;PABPC4;RBMS2;SERBP1;RPS7;HNRNPA0;ZFP36L1
prerank,proton transmembrane transporter activity (GO:0015078),-0.19461617415851815,-0.7005466297792392,0.9787234042553191,0.9496226676986732,1.0,10/39,21.76%,SLC33A1;UQCRH;COX5A;NDUFA4;DMAC2L;COX15;UQCRC1;UQCRQ;NNT;COX5B
prerank,acetyltransferase activity (GO:0016407),-0.19587844340735272,-0.7002658084628579,0.9428571428571428,0.9433912112343685,1.0,4/31,9.68%,ESCO1;ELP3;SAT1;NAT10
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3188023549060592,0.6999015023202649,0.8388683886838868,1.0,1.0,6/20,19.56%,LPCAT1;LPCAT2;PNPLA3;LCLAT1;DGAT2;MOGAT1
prerank,tRNA methyltransferase activity (GO:0008175),-0.24248154763735444,-0.6996711085054833,0.9130434782608695,0.9376235202156977,1.0,9/16,35.46%,THUMPD3;TARBP1;TRMT5;LCMT2;TRMT44;TRMT13;TYW3;TRMT12;TRMT9B
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.34974435593673153,0.697544917119685,0.826271186440678,1.0,1.0,5/12,23.10%,TAF1;GTF2B;POU2F1;H3-3A;GTF2A1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3589053154933397,0.6971210485892771,0.8142235123367199,1.0,1.0,4/10,23.08%,ASH1L;SUV39H1;SETD5;SETDB1
prerank,filamin binding (GO:0031005),0.3523720365500085,0.6971078843286662,0.78954802259887,1.0,1.0,4/11,19.86%,MICALL2;RFLNA;FBLIM1;TMEM67
prerank,signal sequence binding (GO:0005048),0.2944616755085944,0.6947372392099079,0.854524627720504,1.0,1.0,9/35,21.01%,KCNIP2;KDELR2;TIMM22;BABAM2;AP2M1;CEMIP;KPNA1;TOMM20;IPO4
prerank,FAD binding (GO:0071949),0.3153376274935629,0.6939986566197764,0.8248175182481752,1.0,1.0,3/24,7.82%,CYB5R1;MICAL1;KMO
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2947121689403947,0.693017179745772,0.8737316798196166,1.0,1.0,5/34,10.60%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2947121689403947,0.693017179745772,0.8737316798196166,1.0,1.0,5/34,10.60%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.33693621150064335,0.6928263794637894,0.8223684210526315,1.0,1.0,3/14,20.72%,KCNIP2;KCNA5;KCNJ2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.33132406016893556,0.6924174201679711,0.8424657534246576,1.0,1.0,4/15,18.42%,CXXC1;RBBP5;SETD1B;WDR82
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2848610857739019,0.6920759341469153,0.8794402583423035,1.0,1.0,10/55,17.27%,PKD2;ATP2C1;ATP2B1;ITPR2;CACNB2;ATP2B3;ATP2A3;TRPV3;CACNA1D;TMEM165
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.22301928562812473,-0.6915672256215315,0.9187817258883249,0.9398572356498677,1.0,7/22,19.27%,CPEB1;RBMS3;ELAVL3;EXOSC8;ZC3H12A;DHX36;EXOSC9
prerank,ligand-gated calcium channel activity (GO:0099604),0.3217773387763032,0.6886336459725555,0.827455919395466,1.0,1.0,2/19,5.57%,RASA3;P2RX4
prerank,carboxy-lyase activity (GO:0016831),0.3117298464101477,0.6879375516450638,0.830367734282325,1.0,1.0,6/23,21.84%,DDC;AMD1;PPCDC;ECHDC1;AZIN2;UROD
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.30138319869712327,0.6874652911705893,0.8390532544378698,1.0,1.0,5/26,18.69%,CHSY3;B3GALNT1;CHSY1;B4GALNT1;CHPF
prerank,ion channel activity (GO:0005216),0.2716106765497817,0.6831134091273031,0.9029622063329928,1.0,1.0,4/80,6.71%,P2RX1;TMC6;PKD2;CNGB1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.31182733046989763,0.6804302063409209,0.8514007308160779,1.0,1.0,1/23,1.63%,SH3PXD2B
prerank,actinin binding (GO:0042805),0.31514551733839263,0.6790231837174197,0.8501228501228502,1.0,1.0,6/21,16.60%,PKD2;TTN;NFKB1;KCNA5;CSRP1;CACNA1D
prerank,neuropeptide receptor binding (GO:0071855),0.3310232777342601,0.6789466353155752,0.8543689320388349,1.0,1.0,1/14,8.28%,PPY
prerank,RNA cap binding (GO:0000339),0.32042887691446187,0.6781083580813838,0.8322056833558863,1.0,1.0,4/16,17.89%,EIF4A1;LARP1;CYFIP1;AGO2
prerank,exopeptidase activity (GO:0008238),0.27765159182355625,0.6779624378129804,0.8693304535637149,1.0,1.0,12/50,20.90%,CTSA;ZMPSTE24;CTSZ;NAALADL1;GGH;ERAP1;METAP2;PRCP;RNPEP;LAP3;DPP4;CNDP2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.26796048408568607,-0.6777351680748177,0.8729096989966555,0.9471763579117295,1.0,4/11,24.32%,NDUFAF7;PRMT8;PRMT1;PRMT7
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.26954613886155543,-0.6766492367856645,0.8407643312101911,0.941895398060904,1.0,2/10,9.75%,FAP;DPP8
prerank,potassium channel regulator activity (GO:0015459),0.2823111396858217,0.6743900319996978,0.8796095444685467,1.0,1.0,11/49,22.71%,KCNIP2;WNK1;ENSA;NEDD4L;WNK4;SGK3;RASA1;AKAP9;FLNA;CHP1;SGK1
prerank,cGMP binding (GO:0030553),0.3428655753687334,0.6733446608097244,0.8437067773167358,1.0,1.0,2/11,10.59%,CNGB1;PDE11A
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.26061090924637753,-0.6729249815899342,0.8733766233766234,0.9391086140347387,1.0,8/12,30.26%,SLC25A42;SLC25A23;SLC25A24;SLC19A1;SLC25A5;SLC35B2;SLC25A17;SLC17A9
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.2006740385664206,-0.6718136860792756,0.9337748344370861,0.933960152407269,1.0,3/28,9.39%,GRIK4;GABRA2;CHRNA7
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.35104006665407167,0.6696871491019887,0.8478581979320532,1.0,1.0,4/10,21.86%,KDM7A;RIOX2;KDM4C;KDM2B
prerank,alpha-actinin binding (GO:0051393),0.3041128769409592,0.6684231654990882,0.8590361445783132,1.0,1.0,7/24,19.52%,PKD2;TTN;LDB3;KCNA5;PDLIM1;CACNA1D;PALLD
prerank,pyrophosphatase activity (GO:0016462),0.2754111636941117,0.6679197363828536,0.8779697624190065,1.0,1.0,6/50,11.49%,DHX9;NUDT4;PPA2;ATCAY;ADPRM;ENTPD1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.3276958104900719,0.6640495996738264,0.8610315186246418,1.0,1.0,2/11,8.63%,MAP3K5;MAP3K1
prerank,motor activity (GO:0003774),0.26692895452238125,0.6625640045752422,0.9159574468085107,1.0,1.0,7/60,10.27%,MYO1E;MYH9;STARD9;KIF14;KIF20B;KIF23;APPBP2
prerank,syntaxin-1 binding (GO:0017075),0.30343865617755555,0.6616390527361756,0.8396572827417381,1.0,1.0,5/22,20.01%,VAMP3;STXBP3;LRRK2;STXBP5;UNC13A
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3170914179022486,0.6557327124647041,0.842456608811749,1.0,1.0,5/14,20.67%,IREB2;ACO1;SDHB;ETFDH;CIAO3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.29596388890163516,0.6530509178732705,0.8811764705882353,1.0,1.0,3/25,7.82%,FMO5;MICAL1;KMO
prerank,phosphatase activator activity (GO:0019211),-0.23442114045165724,-0.6519195678707113,0.926829268292683,0.9445215885975108,1.0,6/14,38.10%,CALM3;GTF2F1;CALM2;FRS2;B3GAT3;PPP1R15A
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.31162043575382137,0.6483310868671951,0.867948717948718,1.0,1.0,5/15,24.26%,NDST1;HS3ST4;NDST2;NDST4;HS3ST3A1
prerank,magnesium ion binding (GO:0000287),0.25350323840998523,0.6435072143201213,0.9687814702920443,1.0,1.0,37/135,25.64%,HPGDS;RAP2A;ERN1;NEK6;SNCA;PI4K2A;RP2;MAP3K5;CERK;ENDOV;PPA2;PDCD6;NLK;PRKACB;STK3;UBA2;LRRK2;NIM1K;TOP2A;STK4;SIK2;TESC;DIS3L2;MARK1;BRSK1;XXYLT1;NUDT3;NUDT12;HMGCL;ADPRH;IDH1;NT5C3A;ABL2;PSPH;MARK2;NUAK2;DXO
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2852709836236481,0.639312119590981,0.8882282996432818,1.0,1.0,2/27,3.62%,RNF180;RNF19B
prerank,histone methyltransferase activity (GO:0042054),0.2751063261120909,0.6369949740813631,0.9010477299185099,1.0,1.0,9/32,23.08%,FBL;DOT1L;SETD2;TTLL12;SMYD3;SUV39H1;EED;NSD3;SETDB1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2733450375702022,0.6365690003781396,0.9049295774647887,1.0,1.0,10/34,23.08%,SETD6;DOT1L;SETD2;TTLL12;ETFBKMT;SMYD3;SUV39H1;EEF1AKMT1;NSD3;SETDB1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.291116192118751,0.6349355256023165,0.8868175765645806,1.0,1.0,1/17,3.98%,NME6
prerank,nucleotidyltransferase activity (GO:0016779),0.2964081682074896,0.6347441983776555,0.9007537688442211,1.0,1.0,4/19,16.57%,TENT4B;PAPSS1;YRDC;TUT7
prerank,neuropeptide hormone activity (GO:0005184),0.2820355397493347,0.6333112905673124,0.9063670411985019,1.0,1.0,2/22,14.06%,PPY;NMB
prerank,iron ion binding (GO:0005506),0.26180010903088063,0.632372466724707,0.9207920792079208,1.0,1.0,9/48,19.67%,SNCA;HAAO;KDM7A;FTL;AGMO;FTH1;FDX1;TET2;FTO
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.20381654867135834,-0.6298323826568215,0.9457013574660633,0.9550669272646639,1.0,12/21,46.91%,KL;FGF9;FGF10;FGF7;FRS2;FGF1;FRS3;FGF18;KLB;FGF22;FGF5;FGF20
prerank,AMP binding (GO:0016208),0.31680476783803013,0.6289029624705263,0.8771186440677966,1.0,1.0,1/11,3.12%,PFKL
prerank,organic anion transmembrane transporter activity (GO:0008514),0.24664363359727798,0.6281814049587157,0.9606854838709677,1.0,1.0,18/134,17.03%,SLC52A1;SLCO2B1;SLC7A8;SLC38A6;SLC36A1;SLC35B3;SLC25A38;SLC36A4;SLC16A1;ABCC1;SLC66A1;SLC25A18;CTNS;SLC35A3;SLCO1B1;SLC1A4;CD36;SLC13A3
prerank,store-operated calcium channel activity (GO:0015279),0.3254254530366257,0.6279635588139619,0.8751814223512336,1.0,1.0,1/10,4.89%,ORAI2
prerank,5'-3' exonuclease activity (GO:0008409),0.3003513165338647,0.6198757226716777,0.8962264150943396,1.0,1.0,6/14,25.64%,EXO1;TRIR;DCLRE1C;DCP2;XRN2;DXO
prerank,cell-cell adhesion mediator activity (GO:0098632),0.26247673475516864,0.6197867787735766,0.9211986681465039,1.0,1.0,9/42,20.03%,SIRPA;EMB;ANXA1;NPTN;PDLIM1;CD47;VSTM2L;PALLD;CNTN4
prerank,snoRNA binding (GO:0030515),0.27443066361059987,0.6181789438342072,0.9216589861751152,1.0,1.0,6/30,15.86%,XRCC5;NUDT4;HEATR1;TSR1;IMP3;NUFIP1
prerank,cation channel activity (GO:0005261),0.24570098025273082,0.6176760342342567,0.9579055441478439,1.0,1.0,6/94,10.48%,P2RX1;AQP1;PKD2;TMEM38A;TMEM63A;CACNB2
prerank,histone acetyltransferase activity (GO:0004402),0.2740771686321213,0.6166810749782132,0.9140534262485482,0.9992068369395368,1.0,6/30,16.66%,SRCAP;TAF1;BAZ1A;NAA40;KAT7;NAA50
prerank,exoribonuclease activity (GO:0004532),0.3056935739775518,0.6148746334931539,0.8937931034482759,0.9985836087794127,1.0,4/12,22.63%,EXOSC1;EXOSC3;CNOT7;EXOSC2
prerank,methyl-CpG binding (GO:0008327),0.27816723367749135,0.6147615316310096,0.9100719424460432,0.9966655571466477,1.0,7/22,24.57%,TET3;MBD1;LRWD1;ERH;CXXC5;MBD2;ZBTB21
prerank,miRNA binding (GO:0035198),0.26965328656163495,0.6134210115268192,0.9064665127020786,0.9957014165091501,1.0,12/30,26.65%,RC3H1;PUM2;AGO4;AGO3;SOX2;TUT7;AGO2;ZC3H7A;ZC3H7B;AGO1;PUM1;ELAVL1
prerank,NAD+ binding (GO:0070403),0.3094503585428947,0.6123455444701933,0.8848920863309353,0.9944907773002296,1.0,1/12,4.51%,HPGD
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3079909868446461,0.5978772525445435,0.8948126801152738,1.0,1.0,5/10,26.38%,NAA50;NAA25;NAA15;NAA80;NAA10
prerank,NAD binding (GO:0051287),0.26896075186649365,0.5976225438550742,0.9119420989143546,1.0,1.0,3/26,9.08%,HPGD;SORD;QDPR
prerank,amino acid:sodium symporter activity (GO:0005283),0.3019906900660767,0.5956221058860177,0.9122562674094707,1.0,1.0,1/11,9.15%,SLC6A15
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.2990469867472413,0.5931621821091195,0.9263456090651558,1.0,1.0,3/12,17.83%,XDH;SDHB;FDX1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.21163394463033808,-0.5919019025753989,0.9713114754098361,0.9707964819673817,1.0,6/15,29.60%,COX5A;NDUFA4;COX15;COX5B;COX8A;COX10
prerank,DNA secondary structure binding (GO:0000217),0.2593854237195876,0.5892361928861428,0.9251700680272109,1.0,1.0,7/31,19.94%,HMGB1;YY1;MEF2C;ERCC5;RAD51B;RAD51D;LIN54
prerank,acyl-CoA hydrolase activity (GO:0047617),0.28058329804985194,0.585047577891274,0.910025706940874,1.0,1.0,6/17,24.73%,ABCD1;ACOT9;ACOT2;ACOT8;PLA2G6;ACOT7
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.20325254301142787,-0.5843958292443668,0.9545454545454546,0.9680176118713845,1.0,15/15,79.70%,PLA2G12A;PLA2G4C;PLA2G4F;PLA2G4B;PLA2G4A;PLA2G3;PLA2G2C;PLA2G2D;PLA2G10;PLA2G1B;PLA2G2E;PLA2G2F;PLA2G4D;PLA2G4E;PLA2G5
prerank,poly(A) binding (GO:0008143),0.26174074349384,0.5780027934915808,0.9293820933165196,1.0,1.0,4/21,18.81%,PPIE;DDX1;PABPC4;RBMS2
prerank,lysine N-methyltransferase activity (GO:0016278),0.2614867770571184,0.5752234144915611,0.928391959798995,1.0,1.0,3/20,13.86%,SETD6;SETD2;ETFBKMT
prerank,ATPase activator activity (GO:0001671),0.26721652071231783,0.5742736561170467,0.9320512820512821,1.0,1.0,6/20,21.63%,AHSA1;ATP1B3;TOR1AIP2;ATP1B2;DNAJB6;DNAJC15
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2486668111426199,0.5729678838638168,0.9362186788154897,1.0,1.0,2/33,3.62%,RNF180;RNF19B
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.24629710821025189,0.5726339909378463,0.9392575928008999,0.9995579541986073,1.0,10/35,24.82%,GATB;ELAC2;ELAC1;BCDIN3D;TARS2;DUS1L;FTO;NT5C3A;DUS3L;GATC
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2487626876295834,0.5711473746521383,0.9504608294930875,0.9985792392225747,1.0,11/33,24.74%,CNOT8;ANGEL2;EXOSC3;DIS3L2;REXO2;TOE1;PNLDC1;CNOT7;EXOSC2;DCP2;XRN2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.24743955749292568,0.5703071273396209,0.9404352806414662,0.9971834544107917,1.0,12/34,24.74%,CNOT8;ANGEL2;EXOSC3;DIS3L2;REXO2;TOE1;PNLDC1;CNOT7;CNOT1;EXOSC2;CNOT2;XRN2
prerank,damaged DNA binding (GO:0003684),-0.14741355774653497,-0.5667042714027011,1.0,0.9696122611273104,1.0,20/44,36.18%,DDB2;DDB1;TDG;XRCC1;XPA;SMC6;SDE2;DCLRE1A;RAD18;POLQ;DCLRE1B;RPA3;FANCG;NEIL3;RPA2;CUL4B;PCNA;NTHL1;POLD1;MPG
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.22902026151101804,0.5620975995405555,0.979765708200213,0.9999216203970437,1.0,7/57,11.91%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6;CYB5A;CYB561D2
prerank,nucleosomal DNA binding (GO:0031492),0.25509725993840604,0.5605536783128716,0.9424280350438048,0.9988069552500749,1.0,9/21,28.19%,ACTB;SMARCB1;CHD4;RBBP4;H3-3A;MBD2;SMARCC1;MTA2;HDAC1
prerank,NF-kappaB binding (GO:0051059),0.24793444126889502,0.5557497812013565,0.9446450060168472,0.9994759990185229,1.0,5/24,20.45%,SETD6;ANXA4;MTDH;FAF1;GSK3B
prerank,four-way junction DNA binding (GO:0000400),0.2621384935117558,0.5529676751853467,0.9343629343629344,0.9990151855486851,1.0,4/17,19.47%,HMGB1;YY1;RAD51B;RAD51D
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2738981218453257,0.5512752385115252,0.9493487698986975,0.9979309379017898,1.0,3/12,17.89%,LARP1;CYFIP1;AGO2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.27938178136004377,0.5506286598278293,0.9182763744427934,0.9963539065626817,1.0,1/11,5.64%,SLC35B3
prerank,TBP-class protein binding (GO:0017025),0.24810452906523778,0.5478348660428368,0.9588014981273408,0.9957750746194197,1.0,7/21,24.79%,TAF1;GTF2B;TAF11;HHEX;YEATS2;GTF2A1;THRA
prerank,methyltransferase activity (GO:0008168),0.2278952620148108,0.5419993751871146,0.9758241758241758,0.9967643938578205,1.0,11/46,21.50%,METTL4;PRMT3;MGMT;METTL3;COMT;BCDIN3D;SUV39H1;AS3MT;NSUN4;COQ3;EEF1AKMT1
prerank,cyclic nucleotide binding (GO:0030551),0.24758039291301961,0.5418919709362932,0.946078431372549,0.9948968085794365,1.0,3/21,11.39%,CNGB1;PDE11A;PDE4A
prerank,pyridoxal phosphate binding (GO:0030170),0.2480852159618715,0.5397840051610173,0.947109471094711,0.9939734469794892,1.0,6/20,20.09%,THNSL2;OAT;CBS;ACCS;PSAT1;PYGL
prerank,microtubule plus-end binding (GO:0051010),0.2479002759797719,0.5384849017739699,0.9558080808080808,0.992709093479804,1.0,6/20,22.70%,MAPRE1;CLIP2;DST;MAPRE2;FBXW11;CLASP1
prerank,U6 snRNA binding (GO:0017070),0.26131326335331595,0.5369766693528953,0.9410958904109589,0.9915842466756927,1.0,3/14,16.31%,DDX39B;PRPF8;LSM8
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.23958041536834912,0.5305270990392775,0.9687123947051745,0.9927664292756755,1.0,9/24,28.81%,OSBP;OSBPL8;ARFIP2;PLEKHA5;GOLPH3;PLA2G4E;CERT1;SESTD1;OSBPL5
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.24577405697702015,0.5299460862877596,0.9547218628719275,0.9911364587992971,1.0,5/19,25.35%,GABRA5;GABRA4;GABRG1;GRIK3;GABRG2
prerank,calcium channel activity (GO:0005262),0.21045113426260104,0.528867322229186,0.9886714727085479,0.9897605645919562,1.0,9/84,13.91%,PKD2;ORAI2;P2RX4;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;TRPV3
prerank,poly-purine tract binding (GO:0070717),0.2283138790890341,0.5213593253190523,0.9702734839476813,0.9910152953783005,1.0,5/27,18.81%,PPIE;MCRS1;DDX1;PABPC4;RBMS2
prerank,ubiquitin-specific protease binding (GO:1990381),0.2405961595476796,0.5213326573125483,0.9558638083228247,0.9891420646534511,1.0,8/19,28.38%,DERL1;CLTC;PTEN;PRKN;AMFR;SART3;VCP;SUMO1
prerank,snRNA binding (GO:0017069),0.21412422977162734,0.5108904268237157,0.9845814977973568,0.9913717236659636,1.0,10/42,21.18%,LSM11;DDX39B;PRPF8;RBM41;LSM8;SNRPB2;SNRNP35;SF3B3;HEXIM1;TOE1
prerank,protein phosphatase activator activity (GO:0072542),0.24884836261311638,0.5106248879442644,0.9647218453188603,0.9896108508610391,1.0,7/13,31.96%,PTPA;PPP2R5C;PPP2R5B;IGFBP3;PHACTR4;CALM1;PPP2R5A
prerank,ion gated channel activity (GO:0022839),0.213594450118281,0.4793007156392637,0.9842424242424243,0.9977320427710449,1.0,3/24,13.35%,TMEM63A;KCNT1;TTYH2
prerank,gap junction channel activity (GO:0005243),0.2133320412999205,0.47475276869432875,0.9786700125470514,0.9970621882681662,1.0,1/22,7.41%,GJB6
prerank,wide pore channel activity (GO:0022829),0.20951792809960237,0.46769044703562174,0.982521847690387,0.9970357412763381,1.0,1/23,7.41%,GJB6
prerank,SUMO transferase activity (GO:0019789),0.2092856354153128,0.44190123468504033,0.9921465968586387,1.0,1.0,5/16,26.02%,HDAC4;PIAS1;NSMCE2;UBE2I;CBX4
prerank,active ion transmembrane transporter activity (GO:0022853),0.18608339564741824,0.43591078884722617,0.992196209587514,0.9995459196561683,1.0,6/37,21.38%,SLCO2B1;CYB5A;SLCO1B1;COX6B1;COX4I1;SLC16A7
prerank,sulfotransferase activity (GO:0008146),0.18813904321971925,0.4339586693900166,0.996551724137931,0.9979865725602269,1.0,3/33,12.83%,SULT4A1;TPST1;CHST15
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.2182440332048704,0.4310098463199638,0.986130374479889,0.9965925284578353,1.0,1/11,6.79%,NUDT4
prerank,transaminase activity (GO:0008483),0.21515598839330258,0.43047938918493134,0.9816901408450704,0.9947916360609824,1.0,3/11,23.46%,OAT;PSAT1;BCAT1
prerank,lipid phosphatase activity (GO:0042577),0.19109528238322426,0.3979871193369611,0.9986282578875172,0.9965296226538325,1.0,3/14,22.36%,PLPPR1;INPP5K;PLPP7
